data_1go0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1go0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.7 t80 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.987 0.422 . . . . 1.6299999999999999 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 1.29 111.757 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 2.0299999999999998 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.0899999999999999 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.45 ' HA ' HD11 ' A' ' 7' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 2.1600000000000001 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 4.3499999999999996 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 3.4100000000000001 110.173 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 1.1399999999999999 110.835 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 3.0600000000000001 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.4299999999999999 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 2.4100000000000001 111.136 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.92000000000000004 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.98 109.716 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 85' ' ' VAL . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 1.6599999999999999 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.5700000000000001 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.5499999999999998 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 1.5 110.327 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 5.4500000000000002 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 2.5299999999999998 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.6200000000000001 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 1.3200000000000001 110.543 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.25 111.358 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.21 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.5699999999999998 112.401 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.6600000000000001 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.8899999999999999 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.6699999999999999 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 1.22 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 2.52 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.72 110.51 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 1.0800000000000001 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 1.1499999999999999 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 1.1399999999999999 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 1.1499999999999999 110.834 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.7000000000000002 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.9900000000000002 111.477 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 1.1499999999999999 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 4.6699999999999999 110.748 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.85999999999999999 112.63 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 49' ' ' ILE . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 1.3 110.591 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 2.0699999999999998 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6000000000000001 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 45' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 1.03 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.6699999999999999 111.337 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.3799999999999999 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.52 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.5700000000000001 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 1.0600000000000001 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.79 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.98 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.6399999999999999 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.83999999999999997 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 1.1299999999999999 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46000000000000002 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 110.457 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 1.1299999999999999 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.4700000000000002 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.91000000000000003 110.273 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.81999999999999995 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 2.0899999999999999 110.874 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.6200000000000001 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 1.52 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.6499999999999999 110.328 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.506 ' O ' HD11 ' A' ' 74' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 1.21 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.658 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.83999999999999997 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.8100000000000001 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' HD11 ' A' ' 73' ' ' LEU . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 2.0699999999999998 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 2.4399999999999999 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.2200000000000002 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.8600000000000003 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.9099999999999999 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.8999999999999999 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.75 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 ' HA3' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.6200000000000001 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 1.1100000000000001 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 1.6100000000000001 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 1.01 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 16' ' ' ILE . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.6599999999999999 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 1.27 109.936 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.1499999999999999 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.6799999999999999 112.322 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.0299999999999998 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 2.0699999999999998 111.638 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 5.1900000000000004 109.497 173.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 96' ' ' LEU . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 1.4299999999999999 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 2.1600000000000001 112.222 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 1.4399999999999999 110.335 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 93' ' ' ILE . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 2.1699999999999999 110.901 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HE1' HD12 ' A' ' 36' ' ' ILE . 58.1 t80 . . . . . 0 C--O 1.222 -0.344 0 N-CA-C 111.972 0.36 . . . . 1.6299999999999999 111.972 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 1.29 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 2.0299999999999998 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.0899999999999999 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 2.1600000000000001 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 4.3499999999999996 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 3.4100000000000001 110.766 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 1.1399999999999999 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 3.0600000000000001 111.619 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.4299999999999999 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 2.4100000000000001 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.92000000000000004 112.286 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.98 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.574 HD13 ' HB1' ' A' ' 10' ' ' ALA . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 1.6599999999999999 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.5700000000000001 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.5499999999999998 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 1.5 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 5.4500000000000002 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 2.5299999999999998 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.6200000000000001 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 1.3200000000000001 110.283 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.25 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 1.21 111.295 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 1.1100000000000001 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.5699999999999998 110.638 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.6600000000000001 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.8899999999999999 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.6699999999999999 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 1.22 109.732 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 2.52 111.685 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.912 HD23 ' HA2' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.72 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 1.0800000000000001 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 1.1399999999999999 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 1.1499999999999999 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.7000000000000002 110.849 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.9900000000000002 111.374 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 1.1499999999999999 109.472 173.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 4.6699999999999999 110.446 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.85999999999999999 112.72 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 1.3 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 2.0699999999999998 110.91 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6000000000000001 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 45' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 1.03 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.6699999999999999 111.408 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.3799999999999999 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.5700000000000001 112.084 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 1.0600000000000001 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.79 110.598 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.98 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.6399999999999999 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 1.1299999999999999 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46000000000000002 112.012 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 1.0600000000000001 110.578 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 1.1299999999999999 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.4700000000000002 109.999 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.91000000000000003 110.425 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.81999999999999995 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 2.0899999999999999 110.661 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.592 ' HG ' ' HA ' ' A' ' 81' ' ' SER . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 111.103 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 1.52 110.545 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.6499999999999999 111.02 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 1.21 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.83999999999999997 112.28 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.8100000000000001 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 2.0699999999999998 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 2.4399999999999999 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.2200000000000002 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.8600000000000003 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.9099999999999999 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.8999999999999999 110.243 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.75 110.912 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.9299999999999999 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.592 ' HA ' ' HG ' ' A' ' 67' ' ' SER . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.6200000000000001 110.526 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 1.1100000000000001 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 1.6100000000000001 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 1.01 111.014 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.6599999999999999 109.717 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 1.27 111.357 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.1499999999999999 111.719 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.6799999999999999 112.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.0299999999999998 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 2.0699999999999998 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 5.1900000000000004 110.795 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 94' ' ' LEU . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 1.4299999999999999 111.069 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 2.1600000000000001 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 2.1699999999999999 110.593 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.912 ' HA2' HD23 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.7 t80 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.815 0.341 . . . . 1.6299999999999999 110.717 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 1.29 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 2.0299999999999998 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.0899999999999999 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.443 ' HA ' HD21 ' A' ' 7' ' ' LEU . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 2.1600000000000001 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 4.3499999999999996 110.553 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 3.4100000000000001 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 1.1399999999999999 111.254 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 3.0600000000000001 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.4299999999999999 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 2.4100000000000001 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.92000000000000004 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.98 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 1.6599999999999999 110.441 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.5700000000000001 109.855 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.5499999999999998 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 45' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 1.5 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 5.4500000000000002 109.728 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 2.5299999999999998 110.706 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.6200000000000001 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 1.3200000000000001 110.723 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.25 110.327 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 1.21 111.618 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 1.1100000000000001 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.5699999999999998 111.102 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.6600000000000001 111.944 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.8899999999999999 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.6699999999999999 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 1.22 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 2.52 111.171 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' C ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.72 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 1.0800000000000001 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.555 ' HB ' HD22 ' A' ' 83' ' ' LEU . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 1.1499999999999999 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 82' ' ' ALA . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 1.1399999999999999 110.957 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 1.1499999999999999 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.7000000000000002 110.874 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.9900000000000002 111.54 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 1.1499999999999999 109.614 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 4.6699999999999999 110.932 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.85999999999999999 112.642 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 1.3 111.23 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 2.0699999999999998 111.176 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6000000000000001 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 1.03 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.6699999999999999 111.047 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.3799999999999999 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.5700000000000001 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 1.0600000000000001 110.796 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.79 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.98 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.6399999999999999 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.83999999999999997 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 1.1299999999999999 110.364 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46000000000000002 112.117 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 1.0600000000000001 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 1.1299999999999999 110.165 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.4700000000000002 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.91000000000000003 110.698 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.81999999999999995 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 2.0899999999999999 111.493 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.6200000000000001 111.467 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 1.52 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.6499999999999999 110.46 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 1.21 110.437 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.898 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.83999999999999997 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 73' ' ' LEU . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.8100000000000001 110.384 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.5 ' N ' HG21 ' A' ' 72' ' ' THR . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 2.0699999999999998 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 2.4399999999999999 111.351 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.2200000000000002 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.8600000000000003 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.9099999999999999 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.473 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.8999999999999999 112.062 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.75 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.898 HG22 ' HA3' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.9299999999999999 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.6200000000000001 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB3' HG11 ' A' ' 37' ' ' VAL . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.554 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 1.6100000000000001 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 109.915 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.1499999999999999 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.6799999999999999 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.0299999999999998 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 5.1900000000000004 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 1.4299999999999999 110.251 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 111.432 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 1.4399999999999999 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 2.1699999999999999 110.265 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HD2' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.852 0.686 . . . . 1.6299999999999999 112.852 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 1.29 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 2.0299999999999998 110.046 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.0899999999999999 111.47 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 2.1600000000000001 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 4.3499999999999996 110.979 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 3.4100000000000001 110.628 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 1.1399999999999999 111.212 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 3.0600000000000001 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 2.4100000000000001 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.92000000000000004 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.98 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 1.6599999999999999 109.529 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.5700000000000001 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.5499999999999998 110.565 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 1.5 111.293 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 5.4500000000000002 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 2.5299999999999998 111.629 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.6200000000000001 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 1.3200000000000001 111.127 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.25 110.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 1.21 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 1.1100000000000001 110.604 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.5699999999999998 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.6600000000000001 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.884 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.8899999999999999 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.6699999999999999 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 1.22 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 2.52 111.15 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.72 110.527 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 1.0800000000000001 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 1.1499999999999999 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 1.1399999999999999 110.25 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 1.1499999999999999 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.7000000000000002 110.829 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.9900000000000002 111.15 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 1.1499999999999999 111.271 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 4.6699999999999999 111.404 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.85999999999999999 112.685 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 1.3 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 2.0699999999999998 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6000000000000001 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 1.03 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.6699999999999999 111.39 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.3799999999999999 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 1.0600000000000001 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.79 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.98 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.6399999999999999 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.83999999999999997 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.884 HD13 ' HA3' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 1.1299999999999999 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46000000000000002 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 1.0600000000000001 110.043 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 1.1299999999999999 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.4700000000000002 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 110.202 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.81999999999999995 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 2.0899999999999999 110.425 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 80' ' ' VAL . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.6200000000000001 110.788 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 1.52 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.6499999999999999 111.141 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 70' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 1.21 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.727 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.83999999999999997 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.8100000000000001 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 2.0699999999999998 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 2.4399999999999999 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.2200000000000002 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.8600000000000003 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.9099999999999999 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.8999999999999999 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.75 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.727 HG22 ' HA3' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.9299999999999999 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.6200000000000001 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 1.1100000000000001 110.645 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 1.6100000000000001 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 1.01 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.6599999999999999 109.548 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.1499999999999999 110.028 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.6799999999999999 112.153 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.0299999999999998 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 2.0699999999999998 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 5.1900000000000004 110.036 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 1.4299999999999999 110.573 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 2.1600000000000001 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 92' ' ' ARG . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 1.4399999999999999 110.772 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 HD23 ' HD2' ' A' ' 3' ' ' PHE . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 2.1699999999999999 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' ' HE1' ' A' ' 63' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.704 0.288 . . . . 1.6299999999999999 110.949 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 1.29 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 2.0299999999999998 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.0899999999999999 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.441 ' HA ' HD11 ' A' ' 7' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 2.1600000000000001 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 4.3499999999999996 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 3.4100000000000001 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 1.1399999999999999 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 3.0600000000000001 110.54 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.4299999999999999 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 2.4100000000000001 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.92000000000000004 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.98 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 16' ' ' ILE . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 1.6599999999999999 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.5499999999999998 110.822 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 1.5 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 5.4500000000000002 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 2.5299999999999998 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.6200000000000001 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 1.3200000000000001 110.266 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.25 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.515 ' CZ ' HG22 ' A' ' 17' ' ' VAL . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 1.21 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 1.1100000000000001 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.5699999999999998 111.379 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.6600000000000001 111.507 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.8899999999999999 112.156 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.6699999999999999 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 1.22 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 2.52 110.621 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.72 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 1.0800000000000001 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 1.1499999999999999 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 1.1399999999999999 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.558 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 1.1499999999999999 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.7000000000000002 111.457 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.9900000000000002 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 1.1499999999999999 110.853 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 4.6699999999999999 111.086 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.85999999999999999 112.527 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 1.3 110.618 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 2.0699999999999998 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6000000000000001 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 49' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 1.03 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.6699999999999999 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.3799999999999999 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 48' ' ' ASP . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.5700000000000001 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 1.0600000000000001 110.806 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.79 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.98 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.6399999999999999 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.83999999999999997 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 1.1299999999999999 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.462 ' O ' HD13 ' A' ' 34' ' ' LEU . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46000000000000002 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 1.1299999999999999 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.4700000000000002 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' HE1' ' CE1' ' A' ' 3' ' ' PHE . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.91000000000000003 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 2.0899999999999999 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.6200000000000001 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 1.52 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.6499999999999999 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.21 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.83999999999999997 112.138 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.8100000000000001 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 2.0699999999999998 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 2.4399999999999999 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.2200000000000002 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.8600000000000003 109.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.9099999999999999 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.8999999999999999 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.75 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.711 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.6200000000000001 110.715 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.1100000000000001 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 1.6100000000000001 110.929 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 1.01 110.706 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 109.608 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 1.27 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.1499999999999999 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.6799999999999999 112.833 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.0299999999999998 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 2.0699999999999998 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 5.1900000000000004 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 1.4299999999999999 110.786 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 1.4399999999999999 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.487 ' H ' HD21 ' A' ' 96' ' ' LEU . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 2.1699999999999999 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 1.6299999999999999 112.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 1.29 111.423 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 2.0299999999999998 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.0899999999999999 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 2.1600000000000001 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 4.3499999999999996 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 3.4100000000000001 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 16' ' ' ILE . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 1.1399999999999999 110.519 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 3.0600000000000001 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.4299999999999999 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 2.4100000000000001 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.92000000000000004 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.98 110.419 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 10' ' ' ALA . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 1.6599999999999999 110.476 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.5700000000000001 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.5499999999999998 108.87 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 1.5 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 5.4500000000000002 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 2.5299999999999998 110.886 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.6200000000000001 110.92 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 1.3200000000000001 110.144 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.21 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 1.1100000000000001 110.7 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.5699999999999998 110.636 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.6600000000000001 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.8899999999999999 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.6699999999999999 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 1.22 111.444 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 2.52 110.513 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.72 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 1.0800000000000001 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.67 ' HB ' HD22 ' A' ' 83' ' ' LEU . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 1.1499999999999999 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 1.1399999999999999 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 1.1499999999999999 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.7000000000000002 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.9900000000000002 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 1.1499999999999999 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 4.6699999999999999 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.85999999999999999 112.403 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 45' ' ' ILE . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.786 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 2.0699999999999998 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6000000000000001 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 1.03 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.6699999999999999 111.094 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.3799999999999999 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.5700000000000001 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 1.0600000000000001 111.542 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.79 112.092 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.98 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.6399999999999999 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.83999999999999997 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 1.1299999999999999 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.448 ' O ' HD11 ' A' ' 34' ' ' LEU . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46000000000000002 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 1.0600000000000001 109.744 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 1.1299999999999999 110.699 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.4700000000000002 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.91000000000000003 109.887 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.81999999999999995 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 2.0899999999999999 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.6200000000000001 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 1.52 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 72' ' ' THR . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.6499999999999999 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 1.21 110.403 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.83999999999999997 112.825 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 73' ' ' LEU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.8100000000000001 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 2.0699999999999998 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 HD11 ' A' ' 83' ' ' LEU . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 2.4399999999999999 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.2200000000000002 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.8600000000000003 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.9099999999999999 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.8999999999999999 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.75 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.702 HG22 ' HA3' ' A' ' 71' ' ' GLY . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.9299999999999999 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.6200000000000001 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 1.1100000000000001 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.67 HD22 ' HB ' ' A' ' 36' ' ' ILE . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 1.6100000000000001 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 1.01 111.046 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.6599999999999999 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 1.27 109.984 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.1499999999999999 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.6799999999999999 112.169 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.0299999999999998 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 2.0699999999999998 111.917 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 5.1900000000000004 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 1.4299999999999999 111.125 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 2.1600000000000001 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 1.4399999999999999 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 96' ' ' LEU . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 2.1699999999999999 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.631 0.234 . . . . 1.6299999999999999 111.631 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 1.29 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 2.0299999999999998 109.944 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.0899999999999999 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 2.1600000000000001 110.974 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 4.3499999999999996 110.531 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 3.4100000000000001 110.277 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 1.1399999999999999 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 3.0600000000000001 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.4299999999999999 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.494 HG22 ' HA2' ' A' ' 89' ' ' GLY . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 2.4100000000000001 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.92000000000000004 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.98 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.6599999999999999 110.506 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.5700000000000001 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.5499999999999998 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 1.5 110.608 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 5.4500000000000002 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 2.5299999999999998 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.6200000000000001 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 1.3200000000000001 110.537 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.25 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 1.21 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 1.1100000000000001 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.5699999999999998 110.729 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.6600000000000001 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.8899999999999999 111.54 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.6699999999999999 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 1.22 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 2.52 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.72 109.648 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 1.0800000000000001 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 1.1499999999999999 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.191 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 1.1499999999999999 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.7000000000000002 110.362 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 1.1499999999999999 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 4.6699999999999999 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.85999999999999999 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 1.3 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 2.0699999999999998 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6000000000000001 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.442 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 1.03 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.6699999999999999 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.3799999999999999 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.5700000000000001 110.926 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 49' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 1.0600000000000001 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.79 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.98 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.6399999999999999 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.83999999999999997 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 1.1299999999999999 109.917 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46000000000000002 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 1.0600000000000001 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 1.1299999999999999 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.4700000000000002 109.883 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HE1' ' HE1' ' A' ' 3' ' ' PHE . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.91000000000000003 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.81999999999999995 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 2.0899999999999999 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.6200000000000001 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HG23 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 1.52 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.6499999999999999 110.605 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 63' ' ' PHE . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 1.21 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.83999999999999997 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.8100000000000001 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 2.0699999999999998 110.28 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.966 HD12 HD23 ' A' ' 83' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 2.4399999999999999 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.2200000000000002 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.8600000000000003 109.956 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.9099999999999999 112.888 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.504 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.8999999999999999 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.457 HG23 HG21 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.75 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.491 HG13 ' HA3' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.9299999999999999 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.6200000000000001 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 1.1100000000000001 110.731 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.966 HD23 HD12 ' A' ' 74' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 1.6100000000000001 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.01 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.6599999999999999 109.971 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 1.27 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.1499999999999999 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.33 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.494 ' HA2' HG22 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.0299999999999998 110.852 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 2.0699999999999998 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HA ' ' NE ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 5.1900000000000004 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 94' ' ' LEU . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 1.4299999999999999 111.198 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 93' ' ' ILE . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 2.1600000000000001 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 1.4399999999999999 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.471 HD13 HD13 ' A' ' 93' ' ' ILE . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 2.1699999999999999 111.847 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.479 ' O ' ' HD1' ' A' ' 3' ' ' PHE . 1.6 p90 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.1 1.148 . . . . 1.6299999999999999 114.1 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 1.29 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 2.0299999999999998 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.0899999999999999 111.775 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 2.1600000000000001 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 4.3499999999999996 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 3.4100000000000001 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 1.1399999999999999 110.669 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 3.0600000000000001 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.4299999999999999 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 2.4100000000000001 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.92000000000000004 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.98 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 1.6599999999999999 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.5700000000000001 110.056 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.5499999999999998 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 1.5 110.332 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 5.4500000000000002 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 2.5299999999999998 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.6200000000000001 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 1.3200000000000001 110.079 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.25 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 1.21 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 1.1100000000000001 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.5699999999999998 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.6600000000000001 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.815 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.8899999999999999 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.6699999999999999 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 1.22 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 2.52 110.881 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.72 110.351 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 35' ' ' ILE . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 1.0800000000000001 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 1.1499999999999999 110.205 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 82' ' ' ALA . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 1.1399999999999999 110.983 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 1.1499999999999999 110.353 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.7000000000000002 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.9900000000000002 110.558 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 1.1499999999999999 109.552 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 4.6699999999999999 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.85999999999999999 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 HG21 HD13 ' A' ' 49' ' ' ILE . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.3 111.308 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 2.0699999999999998 112.293 -174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6000000000000001 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 45' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 1.03 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.6699999999999999 111.399 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.3799999999999999 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.5700000000000001 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 1.0600000000000001 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.79 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.98 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.6399999999999999 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.83999999999999997 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.815 HD13 ' HA3' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 1.1299999999999999 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46000000000000002 111.538 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 1.0600000000000001 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 1.1299999999999999 110.474 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.4700000000000002 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.91000000000000003 110.66 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.81999999999999995 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 2.0899999999999999 110.439 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.6200000000000001 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 1.52 110.201 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.6499999999999999 110.822 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.525 HD12 HD22 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 1.21 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.83999999999999997 112.257 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.8100000000000001 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 73' ' ' LEU . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 2.0699999999999998 110.675 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 2.4399999999999999 110.892 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.2200000000000002 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.8600000000000003 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.9099999999999999 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.8999999999999999 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.75 111.521 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.464 HG13 ' HA3' ' A' ' 71' ' ' GLY . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.9299999999999999 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.6200000000000001 111.609 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 37' ' ' VAL . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 1.1100000000000001 111.488 -174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.525 HD22 HD12 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 1.6100000000000001 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 1.01 110.773 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.6599999999999999 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 1.27 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.1499999999999999 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.6799999999999999 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.0299999999999998 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 2.0699999999999998 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 5.1900000000000004 110.345 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.498 HG21 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 1.4299999999999999 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' HG21 ' A' ' 93' ' ' ILE . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 2.1600000000000001 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 1.4399999999999999 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.787 ' H ' HD21 ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 2.1699999999999999 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.539 ' HE1' HD12 ' A' ' 36' ' ' ILE . 81.4 t80 . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.938 0.399 . . . . 1.6299999999999999 110.092 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 1.29 112.093 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 2.0299999999999998 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.0899999999999999 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.517 HD21 HD22 ' A' ' 73' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 4.3499999999999996 110.707 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 3.4100000000000001 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 1.1399999999999999 111.567 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.525 ' NE2' ' HB ' ' A' ' 16' ' ' ILE . 68.6 mm-40 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 3.0600000000000001 111.235 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.4299999999999999 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 2.4100000000000001 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.92000000000000004 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.98 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.525 ' HB ' ' NE2' ' A' ' 11' ' ' GLN . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 1.6599999999999999 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.5700000000000001 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.5499999999999998 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 1.5 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 5.4500000000000002 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 2.5299999999999998 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.6200000000000001 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.502 HG22 ' OD2' ' A' ' 48' ' ' ASP . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 1.3200000000000001 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.25 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.677 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 1.21 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 1.1100000000000001 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.5699999999999998 111.59 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.6600000000000001 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.6699999999999999 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 1.22 110.299 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 2.52 110.228 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.667 ' H ' HG11 ' A' ' 85' ' ' VAL . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.72 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 1.0800000000000001 109.957 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.743 ' HB ' HD22 ' A' ' 83' ' ' LEU . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 1.1499999999999999 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HZ2' ' A' ' 46' ' ' LYS . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 1.1399999999999999 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 1.1499999999999999 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.7000000000000002 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.9900000000000002 111.103 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 1.1499999999999999 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 4.6699999999999999 110.853 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.85999999999999999 111.523 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.537 HG21 HD13 ' A' ' 49' ' ' ILE . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 1.3 110.304 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HZ2' HG22 ' A' ' 37' ' ' VAL . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 2.0699999999999998 112.018 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6000000000000001 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' OD2' HG22 ' A' ' 24' ' ' ILE . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 45' ' ' ILE . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 1.03 111.611 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.6699999999999999 111.732 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.3799999999999999 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.5700000000000001 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 49' ' ' ILE . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 1.0600000000000001 111.066 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.79 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.98 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.6399999999999999 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.83999999999999997 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 27' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 1.1299999999999999 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46000000000000002 112.043 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.0600000000000001 110.802 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 110.639 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.4700000000000002 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.91000000000000003 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.81999999999999995 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 2.0899999999999999 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.6200000000000001 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.52 110.809 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.6499999999999999 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 1.21 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.83999999999999997 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.8100000000000001 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 HD21 ' A' ' 7' ' ' LEU . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 2.0699999999999998 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.634 HD11 HG22 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 2.4399999999999999 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.2200000000000002 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 78' ' ' HIS . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.8600000000000003 110.088 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.9099999999999999 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 76' ' ' ARG . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.8999999999999999 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.75 110.849 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.9299999999999999 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.6200000000000001 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 36' ' ' ILE . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 1.6100000000000001 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 1.01 111.218 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' H ' ' A' ' 34' ' ' LEU . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.6599999999999999 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 1.27 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.475 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.1499999999999999 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.6799999999999999 112.208 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.0299999999999998 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 2.0699999999999998 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 5.1900000000000004 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 96' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 1.4299999999999999 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 2.1600000000000001 111.86 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 1.4399999999999999 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 93' ' ' ILE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.233 0.54 . . . . 1.6299999999999999 110.098 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 1.29 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 2.0299999999999998 110.123 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.0899999999999999 111.164 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.41 ' HA ' HD21 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 2.1600000000000001 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 4.3499999999999996 110.723 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 3.4100000000000001 110.528 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 16' ' ' ILE . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 1.1399999999999999 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 3.0600000000000001 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.4299999999999999 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' HA2' ' A' ' 89' ' ' GLY . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 2.4100000000000001 111.81 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.92000000000000004 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.98 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 10' ' ' ALA . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.5700000000000001 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.5499999999999998 111.3 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 1.5 110.51 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 5.4500000000000002 110.659 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 2.5299999999999998 110.057 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.6200000000000001 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 45' ' ' ILE . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 1.3200000000000001 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.25 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 1.21 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.1100000000000001 110.752 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 111.416 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.6600000000000001 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.8899999999999999 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.6699999999999999 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 1.22 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 2.52 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.693 HD12 ' HA2' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 36' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 1.0800000000000001 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.409 ' N ' HG21 ' A' ' 35' ' ' ILE . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 1.1499999999999999 110.0 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 1.1399999999999999 110.603 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 1.1499999999999999 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.7000000000000002 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.452 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.9900000000000002 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 1.1499999999999999 111.858 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 4.6699999999999999 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.85999999999999999 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.541 HG21 HD13 ' A' ' 49' ' ' ILE . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 1.3 110.906 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 2.0699999999999998 112.125 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6000000000000001 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 45' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 1.03 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.6699999999999999 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.3799999999999999 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.5700000000000001 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.79 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.98 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.6399999999999999 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.83999999999999997 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 1.1299999999999999 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' O ' HD13 ' A' ' 34' ' ' LEU . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46000000000000002 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' HB ' ' OE2' ' A' ' 50' ' ' GLU . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 1.0600000000000001 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 1.1299999999999999 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.4700000000000002 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.91000000000000003 109.376 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.81999999999999995 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 40' ' ' ASN . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 2.0899999999999999 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.6200000000000001 111.42 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 1.52 110.156 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.6499999999999999 110.689 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 83' ' ' LEU . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 1.21 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.83999999999999997 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.8100000000000001 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 2.0699999999999998 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 2.4399999999999999 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.2200000000000002 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 78' ' ' HIS . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.8600000000000003 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.9099999999999999 111.632 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 76' ' ' ARG . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.8999999999999999 108.874 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.75 111.422 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.9299999999999999 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.6200000000000001 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 1.1100000000000001 110.781 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 1.6100000000000001 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 1.01 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.6599999999999999 109.556 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 1.27 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.1499999999999999 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.6799999999999999 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 13' ' ' THR . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.0299999999999998 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 2.0699999999999998 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 5.1900000000000004 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 1.4299999999999999 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 94' ' ' LEU . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 2.1600000000000001 111.718 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 1.4399999999999999 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 2.1699999999999999 110.211 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.693 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.971 0 N-CA-C 112.715 -0.154 . . . . 7.8300000000000001 112.715 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.564 ' O ' HG11 ' A' ' 1' ' ' VAL . 48.4 m -148.75 61.13 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.789 -0.449 . . . . 6.8799999999999999 109.789 177.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.564 HG11 ' O ' ' A' ' -1' ' ' SER . 7.1 p 46.41 49.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 122.542 1.163 . . . . 4.0800000000000001 110.801 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.31 120.56 11.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.482 -1.235 . . . . 2.6600000000000001 111.069 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -60.44 -48.94 79.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.51 -0.768 . . . . 1.6299999999999999 110.836 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 1.29 111.757 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 2.0299999999999998 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.0899999999999999 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.45 ' HA ' HD11 ' A' ' 7' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 2.1600000000000001 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 4.3499999999999996 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 3.4100000000000001 110.173 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 1.1399999999999999 110.835 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 3.0600000000000001 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.4299999999999999 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 2.4100000000000001 111.136 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.92000000000000004 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.98 109.716 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.627 HD11 ' HA ' ' A' ' 85' ' ' VAL . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 1.6599999999999999 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.511 ' HB ' ' HB1' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.5700000000000001 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.5499999999999998 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 1.5 110.327 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 5.4500000000000002 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 2.5299999999999998 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.6200000000000001 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 1.3200000000000001 110.543 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.25 111.358 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 1.21 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.5699999999999998 112.401 -176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.6600000000000001 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.8899999999999999 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.6699999999999999 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 1.22 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 2.52 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.72 110.51 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 1.0800000000000001 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 ' HB ' ' HG ' ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 1.1499999999999999 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 1.1399999999999999 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 1.1499999999999999 110.834 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.7000000000000002 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.9900000000000002 111.477 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 1.1499999999999999 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 4.6699999999999999 110.748 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.85999999999999999 112.63 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 49' ' ' ILE . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 1.3 110.591 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 2.0699999999999998 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6000000000000001 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.451 HD13 HG21 ' A' ' 45' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 1.03 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.6699999999999999 111.337 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.3799999999999999 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.52 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.5700000000000001 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 1.0600000000000001 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.79 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.98 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.6399999999999999 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.83999999999999997 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 1.1299999999999999 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46000000000000002 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 110.457 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 1.1299999999999999 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.4700000000000002 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.91000000000000003 110.273 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.81999999999999995 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 2.0899999999999999 110.874 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.6200000000000001 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 1.52 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.6499999999999999 110.328 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.506 ' O ' HD11 ' A' ' 74' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 1.21 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.658 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.83999999999999997 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.8100000000000001 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.477 ' HA ' HD11 ' A' ' 73' ' ' LEU . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 2.0699999999999998 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 2.4399999999999999 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.2200000000000002 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.8600000000000003 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.9099999999999999 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.8999999999999999 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.75 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.658 HG13 ' HA3' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.9299999999999999 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.6200000000000001 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 1.1100000000000001 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 1.6100000000000001 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 1.01 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.627 ' HA ' HD11 ' A' ' 16' ' ' ILE . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.6599999999999999 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 1.27 109.936 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.1499999999999999 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.6799999999999999 112.322 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.0299999999999998 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 2.0699999999999998 111.638 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 5.1900000000000004 109.497 173.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 96' ' ' LEU . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 1.4299999999999999 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 2.1600000000000001 112.222 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 1.4399999999999999 110.335 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.492 HD11 HD13 ' A' ' 93' ' ' ILE . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 2.1699999999999999 110.901 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.09 55.01 0.73 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.39 44.07 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.268 -0.733 . . . . 2.8500000000000001 111.268 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -164.78 129.46 2.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.421 -0.585 . . . . 7.04 109.421 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.319 -0.993 . . . . 7.0099999999999998 108.319 -177.593 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 N-CA-C 111.522 -0.631 . . . . 7.8300000000000001 111.522 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p -160.35 139.68 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.808 -0.441 . . . . 6.8799999999999999 109.808 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 96' ' ' LEU . 3.2 t -111.95 40.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.474 0.654 . . . . 4.0800000000000001 109.958 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.2 -44.14 14.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 2.6600000000000001 110.259 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.635 ' HE1' HD12 ' A' ' 36' ' ' ILE . 58.1 t80 72.66 -50.99 0.71 Allowed 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.036 -0.984 . . . . 1.6299999999999999 111.972 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HB2' HD12 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 1.29 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 2.0299999999999998 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.0899999999999999 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 2.1600000000000001 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 4.3499999999999996 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 3.4100000000000001 110.766 174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 1.1399999999999999 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 3.0600000000000001 111.619 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.4299999999999999 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 2.4100000000000001 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.92000000000000004 112.286 177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.98 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.574 HD13 ' HB1' ' A' ' 10' ' ' ALA . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 1.6599999999999999 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.5700000000000001 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.5499999999999998 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 1.5 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 5.4500000000000002 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 2.5299999999999998 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.6200000000000001 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 1.3200000000000001 110.283 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.25 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 1.21 111.295 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 1.1100000000000001 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.5699999999999998 110.638 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.6600000000000001 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.8899999999999999 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.6699999999999999 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 1.22 109.732 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 2.52 111.685 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.912 HD23 ' HA2' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.72 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 1.0800000000000001 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.635 HD12 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 1.1499999999999999 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 1.1399999999999999 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 1.1499999999999999 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.7000000000000002 110.849 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.9900000000000002 111.374 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 1.1499999999999999 109.472 173.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 4.6699999999999999 110.446 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.85999999999999999 112.72 -176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.44 HG21 HD13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 1.3 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 2.0699999999999998 110.91 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6000000000000001 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 45' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 1.03 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.6699999999999999 111.408 -177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.643 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.3799999999999999 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.472 ' HA ' HD13 ' A' ' 55' ' ' LEU . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.5700000000000001 112.084 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 1.0600000000000001 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.79 110.598 178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.98 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.6399999999999999 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.83999999999999997 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 1.1299999999999999 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46000000000000002 112.012 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 1.0600000000000001 110.578 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 1.1299999999999999 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.4700000000000002 109.999 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.91000000000000003 110.425 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.81999999999999995 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 2.0899999999999999 110.661 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.592 ' HG ' ' HA ' ' A' ' 81' ' ' SER . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.6200000000000001 111.103 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 1.52 110.545 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.6499999999999999 111.02 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 1.21 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.83999999999999997 112.28 178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.8100000000000001 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.4 HD12 ' HB2' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 2.0699999999999998 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 2.4399999999999999 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.2200000000000002 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.8600000000000003 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.9099999999999999 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.8999999999999999 110.243 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.75 110.912 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.9299999999999999 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.592 ' HA ' ' HG ' ' A' ' 67' ' ' SER . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.6200000000000001 110.526 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.455 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 1.1100000000000001 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 1.6100000000000001 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 1.01 111.014 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.6599999999999999 109.717 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 1.27 111.357 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.1499999999999999 111.719 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.6799999999999999 112.166 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.0299999999999998 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 2.0699999999999998 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 5.1900000000000004 110.795 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 94' ' ' LEU . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 1.4299999999999999 111.069 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 2.1600000000000001 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.4399999999999999 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 1' ' ' VAL . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 2.1699999999999999 110.593 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.912 ' HA2' HD23 ' A' ' 34' ' ' LEU . . . -75.39 -47.89 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 129.09 17.5 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.762 -0.732 . . . . 2.8500000000000001 111.914 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.17 -34.65 75.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.506 0.194 . . . . 7.04 111.114 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.909 -0.567 . . . . 7.0099999999999998 109.772 178.124 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.188 -0.365 . . . . 7.8300000000000001 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.5 p -81.47 39.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.117 0.484 . . . . 6.8799999999999999 111.269 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.49 139.19 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.854 -0.612 . . . . 4.0800000000000001 110.599 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -40.1 93.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.992 -0.549 . . . . 2.6600000000000001 110.475 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.7 t80 73.75 -51.17 0.69 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.37 -0.832 . . . . 1.6299999999999999 110.717 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 1.29 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 2.0299999999999998 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.0899999999999999 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.443 ' HA ' HD21 ' A' ' 7' ' ' LEU . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 2.1600000000000001 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 4.3499999999999996 110.553 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 3.4100000000000001 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 1.1399999999999999 111.254 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 3.0600000000000001 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.4299999999999999 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 2.4100000000000001 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.92000000000000004 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.98 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 1.6599999999999999 110.441 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.5700000000000001 109.855 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.5499999999999998 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.415 ' HB2' HG22 ' A' ' 45' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 1.5 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 5.4500000000000002 109.728 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 2.5299999999999998 110.706 178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.6200000000000001 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 1.3200000000000001 110.723 176.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.25 110.327 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 1.21 111.618 178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 1.1100000000000001 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.5699999999999998 111.102 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.6600000000000001 111.944 -175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.8899999999999999 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.6699999999999999 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 1.22 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 2.52 111.171 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' C ' ' A' ' 34' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.72 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 1.0800000000000001 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.555 ' HB ' HD22 ' A' ' 83' ' ' LEU . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 1.1499999999999999 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG11 ' HB3' ' A' ' 82' ' ' ALA . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 1.1399999999999999 110.957 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.404 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 1.1499999999999999 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.7000000000000002 110.874 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.9900000000000002 111.54 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 1.1499999999999999 109.614 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 4.6699999999999999 110.932 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.85999999999999999 112.642 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG22 ' HB2' ' A' ' 20' ' ' ALA . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 1.3 111.23 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 2.0699999999999998 111.176 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6000000000000001 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 49' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 1.03 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.6699999999999999 111.047 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.3799999999999999 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.5700000000000001 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 1.0600000000000001 110.796 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.79 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.98 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.6399999999999999 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.83999999999999997 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 1.1299999999999999 110.364 178.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46000000000000002 112.117 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 1.0600000000000001 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 1.1299999999999999 110.165 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.4700000000000002 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.91000000000000003 110.698 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.81999999999999995 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 2.0899999999999999 111.493 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.6200000000000001 111.467 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 1.52 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.6499999999999999 110.46 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 1.21 110.437 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.898 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.83999999999999997 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.5 HG21 ' N ' ' A' ' 73' ' ' LEU . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.8100000000000001 110.384 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.5 ' N ' HG21 ' A' ' 72' ' ' THR . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 2.0699999999999998 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 2.4399999999999999 111.351 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.2200000000000002 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.8600000000000003 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.9099999999999999 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.473 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.8999999999999999 112.062 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.75 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.898 HG22 ' HA3' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.9299999999999999 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.6200000000000001 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.515 ' HB3' HG11 ' A' ' 37' ' ' VAL . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 1.1100000000000001 110.554 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.555 HD22 ' HB ' ' A' ' 36' ' ' ILE . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 1.6100000000000001 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.6599999999999999 109.915 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 1.27 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.1499999999999999 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.6799999999999999 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.0299999999999998 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 5.1900000000000004 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 1.4299999999999999 110.251 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 2.1600000000000001 111.432 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 1.4399999999999999 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 2.1699999999999999 110.265 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.09 -34.13 85.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.23 -61.14 4.19 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 112.149 -0.38 . . . . 2.8500000000000001 112.149 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? 69.5 -51.83 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.655 0.782 . . . . 7.04 111.924 177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.165 -0.922 . . . . 7.0099999999999998 110.733 179.204 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.091 -0.403 . . . . 7.8300000000000001 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 t -78.61 132.18 37.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.925 0.393 . . . . 6.8799999999999999 110.618 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.622 HG22 ' HG ' ' A' ' 96' ' ' LEU . 54.6 t -65.07 -25.23 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.636 . . . . 4.0800000000000001 110.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.98 59.47 0.86 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.539 -0.755 . . . . 2.6600000000000001 109.109 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.528 ' HD2' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -73.41 42.06 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.559 -1.2 . . . . 1.6299999999999999 112.852 -172.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 1.29 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 2.0299999999999998 110.046 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.0899999999999999 111.47 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 2.1600000000000001 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 4.3499999999999996 110.979 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 3.4100000000000001 110.628 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 1.1399999999999999 111.212 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 3.0600000000000001 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.4299999999999999 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 2.4100000000000001 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.92000000000000004 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.98 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 1.6599999999999999 109.529 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.5700000000000001 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.5499999999999998 110.565 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 1.5 111.293 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 5.4500000000000002 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 2.5299999999999998 111.629 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.6200000000000001 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 1.3200000000000001 111.127 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.25 110.837 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 1.21 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 1.1100000000000001 110.604 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.5699999999999998 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.6600000000000001 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.884 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.8899999999999999 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.6699999999999999 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 1.22 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 2.52 111.15 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.72 110.527 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 1.0800000000000001 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 1.1499999999999999 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 1.1399999999999999 110.25 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.5 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 1.1499999999999999 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.7000000000000002 110.829 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.9900000000000002 111.15 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 1.1499999999999999 111.271 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 4.6699999999999999 111.404 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.85999999999999999 112.685 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 1.3 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 2.0699999999999998 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6000000000000001 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 1.03 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.6699999999999999 111.39 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.465 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.3799999999999999 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.5700000000000001 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 1.0600000000000001 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.79 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.98 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.6399999999999999 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.83999999999999997 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.884 HD13 ' HA3' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 1.1299999999999999 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46000000000000002 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 1.0600000000000001 110.043 177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 1.1299999999999999 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.4700000000000002 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 110.202 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.81999999999999995 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 2.0899999999999999 110.425 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' A' ' 80' ' ' VAL . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.6200000000000001 110.788 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 1.52 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.6499999999999999 111.141 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.405 ' HA ' HD11 ' A' ' 70' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 1.21 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.727 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.83999999999999997 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.8100000000000001 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.614 HD11 HD13 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 2.0699999999999998 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 2.4399999999999999 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.2200000000000002 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.8600000000000003 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.9099999999999999 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.8999999999999999 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.75 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.727 HG22 ' HA3' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.9299999999999999 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.6200000000000001 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 1.1100000000000001 110.645 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 1.6100000000000001 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 1.01 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.6599999999999999 109.548 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 1.27 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.1499999999999999 110.028 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.6799999999999999 112.153 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.0299999999999998 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 2.0699999999999998 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 5.1900000000000004 110.036 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 1.4299999999999999 110.573 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 2.1600000000000001 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 92' ' ' ARG . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 1.4399999999999999 110.772 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 1' ' ' VAL . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 2.1699999999999999 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.26 -69.67 2.22 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.06 -133.53 3.16 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.985 -0.626 . . . . 2.8500000000000001 112.047 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.78 -48.52 66.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.704 0.288 . . . . 7.04 110.969 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 116.071 -0.513 . . . . 7.0099999999999998 110.03 -176.166 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.019 -0.433 . . . . 7.8300000000000001 112.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.3 m -79.17 47.86 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 6.8799999999999999 111.312 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t 54.05 -120.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.823 -0.626 . . . . 4.0800000000000001 110.502 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -168.58 130.68 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.304 -0.999 . . . . 2.6600000000000001 108.304 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' CE1' ' HE1' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -128.95 32.53 4.74 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.537 -0.301 . . . . 1.6299999999999999 110.949 -176.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 1.29 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 2.0299999999999998 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.0899999999999999 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.441 ' HA ' HD11 ' A' ' 7' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 2.1600000000000001 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 4.3499999999999996 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 3.4100000000000001 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 1.1399999999999999 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 3.0600000000000001 110.54 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.4299999999999999 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 2.4100000000000001 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.92000000000000004 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.98 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 16' ' ' ILE . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 1.6599999999999999 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.515 HG22 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.5700000000000001 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.5499999999999998 110.822 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 1.5 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 5.4500000000000002 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 2.5299999999999998 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.6200000000000001 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 1.3200000000000001 110.266 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.25 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' CZ ' HG22 ' A' ' 17' ' ' VAL . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 1.21 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 1.1100000000000001 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.5699999999999998 111.379 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.6600000000000001 111.507 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.8899999999999999 112.156 -177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.6699999999999999 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 1.22 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 2.52 110.621 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.72 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 1.0800000000000001 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 1.1499999999999999 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 1.1399999999999999 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.558 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 1.1499999999999999 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.7000000000000002 111.457 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.9900000000000002 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 1.1499999999999999 110.853 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 4.6699999999999999 111.086 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.85999999999999999 112.527 -176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 1.3 110.618 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 2.0699999999999998 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6000000000000001 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 49' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 1.03 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.6699999999999999 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.3799999999999999 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 48' ' ' ASP . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.5700000000000001 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 58' ' ' ILE . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 1.0600000000000001 110.806 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.79 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.98 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.6399999999999999 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.83999999999999997 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.438 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 1.1299999999999999 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.462 ' O ' HD13 ' A' ' 34' ' ' LEU . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46000000000000002 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 1.0600000000000001 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 1.1299999999999999 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.4700000000000002 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' HE1' ' CE1' ' A' ' 3' ' ' PHE . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.91000000000000003 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.81999999999999995 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 2.0899999999999999 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.6200000000000001 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.604 ' HA ' HG23 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 1.52 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.6499999999999999 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 1.21 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.83999999999999997 112.138 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.8100000000000001 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD1' ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 2.0699999999999998 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 2.4399999999999999 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.2200000000000002 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.8600000000000003 109.214 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.9099999999999999 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.8999999999999999 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.604 HG23 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.75 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.9299999999999999 110.711 179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.6200000000000001 110.715 -176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 1.1100000000000001 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 1.6100000000000001 110.929 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 1.01 110.706 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 109.608 175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 1.27 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.428 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.1499999999999999 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.6799999999999999 112.833 -175.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.0299999999999998 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 2.0699999999999998 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 5.1900000000000004 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 1.4299999999999999 110.786 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 2.1600000000000001 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 1.4399999999999999 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.487 ' H ' HD21 ' A' ' 96' ' ' LEU . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 2.1699999999999999 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . -165.0 110.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 175.18 -116.8 0.59 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.311 -0.715 . . . . 2.8500000000000001 111.311 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -60.72 140.13 57.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.108 -0.33 . . . . 7.04 110.108 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.548 0.53 . . . . 7.0099999999999998 109.826 -175.087 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.905 -0.478 . . . . 7.8300000000000001 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.6 m 59.4 44.48 15.06 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.391 0.615 . . . . 6.8799999999999999 110.833 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 2' ' ' ASP . 6.1 p -78.16 140.92 16.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.444 -0.798 . . . . 4.0800000000000001 111.127 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.491 ' N ' HG21 ' A' ' 1' ' ' VAL . 31.2 t70 -121.81 -36.76 2.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.03 -0.532 . . . . 2.6600000000000001 109.63 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 71.67 -54.37 0.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.657 -1.156 . . . . 1.6299999999999999 112.433 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 1.29 111.423 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 2.0299999999999998 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.0899999999999999 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.407 HD13 HD13 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 2.1600000000000001 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 4.3499999999999996 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 3.4100000000000001 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 16' ' ' ILE . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 1.1399999999999999 110.519 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 3.0600000000000001 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.4299999999999999 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 2.4100000000000001 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.92000000000000004 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.98 110.419 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 10' ' ' ALA . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 1.6599999999999999 110.476 178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.5700000000000001 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.5499999999999998 108.87 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 1.5 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 5.4500000000000002 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 2.5299999999999998 110.886 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.6200000000000001 110.92 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 1.3200000000000001 110.144 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.21 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 1.1100000000000001 110.7 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.5699999999999998 110.636 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.6600000000000001 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.8899999999999999 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.6699999999999999 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 1.22 111.444 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 2.52 110.513 178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.72 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 1.0800000000000001 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.67 ' HB ' HD22 ' A' ' 83' ' ' LEU . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 1.1499999999999999 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 1.1399999999999999 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 1.1499999999999999 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.7000000000000002 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.9900000000000002 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 1.1499999999999999 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 4.6699999999999999 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.85999999999999999 112.403 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 45' ' ' ILE . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.786 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 2.0699999999999998 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6000000000000001 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 1.03 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.6699999999999999 111.094 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.3799999999999999 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.499 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.5700000000000001 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 1.0600000000000001 111.542 -177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.79 112.092 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.98 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.6399999999999999 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.83999999999999997 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.47 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 1.1299999999999999 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.448 ' O ' HD11 ' A' ' 34' ' ' LEU . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46000000000000002 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 1.0600000000000001 109.744 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 1.1299999999999999 110.699 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.4700000000000002 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.91000000000000003 109.887 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.81999999999999995 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 2.0899999999999999 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.6200000000000001 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG21 HG21 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 1.52 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.405 ' O ' HG21 ' A' ' 72' ' ' THR . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.6499999999999999 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 1.21 110.403 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' HA3' HG22 ' A' ' 80' ' ' VAL . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.83999999999999997 112.825 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.437 HG21 ' N ' ' A' ' 73' ' ' LEU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.8100000000000001 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 2.0699999999999998 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.442 HD23 HD11 ' A' ' 83' ' ' LEU . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 2.4399999999999999 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.2200000000000002 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.8600000000000003 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.9099999999999999 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.8999999999999999 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 HG21 HG21 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.75 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.702 HG22 ' HA3' ' A' ' 71' ' ' GLY . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.9299999999999999 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.6200000000000001 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HB2' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 1.1100000000000001 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.67 HD22 ' HB ' ' A' ' 36' ' ' ILE . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 1.6100000000000001 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 1.01 111.046 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.6599999999999999 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 1.27 109.984 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.1499999999999999 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.6799999999999999 112.169 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.0299999999999998 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 2.0699999999999998 111.917 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 5.1900000000000004 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 1.4299999999999999 111.125 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 2.1600000000000001 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 1.4399999999999999 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 96' ' ' LEU . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 2.1699999999999999 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.71 121.75 1.08 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.2 114.81 0.34 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.099 -0.8 . . . . 2.8500000000000001 111.099 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.6 128.4 35.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.017 0.437 . . . . 7.04 110.632 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.682 -0.675 . . . . 7.0099999999999998 110.157 -179.096 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.843 -0.503 . . . . 7.8300000000000001 111.843 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 1' ' ' VAL . 50.7 m 57.32 37.36 28.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.457 0.303 . . . . 6.8799999999999999 110.639 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.596 HG21 ' O ' ' A' ' -1' ' ' SER . 31.5 m 41.08 -147.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.301 1.04 . . . . 4.0800000000000001 112.297 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.31 129.46 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.162 -0.31 . . . . 2.6600000000000001 110.162 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.605 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 -166.85 26.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.605 -0.27 . . . . 1.6299999999999999 111.631 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 1.29 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 2.0299999999999998 109.944 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.0899999999999999 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 2.1600000000000001 110.974 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 4.3499999999999996 110.531 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 3.4100000000000001 110.277 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 1.1399999999999999 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 3.0600000000000001 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.4299999999999999 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.494 HG22 ' HA2' ' A' ' 89' ' ' GLY . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 2.4100000000000001 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.92000000000000004 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.98 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 1.6599999999999999 110.506 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.5700000000000001 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.5499999999999998 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 1.5 110.608 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 5.4500000000000002 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 2.5299999999999998 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.6200000000000001 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 1.3200000000000001 110.537 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.25 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 1.21 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 1.1100000000000001 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.5699999999999998 110.729 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.6600000000000001 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.8899999999999999 111.54 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.6699999999999999 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 1.22 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 2.52 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.72 109.648 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 1.0800000000000001 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 1.1499999999999999 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.191 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 1.1499999999999999 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.7000000000000002 110.362 -175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.9900000000000002 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 1.1499999999999999 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 4.6699999999999999 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.85999999999999999 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 1.3 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 2.0699999999999998 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6000000000000001 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.442 ' O ' ' HB1' ' A' ' 53' ' ' ALA . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 1.03 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.6699999999999999 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.541 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.3799999999999999 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.5700000000000001 110.926 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 49' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 1.0600000000000001 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.79 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.98 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.6399999999999999 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.83999999999999997 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 1.1299999999999999 109.917 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46000000000000002 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 1.0600000000000001 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 1.1299999999999999 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.4700000000000002 109.883 177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' HE1' ' HE1' ' A' ' 3' ' ' PHE . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.91000000000000003 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.81999999999999995 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 2.0899999999999999 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.6200000000000001 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HG23 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 1.52 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.6499999999999999 110.605 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.438 HD11 ' CE1' ' A' ' 63' ' ' PHE . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 1.21 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.83999999999999997 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.8100000000000001 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 2.0699999999999998 110.28 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.966 HD12 HD23 ' A' ' 83' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 2.4399999999999999 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.2200000000000002 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.8600000000000003 109.956 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.9099999999999999 112.888 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.504 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.8999999999999999 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.457 HG23 HG21 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.75 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.491 HG13 ' HA3' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.9299999999999999 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.6200000000000001 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 1.1100000000000001 110.731 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.966 HD23 HD12 ' A' ' 74' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 1.6100000000000001 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 1.01 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.6599999999999999 109.971 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 1.27 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.1499999999999999 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.6799999999999999 112.33 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.494 ' HA2' HG22 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.0299999999999998 110.852 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 2.0699999999999998 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.471 ' HA ' ' NE ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 5.1900000000000004 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.483 HG21 HD11 ' A' ' 94' ' ' LEU . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 1.4299999999999999 111.198 -176.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 93' ' ' ILE . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 2.1600000000000001 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 1.4399999999999999 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD13 HD13 ' A' ' 93' ' ' ILE . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 2.1699999999999999 111.847 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.17 56.93 0.5 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 141.45 3.41 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.154 -0.546 . . . . 2.8500000000000001 111.736 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 139.87 15.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.138 -0.319 . . . . 7.04 110.138 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.757 -0.639 . . . . 7.0099999999999998 109.963 -179.171 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.216 -0.354 . . . . 7.8300000000000001 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.5 p -75.38 134.24 41.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.597 0.237 . . . . 6.8799999999999999 110.833 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.2 155.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 4.0800000000000001 111.635 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -149.88 -44.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 2.6600000000000001 110.657 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.479 ' O ' ' HD1' ' A' ' 3' ' ' PHE . 1.6 p90 45.78 31.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.062 1.345 . . . . 1.6299999999999999 114.1 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 1.29 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 2.0299999999999998 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.0899999999999999 111.775 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 2.1600000000000001 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 4.3499999999999996 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HA ' ' CE ' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 3.4100000000000001 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 1.1399999999999999 110.669 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 3.0600000000000001 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.4299999999999999 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 2.4100000000000001 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.92000000000000004 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.98 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 1.6599999999999999 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.5700000000000001 110.056 178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.5499999999999998 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 1.5 110.332 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 5.4500000000000002 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 2.5299999999999998 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.6200000000000001 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 1.3200000000000001 110.079 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.25 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 1.21 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 1.1100000000000001 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.5699999999999998 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.6600000000000001 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.815 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.8899999999999999 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.6699999999999999 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 1.22 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 2.52 110.881 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.72 110.351 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 35' ' ' ILE . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 1.0800000000000001 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 1.1499999999999999 110.205 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 82' ' ' ALA . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 1.1399999999999999 110.983 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 1.1499999999999999 110.353 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.7000000000000002 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.9900000000000002 110.558 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 1.1499999999999999 109.552 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 4.6699999999999999 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.85999999999999999 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 HG21 HD13 ' A' ' 49' ' ' ILE . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.3 111.308 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 2.0699999999999998 112.293 -174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6000000000000001 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD13 HG21 ' A' ' 45' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 1.03 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.6699999999999999 111.399 -177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.3799999999999999 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.5700000000000001 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 1.0600000000000001 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.79 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.98 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.6399999999999999 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.83999999999999997 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.815 HD13 ' HA3' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 1.1299999999999999 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46000000000000002 111.538 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 1.0600000000000001 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 1.1299999999999999 110.474 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.4700000000000002 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.91000000000000003 110.66 -176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.81999999999999995 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 2.0899999999999999 110.439 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.6200000000000001 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 1.52 110.201 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.6499999999999999 110.822 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.525 HD12 HD22 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 1.21 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.464 ' HA3' HG13 ' A' ' 80' ' ' VAL . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.83999999999999997 112.257 177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.8100000000000001 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' HA ' HD11 ' A' ' 73' ' ' LEU . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 2.0699999999999998 110.675 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 2.4399999999999999 110.892 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.2200000000000002 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.8600000000000003 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.9099999999999999 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.8999999999999999 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.75 111.521 -177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.464 HG13 ' HA3' ' A' ' 71' ' ' GLY . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.9299999999999999 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.6200000000000001 111.609 -174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 37' ' ' VAL . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 1.1100000000000001 111.488 -174.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.525 HD22 HD12 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 1.6100000000000001 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 1.01 110.773 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.6599999999999999 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 1.27 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.1499999999999999 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.6799999999999999 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.0299999999999998 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 2.0699999999999998 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 5.1900000000000004 110.345 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.498 HG21 ' N ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 1.4299999999999999 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.498 ' N ' HG21 ' A' ' 93' ' ' ILE . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 2.1600000000000001 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 1.4399999999999999 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.787 ' H ' HD21 ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 2.1699999999999999 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.38 29.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.76 -150.02 9.68 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.344 -0.703 . . . . 2.8500000000000001 111.344 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -173.6 117.71 0.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.009 0.433 . . . . 7.04 110.83 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.471 -0.776 . . . . 7.0099999999999998 110.005 177.067 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.779 -0.528 . . . . 7.8300000000000001 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.1 t -65.77 131.26 45.87 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 6.8799999999999999 109.953 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' A' ' 95' ' ' ALA . 22.1 m -65.52 133.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.423 . . . . 4.0800000000000001 111.095 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.57 -72.86 0.66 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.995 -0.548 . . . . 2.6600000000000001 110.958 -176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.539 ' HE1' HD12 ' A' ' 36' ' ' ILE . 81.4 t80 161.93 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.646 0.778 . . . . 1.6299999999999999 110.092 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 1.29 112.093 -171.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 2.0299999999999998 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.0899999999999999 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 HD21 HD22 ' A' ' 73' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 2.1600000000000001 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 4.3499999999999996 110.707 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 3.4100000000000001 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.492 ' HB1' HD13 ' A' ' 16' ' ' ILE . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 1.1399999999999999 111.567 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.525 ' NE2' ' HB ' ' A' ' 16' ' ' ILE . 68.6 mm-40 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 3.0600000000000001 111.235 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.4299999999999999 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 2.4100000000000001 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.92000000000000004 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.98 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.525 ' HB ' ' NE2' ' A' ' 11' ' ' GLN . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 1.6599999999999999 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.5700000000000001 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.5499999999999998 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.55 ' HA ' ' HB2' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 1.5 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 5.4500000000000002 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 2.5299999999999998 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.6200000000000001 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.502 HG22 ' OD2' ' A' ' 48' ' ' ASP . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 1.3200000000000001 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.25 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.677 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 1.21 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HA ' HD11 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 1.1100000000000001 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.5699999999999998 111.59 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.6600000000000001 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.677 ' HA2' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.6699999999999999 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 1.22 110.299 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 2.52 110.228 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.667 ' H ' HG11 ' A' ' 85' ' ' VAL . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.72 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 1.0800000000000001 109.957 174.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.743 ' HB ' HD22 ' A' ' 83' ' ' LEU . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 1.1499999999999999 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.552 HG22 ' HZ2' ' A' ' 46' ' ' LYS . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 1.1399999999999999 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' HB1' ' HD2' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 1.1499999999999999 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CE ' ' A' ' 46' ' ' LYS . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.7000000000000002 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.9900000000000002 111.103 176.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 1.1499999999999999 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 4.6699999999999999 110.853 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.85999999999999999 111.523 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.537 HG21 HD13 ' A' ' 49' ' ' ILE . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 1.3 110.304 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HZ2' HG22 ' A' ' 37' ' ' VAL . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 2.0699999999999998 112.018 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6000000000000001 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' OD2' HG22 ' A' ' 24' ' ' ILE . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 45' ' ' ILE . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 1.03 111.611 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.6699999999999999 111.732 -176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.578 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.3799999999999999 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.5700000000000001 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 49' ' ' ILE . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 1.0600000000000001 111.066 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.589 ' NE ' ' HA ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.79 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.98 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.6399999999999999 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.83999999999999997 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 HD11 ' HA ' ' A' ' 27' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 1.1299999999999999 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46000000000000002 112.043 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 1.0600000000000001 110.802 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 1.1299999999999999 110.639 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.4700000000000002 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.91000000000000003 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.81999999999999995 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 2.0899999999999999 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.6200000000000001 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 1.52 110.809 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.6499999999999999 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.447 HD22 ' CD2' ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 1.21 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.83999999999999997 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.8100000000000001 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.517 HD22 HD21 ' A' ' 7' ' ' LEU . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 2.0699999999999998 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.634 HD11 HG22 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 2.4399999999999999 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.2200000000000002 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' A' ' 78' ' ' HIS . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.8600000000000003 110.088 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.9099999999999999 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.426 ' H ' ' C ' ' A' ' 76' ' ' ARG . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.8999999999999999 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.75 110.849 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.9299999999999999 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.6200000000000001 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 1.1100000000000001 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 36' ' ' ILE . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 1.6100000000000001 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 1.01 111.218 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' H ' ' A' ' 34' ' ' LEU . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.6599999999999999 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 1.27 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.475 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.1499999999999999 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.6799999999999999 112.208 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.0299999999999998 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 2.0699999999999998 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 5.1900000000000004 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.439 HD13 HD13 ' A' ' 96' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 1.4299999999999999 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 2.1600000000000001 111.86 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 1.4399999999999999 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 93' ' ' ILE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 2.1699999999999999 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.21 57.77 0.88 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.19 20.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.442 -0.409 . . . . 2.8500000000000001 113.452 -171.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -175.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 7.04 110.553 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.085 -0.96 . . . . 7.0099999999999998 109.463 -176.816 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.169 -0.372 . . . . 7.8300000000000001 112.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . 0.462 ' C ' HG21 ' A' ' 1' ' ' VAL . 9.4 p -85.58 118.93 25.4 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.716 -0.285 . . . . 6.8799999999999999 110.275 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.462 HG21 ' C ' ' A' ' -1' ' ' SER . 9.2 m 35.01 55.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 124.02 0.825 . . . . 4.0800000000000001 112.485 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.09 142.45 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.596 -0.729 . . . . 2.6600000000000001 111.188 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.6 35.43 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.773 -0.648 . . . . 1.6299999999999999 110.098 176.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HA ' HD22 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 1.29 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 2.0299999999999998 110.123 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.0899999999999999 111.164 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.41 ' HA ' HD21 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 2.1600000000000001 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 4.3499999999999996 110.723 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 3.4100000000000001 110.528 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.691 ' HB1' HD12 ' A' ' 16' ' ' ILE . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 1.1399999999999999 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 3.0600000000000001 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.4299999999999999 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.662 HG23 ' HA2' ' A' ' 89' ' ' GLY . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 2.4100000000000001 111.81 -177.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.563 ' HA2' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.92000000000000004 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.98 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.691 HD12 ' HB1' ' A' ' 10' ' ' ALA . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 1.6599999999999999 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' CG1' ' HB1' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.5700000000000001 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.5499999999999998 111.3 -175.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 1.5 110.51 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 5.4500000000000002 110.659 176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 2.5299999999999998 110.057 176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.6200000000000001 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 45' ' ' ILE . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 1.3200000000000001 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.25 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 1.21 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 1.1100000000000001 110.752 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.5699999999999998 111.416 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.6600000000000001 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA3' HD13 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.8899999999999999 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.6699999999999999 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 1.22 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 2.52 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.693 HD12 ' HA2' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 HG21 ' N ' ' A' ' 36' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 1.0800000000000001 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.409 ' N ' HG21 ' A' ' 35' ' ' ILE . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 1.1499999999999999 110.0 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 1.1399999999999999 110.603 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' O ' ' HB1' ' A' ' 41' ' ' ALA . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 1.1499999999999999 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.7000000000000002 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.452 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.9900000000000002 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 38' ' ' ALA . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 1.1499999999999999 111.858 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 4.6699999999999999 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.85999999999999999 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG21 HD13 ' A' ' 49' ' ' ILE . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 1.3 110.906 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 2.0699999999999998 112.125 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6000000000000001 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 45' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 1.03 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.41 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.6699999999999999 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.3799999999999999 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.5700000000000001 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0600000000000001 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.79 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.98 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.6399999999999999 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.83999999999999997 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 53' ' ' ALA . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 1.1299999999999999 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' O ' HD13 ' A' ' 34' ' ' LEU . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46000000000000002 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' HB ' ' OE2' ' A' ' 50' ' ' GLU . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 1.0600000000000001 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 1.1299999999999999 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.4700000000000002 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.91000000000000003 109.376 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.81999999999999995 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 ' HA ' ' CB ' ' A' ' 40' ' ' ASN . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 2.0899999999999999 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.6200000000000001 111.42 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 1.52 110.156 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.6499999999999999 110.689 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.431 HD23 HD22 ' A' ' 83' ' ' LEU . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 1.21 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.83999999999999997 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.8100000000000001 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 2.0699999999999998 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 2.4399999999999999 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.2200000000000002 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.401 ' C ' ' H ' ' A' ' 78' ' ' HIS . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.8600000000000003 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.9099999999999999 111.632 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 76' ' ' ARG . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.8999999999999999 108.874 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.75 111.422 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.9299999999999999 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.419 ' HA ' ' HB3' ' A' ' 41' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.6200000000000001 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 1.1100000000000001 110.781 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 1.6100000000000001 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 1.01 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.6599999999999999 109.556 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 1.27 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' O ' ' HA2' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.1499999999999999 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.6799999999999999 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.662 ' HA2' HG23 ' A' ' 13' ' ' THR . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.0299999999999998 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 2.0699999999999998 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 5.1900000000000004 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 1.4299999999999999 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.456 ' HA ' HD21 ' A' ' 94' ' ' LEU . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 2.1600000000000001 111.718 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 1.4399999999999999 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 2.1699999999999999 110.211 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.693 ' HA2' HD12 ' A' ' 34' ' ' LEU . . . -98.81 45.82 1.56 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.53 131.86 1.41 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.562 -0.828 . . . . 2.8500000000000001 112.393 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.9 56.73 4.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.491 . . . . 7.04 110.85 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.104 -0.95 . . . . 7.0099999999999998 109.308 -179.195 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD1' HD11 ' A' ' 93' ' ' ILE . 86.7 t80 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.987 0.422 . . . . 1.16 110.836 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.478 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.64 111.757 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 1.65 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.09 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.461 HD21 HD11 ' A' ' 74' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 1.45 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 3.56 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 91' ' ' SER . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 2.75 110.173 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 0.47 110.835 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 2.44 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.43 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' LYS . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 1.96 111.136 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.64 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HD2' ' HB ' ' A' ' 86' ' ' VAL . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.52 109.716 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 10' ' ' ALA . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.99 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.04 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.03 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 0.76 110.327 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 4.68 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.14 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 49' ' ' ILE . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 0.66 110.543 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.19 111.358 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.66 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.06 112.401 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.09 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.43 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.67 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 0.55 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 1.85 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 94' ' ' LEU . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.06 110.51 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 0.31 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 0.34 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 0.33 110.834 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.14 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.33 111.477 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 0.47 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 3.98 110.748 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.86 112.63 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.591 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 1.59 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 24' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 0.36 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 60' ' ' VAL . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.67 111.337 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.03 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.09 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 0.42 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.04 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.37 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.48 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 0.36 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 50' ' ' GLU . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 0.5 110.457 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 0.83 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.47 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.67 110.273 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.82 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 1.53 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 0.97 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' H ' HG23 ' A' ' 66' ' ' THR . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.65 110.328 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 HD23 ' A' ' 83' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 0.56 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.84 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.46 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 4' ' ' ALA . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 1.51 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.66 HD21 HD22 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 1.79 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.22 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.36 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.91 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.13 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.25 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.24 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.18 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.34 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.66 HD22 HD21 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 0.88 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.35 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.05 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HB ' ' HD2' ' A' ' 15' ' ' LYS . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 0.54 109.936 -176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.15 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.764 ' HG2' HD23 ' A' ' 94' ' ' LEU . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.68 112.322 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.03 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.682 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 1.65 111.638 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 4.45 109.497 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' CD1' ' A' ' 3' ' ' PHE . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 0.97 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 88' ' ' PRO . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 1.63 112.222 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 0.86 110.335 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.901 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.586 ' HE1' HD13 ' A' ' 36' ' ' ILE . 58.1 t80 . . . . . 0 C--O 1.222 -0.344 0 N-CA-C 111.972 0.36 . . . . 1.16 111.972 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 0.64 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 1.65 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.09 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 1.45 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 3.56 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 2.75 110.766 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.47 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.61 ' HB2' HD12 ' A' ' 16' ' ' ILE . 15.6 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 2.44 111.619 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.43 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 1.96 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.64 112.286 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.52 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 85' ' ' VAL . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.99 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.04 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.03 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.76 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 4.68 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 1.91 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.14 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 49' ' ' ILE . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 0.66 110.283 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.19 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 0.66 111.295 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.55 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.06 110.638 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.09 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.43 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.67 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 84' ' ' ALA . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 0.55 109.732 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 1.85 111.685 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.892 HD21 ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.06 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 0.31 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.33 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.14 110.849 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.805 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.33 111.374 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 0.47 109.472 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 3.98 110.446 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.86 112.72 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 0.62 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 39' ' ' ARG . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 1.59 110.91 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 24' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.36 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.67 111.408 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.03 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.09 112.084 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 0.42 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.04 110.598 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.37 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.48 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 0.36 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46 112.012 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 50' ' ' GLU . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.5 110.578 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 0.83 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 39' ' ' ARG . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.47 109.999 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.67 110.425 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.82 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.805 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 1.53 110.661 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.25 111.103 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 79' ' ' THR . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 0.97 110.545 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 66' ' ' THR . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.65 111.02 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.84 112.28 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.46 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 1.51 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 1.79 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.22 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.36 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.91 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.407 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.13 110.243 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 68' ' ' VAL . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.912 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.24 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.18 110.526 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 0.34 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.88 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.35 111.014 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 16' ' ' ILE . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.05 109.717 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 0.54 111.357 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.15 111.719 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 86' ' ' VAL . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.68 112.166 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.03 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 1.65 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 92' ' ' ARG . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 4.45 110.795 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 0.97 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD23 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 1.63 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.86 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.593 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.892 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.426 ' CZ ' HD11 ' A' ' 7' ' ' LEU . 91.7 t80 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.815 0.341 . . . . 1.16 110.717 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.64 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.65 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.09 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 1.45 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 4' ' ' ALA . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 3.56 110.553 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 2.75 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 0.47 111.254 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 2.44 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.43 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 1.96 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.64 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.52 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' ALA . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 0.99 110.441 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' HE3' ' A' ' 22' ' ' LYS . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.04 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.03 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 0.76 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' ILE . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 4.68 109.728 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HE3' HG13 ' A' ' 17' ' ' VAL . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 1.91 110.706 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.14 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 20' ' ' ALA . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.66 110.723 176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 29' ' ' MET . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.19 110.327 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 0.66 111.618 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 0.55 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.06 111.102 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.09 111.944 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.43 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.67 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 0.55 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 1.85 111.171 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.06 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 0.31 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 61' ' ' TYR . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.4 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 0.34 110.957 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 0.33 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 63' ' ' PHE . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.14 110.874 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.529 ' HB2' ' H ' ' A' ' 67' ' ' SER . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.33 111.54 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 0.47 109.614 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 3.98 110.932 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.86 112.642 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 0.62 111.23 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 1.59 111.176 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 35' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.36 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' HG11 ' A' ' 60' ' ' VAL . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.67 111.047 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.03 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.09 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 0.42 110.796 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.04 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.37 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.28 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.48 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 0.36 110.364 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46 112.117 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.669 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 0.5 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HG12 ' A' ' 36' ' ' ILE . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 0.83 110.165 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.47 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.713 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.67 110.698 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.82 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 69' ' ' GLU . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 1.53 111.493 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' A' ' 40' ' ' ASN . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.25 111.467 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 0.97 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.624 ' H ' HG23 ' A' ' 66' ' ' THR . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.65 110.46 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 38' ' ' ALA . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.56 110.437 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.811 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.84 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.46 110.384 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' HA ' ' A' ' 4' ' ' ALA . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 1.51 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 80' ' ' VAL . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 1.79 111.351 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.22 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.36 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.91 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.13 112.062 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.25 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.811 HG23 ' HA2' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.24 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.18 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 0.34 110.554 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 74' ' ' LEU . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 0.88 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 0.35 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 16' ' ' ILE . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.05 109.915 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 0.54 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.15 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.68 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.03 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 1.65 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 4.45 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.594 HD12 HD13 ' A' ' 96' ' ' LEU . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 0.97 110.251 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 34' ' ' LEU . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 1.63 111.432 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 93' ' ' ILE . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.265 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.852 0.686 . . . . 1.16 112.852 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.673 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.64 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 1.65 110.046 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.09 111.47 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 1.45 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 3.56 110.979 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 5' ' ' PHE . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 2.75 110.628 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.47 111.212 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 2.44 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 1.96 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.64 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.52 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 85' ' ' VAL . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 0.99 109.529 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.04 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.413 ' HB3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.03 110.565 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 0.76 111.293 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 4.68 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 25' ' ' GLN . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 1.91 111.629 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.14 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 0.66 111.127 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 22' ' ' LYS . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.19 110.837 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 0.66 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.604 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.06 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.09 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.751 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.43 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.67 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 0.55 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 1.85 111.15 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 93' ' ' ILE . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.06 110.527 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 0.31 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 0.4 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 82' ' ' ALA . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.34 110.25 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 0.33 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.14 110.829 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.762 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.33 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 0.47 111.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 3.98 111.404 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.86 112.685 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 0.62 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 1.59 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 60' ' ' VAL . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.67 111.39 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.03 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.09 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.42 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.04 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.37 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.28 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.48 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.751 HD11 ' HA2' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 0.36 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 50' ' ' GLU . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 0.5 110.043 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 0.83 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.47 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.67 110.202 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.82 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.77 HG22 ' HG2' ' A' ' 69' ' ' GLU . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 1.53 110.425 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.25 110.788 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.97 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.77 ' HG2' HG22 ' A' ' 66' ' ' THR . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.65 111.141 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 HD21 ' A' ' 83' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.56 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.84 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.46 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 1.51 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.633 HD13 HD22 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 1.79 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.22 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.36 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.91 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.13 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.25 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HA2' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.24 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.18 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 0.34 110.645 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.88 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 0.35 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.557 ' HA ' HG13 ' A' ' 16' ' ' ILE . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.05 109.548 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.15 110.028 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.68 112.153 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.03 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.65 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 4.45 110.036 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 85' ' ' VAL . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.97 110.573 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 1.63 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.86 110.772 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 96' ' ' LEU . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 1.57 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.7 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.704 0.288 . . . . 1.16 110.949 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.64 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 1.65 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.09 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 73' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 1.45 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 3.56 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 2.75 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.47 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 7' ' ' LEU . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 2.44 110.54 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.43 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 1.96 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.64 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.52 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 85' ' ' VAL . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.99 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.04 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 76' ' ' ARG . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.03 110.822 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 0.76 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 4.68 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 1.91 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.588 HG22 ' HE3' ' A' ' 28' ' ' LYS . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 0.66 110.266 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.19 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.66 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 0.55 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.06 111.379 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.61 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.09 111.507 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.43 112.156 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.67 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.55 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 1.85 110.621 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.06 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 0.31 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 0.4 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.34 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 0.33 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.14 111.457 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.33 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 0.47 110.853 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 3.98 111.086 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.86 112.527 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 42' ' ' ARG . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.615 HG21 ' HB1' ' A' ' 20' ' ' ALA . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.62 110.618 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 1.59 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.57 HG13 HG12 ' A' ' 24' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.36 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.67 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.03 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CD2' ' HG2' ' A' ' 28' ' ' LYS . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 0.42 110.806 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.04 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.37 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.28 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.48 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 0.36 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 0.83 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.47 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.67 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.82 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 1.53 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.25 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.97 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.65 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.56 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.84 112.138 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.46 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 1.51 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 1.79 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.22 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HG2' ' SD ' ' A' ' 18' ' ' MET . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.36 109.214 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.91 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.13 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.25 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.24 110.711 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.18 110.715 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.34 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 0.88 110.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 0.35 110.706 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.05 109.608 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.54 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.15 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.574 ' HB3' HG22 ' A' ' 93' ' ' ILE . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.68 112.833 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.03 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 1.65 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 4.45 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 0.97 110.786 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 1.63 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 0.86 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.7 HD11 ' HD2' ' A' ' 3' ' ' PHE . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 1.57 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 1.16 112.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.634 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.64 111.423 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 1.65 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.09 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 1.45 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 3.56 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.75 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 0.47 110.519 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 2.44 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.43 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 1.96 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.64 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.52 110.419 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 0.99 110.476 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.04 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.03 108.87 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 23' ' ' SER . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' H ' ' HB3' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 0.76 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 4.68 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 18' ' ' MET . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 1.91 110.886 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.467 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.14 110.92 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 0.66 110.144 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.19 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.66 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 0.55 110.7 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.06 110.636 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.09 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.977 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.43 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.67 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 0.55 111.444 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.85 110.513 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.06 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 0.31 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.632 HG12 ' HB3' ' A' ' 61' ' ' TYR . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 0.4 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 0.34 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.33 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.14 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.33 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.47 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 3.98 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.86 112.403 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 0.62 110.786 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.59 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.36 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.631 ' HG2' HG11 ' A' ' 60' ' ' VAL . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.094 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.03 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.09 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 0.42 111.542 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.04 112.092 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.37 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.28 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.48 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.977 HD11 ' HA2' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 0.36 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 0.5 109.744 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HB3' HG12 ' A' ' 36' ' ' ILE . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 0.83 110.699 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.47 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.67 109.887 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.82 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 1.53 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.25 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.97 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.65 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 83' ' ' LEU . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 0.56 110.403 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.84 112.825 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' GLU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.46 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.51 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.546 HD12 HG21 ' A' ' 80' ' ' VAL . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.22 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.36 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.91 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.13 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.25 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 74' ' ' LEU . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.24 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.18 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 0.34 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 70' ' ' LEU . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 0.88 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.35 111.046 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.05 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 0.54 109.984 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.15 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 93' ' ' ILE . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.68 112.169 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.03 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 1.65 111.917 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 4.45 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 0.97 111.125 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 1.63 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.86 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.515 HD23 HD12 ' A' ' 93' ' ' ILE . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.631 0.234 . . . . 1.16 111.631 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 0.64 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 1.65 109.944 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.09 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 74' ' ' LEU . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.974 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HG3' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 3.56 110.531 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 90' ' ' GLU . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 2.75 110.277 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 0.47 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 2.44 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.43 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 90' ' ' GLU . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 1.96 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.64 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.52 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 HG22 ' A' ' 85' ' ' VAL . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.99 110.506 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.04 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.03 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 0.76 110.608 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 4.68 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 1.91 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.14 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' ASP . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 0.66 110.537 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.19 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.66 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.55 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.06 110.729 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.09 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.43 111.54 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.67 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 0.55 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 94' ' ' LEU . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.06 109.648 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 0.31 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 0.4 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' HB1' ' A' ' 82' ' ' ALA . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 0.34 110.191 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 0.33 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.14 110.362 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.33 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 0.47 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 3.98 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.86 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 0.62 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 1.59 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 24' ' ' ILE . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 0.36 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.67 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.09 110.926 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.42 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.04 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.37 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.28 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.48 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.466 HD11 ' HA2' ' A' ' 30' ' ' GLY . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.36 109.917 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 0.83 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.47 109.883 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.67 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 1.53 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.25 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.97 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.65 110.605 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 83' ' ' LEU . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 0.56 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.84 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.46 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 1.51 110.28 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 7' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 1.79 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.22 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HD3' ' HD2' ' A' ' 77' ' ' PRO . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.36 109.956 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.633 ' HD2' ' HD3' ' A' ' 76' ' ' ARG . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.91 112.888 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.52 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.13 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.25 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.464 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.24 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.18 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 0.34 110.731 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 70' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 0.88 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 0.35 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 16' ' ' ILE . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.05 109.971 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 0.54 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 94' ' ' LEU . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.68 112.33 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA3' HG23 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 9' ' ' LYS . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.03 110.852 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 1.65 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 4.45 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 0.97 111.198 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.644 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 1.63 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.86 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 1.57 111.847 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.645 ' HD2' HD11 ' A' ' 96' ' ' LEU . 1.6 p90 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.1 1.148 . . . . 1.16 114.1 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 0.64 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 1.65 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CG ' ' HG3' ' A' ' 92' ' ' ARG . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.09 111.775 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 1.45 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 3.56 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 2.75 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.47 110.669 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 2.44 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.43 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 1.96 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.64 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.52 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.04 110.056 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.03 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 0.76 110.332 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 4.68 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 1.91 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.14 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 0.66 110.079 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.19 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.66 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 0.55 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.06 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.09 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.866 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.43 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.67 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 0.55 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 1.85 110.881 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD22 ' HA ' ' A' ' 94' ' ' LEU . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.06 110.351 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 0.31 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 61' ' ' TYR . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 0.4 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 0.34 110.983 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.33 110.353 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.14 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.33 110.558 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 0.47 109.552 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 3.98 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.86 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.62 111.308 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 1.59 112.293 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 35' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.36 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.646 ' HG2' HG11 ' A' ' 60' ' ' VAL . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.67 111.399 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.03 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.09 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 0.42 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.04 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.37 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.28 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.48 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.866 HD11 ' HA2' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 0.36 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46 111.538 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 ' HG2' ' A' ' 50' ' ' GLU . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.5 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.634 ' HB3' HG12 ' A' ' 36' ' ' ILE . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 0.83 110.474 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.47 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.636 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.66 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.82 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 69' ' ' GLU . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 1.53 110.439 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.25 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 79' ' ' THR . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.97 110.201 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 66' ' ' THR . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.65 110.822 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 HD21 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.56 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.84 112.257 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.46 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 1.51 110.675 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 80' ' ' VAL . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 1.79 110.892 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.22 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.36 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.91 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.13 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 68' ' ' VAL . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.25 111.521 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 HD12 ' A' ' 74' ' ' LEU . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.24 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.18 111.609 -174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.34 111.488 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 0.35 110.773 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.05 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.54 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.15 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.68 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.03 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 1.65 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' ' CG ' ' A' ' 6' ' ' GLU . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 4.45 110.345 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.97 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 1.63 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 0.86 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 1.57 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.538 ' HE1' HD13 ' A' ' 36' ' ' ILE . 81.4 t80 . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.938 0.399 . . . . 1.16 110.092 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 0.64 112.093 -171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 1.65 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.09 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 83' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 1.45 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 4' ' ' ALA . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 3.56 110.707 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 2.75 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.47 111.567 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 2.44 111.235 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.43 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 1.96 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.64 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.52 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 85' ' ' VAL . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 0.99 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.04 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.03 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 0.76 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 4.68 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 1.91 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.14 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.587 HG22 ' HE3' ' A' ' 28' ' ' LYS . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.66 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.19 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.704 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 0.66 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 0.55 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.06 111.59 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.09 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.43 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.67 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 58' ' ' ILE . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 0.55 110.299 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.637 ' HG3' HD21 ' A' ' 94' ' ' LEU . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 1.85 110.228 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 94' ' ' LEU . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.06 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 84' ' ' ALA . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 0.31 109.957 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.538 HD13 ' HE1' ' A' ' 3' ' ' PHE . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 0.4 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 82' ' ' ALA . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 0.34 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 0.33 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 40' ' ' ASN . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.14 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.33 111.103 176.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 0.47 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 3.98 110.853 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.86 111.523 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.62 110.304 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 1.59 112.018 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 0.36 111.611 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.67 111.732 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.03 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.09 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 0.42 111.066 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.596 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.04 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.37 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.28 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.48 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 32' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 0.36 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46 112.043 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 50' ' ' GLU . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.5 110.802 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 36' ' ' ILE . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.83 110.639 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.47 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.943 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.67 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.82 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 1.53 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.25 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 79' ' ' THR . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 0.97 110.809 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.65 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 0.56 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.84 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.46 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 4' ' ' ALA . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 1.51 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 1.79 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.22 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.36 110.088 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.91 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.419 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.13 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 68' ' ' VAL . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.25 110.849 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.24 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.18 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 0.34 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 70' ' ' LEU . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 0.88 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.218 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.954 HG23 HG12 ' A' ' 16' ' ' ILE . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.05 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.54 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.15 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HG3' HD13 ' A' ' 94' ' ' LEU . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.68 112.208 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.03 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 1.65 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 4.45 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG23 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.97 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD21 ' HG3' ' A' ' 33' ' ' LYS . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.86 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.86 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 3' ' ' PHE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 1.57 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.526 ' CD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.233 0.54 . . . . 1.16 110.098 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 0.64 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 1.65 110.123 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.09 111.164 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 1.45 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 5' ' ' PHE . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 3.56 110.723 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 9' ' ' LYS . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 2.75 110.528 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 0.47 110.886 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 2.44 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.43 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 1.96 111.81 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.64 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.52 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 85' ' ' VAL . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 0.99 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.85 HG12 ' HB3' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.565 ' HB3' HD23 ' A' ' 74' ' ' LEU . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.03 111.3 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 0.76 110.51 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 4.68 110.659 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 1.91 110.057 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.14 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 20' ' ' ALA . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.19 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.66 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.752 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.06 111.416 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.09 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.649 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.43 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.67 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 0.55 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 1.85 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.06 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 49' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 0.31 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 0.4 110.0 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CB ' ' A' ' 82' ' ' ALA . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.603 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 0.33 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.14 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.33 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.47 111.858 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 3.98 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.86 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 0.62 110.906 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 1.59 112.125 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 35' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.67 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.09 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 0.42 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.04 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.37 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.28 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.48 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' HA2' ' A' ' 30' ' ' GLY . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 0.36 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 35' ' ' ILE . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 0.5 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.47 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.67 109.376 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.82 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 69' ' ' GLU . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 1.53 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.25 111.42 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 79' ' ' THR . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 0.97 110.156 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' H ' HG23 ' A' ' 66' ' ' THR . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.65 110.689 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 0.56 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.84 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.46 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 1.51 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 1.79 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.22 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' HD2' ' A' ' 77' ' ' PRO . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.36 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD2' ' HD2' ' A' ' 76' ' ' ARG . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.91 111.632 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.13 108.874 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 HG22 ' A' ' 68' ' ' VAL . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.25 111.422 -176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.24 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.18 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 0.34 110.781 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 0.88 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 0.35 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.825 ' HA ' HG13 ' A' ' 16' ' ' ILE . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.556 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 0.54 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.15 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.68 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.03 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 1.65 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 4.45 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 0.97 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 0.86 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 3' ' ' PHE . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 1.57 110.211 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.971 0 N-CA-C 112.715 -0.154 . . . . 7.54 112.715 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 48.4 m -148.75 61.13 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.789 -0.449 . . . . 6.58 109.789 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.1 p 46.41 49.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 122.542 1.163 . . . . 3.59 110.801 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.31 120.56 11.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.482 -1.235 . . . . 2.66 111.069 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD1' HD11 ' A' ' 93' ' ' ILE . 86.7 t80 -60.44 -48.94 79.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.51 -0.768 . . . . 1.16 110.836 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.478 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.64 111.757 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 1.65 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.09 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.461 HD21 HD11 ' A' ' 74' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 1.45 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 3.56 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 91' ' ' SER . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 2.75 110.173 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 0.47 110.835 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 2.44 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.43 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' LYS . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 1.96 111.136 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.64 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HD2' ' HB ' ' A' ' 86' ' ' VAL . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.52 109.716 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 10' ' ' ALA . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.99 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.04 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.03 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 0.76 110.327 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 4.68 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.14 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 49' ' ' ILE . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 0.66 110.543 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.19 111.358 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.66 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.06 112.401 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.09 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.43 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.67 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 0.55 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 1.85 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 94' ' ' LEU . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.06 110.51 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 0.31 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 0.34 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 0.33 110.834 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.14 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.33 111.477 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 0.47 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 3.98 110.748 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.86 112.63 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.591 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 1.59 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 24' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 0.36 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 60' ' ' VAL . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.67 111.337 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.03 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.09 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 0.42 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.04 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.37 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.48 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 0.36 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 50' ' ' GLU . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 0.5 110.457 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 0.83 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.47 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.67 110.273 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.82 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 1.53 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 0.97 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' H ' HG23 ' A' ' 66' ' ' THR . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.65 110.328 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 HD23 ' A' ' 83' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 0.56 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.84 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.46 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 4' ' ' ALA . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 1.51 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD21 HD22 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 1.79 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.22 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.36 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.91 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.13 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.25 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.24 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.18 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.34 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.66 HD22 HD21 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 0.88 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.35 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.05 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HB ' ' HD2' ' A' ' 15' ' ' LYS . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 0.54 109.936 -176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.15 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.764 ' HG2' HD23 ' A' ' 94' ' ' LEU . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.68 112.322 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.03 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.682 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 1.65 111.638 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 4.45 109.497 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' CD1' ' A' ' 3' ' ' PHE . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 0.97 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 88' ' ' PRO . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 1.63 112.222 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 0.86 110.335 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.901 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.09 55.01 0.73 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.39 44.07 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.268 -0.733 . . . . 2.85 111.268 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -164.78 129.46 2.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.421 -0.585 . . . . 6.7 109.421 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.319 -0.993 . . . . 7.01 108.319 -177.593 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 N-CA-C 111.522 -0.631 . . . . 7.54 111.522 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p -160.35 139.68 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.808 -0.441 . . . . 6.58 109.808 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.486 ' HA ' HD21 ' A' ' 96' ' ' LEU . 3.2 t -111.95 40.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.474 0.654 . . . . 3.59 109.958 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.2 -44.14 14.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 2.66 110.259 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.586 ' HE1' HD13 ' A' ' 36' ' ' ILE . 58.1 t80 72.66 -50.99 0.71 Allowed 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.036 -0.984 . . . . 1.16 111.972 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 0.64 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 1.65 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.09 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 1.45 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 3.56 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 2.75 110.766 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.47 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.61 ' HB2' HD12 ' A' ' 16' ' ' ILE . 15.6 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 2.44 111.619 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.43 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 1.96 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.64 112.286 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.52 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 85' ' ' VAL . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.99 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.04 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.03 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.76 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 4.68 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 1.91 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.14 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 49' ' ' ILE . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 0.66 110.283 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.19 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 0.66 111.295 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.55 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.06 110.638 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.09 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.43 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.67 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 84' ' ' ALA . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 0.55 109.732 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 1.85 111.685 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.892 HD21 ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.06 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 0.31 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.33 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.14 110.849 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.805 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.33 111.374 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 0.47 109.472 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 3.98 110.446 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.86 112.72 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 0.62 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 39' ' ' ARG . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 1.59 110.91 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 24' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.36 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.67 111.408 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.03 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.09 112.084 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 0.42 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.04 110.598 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.37 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.48 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 0.36 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46 112.012 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 50' ' ' GLU . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.5 110.578 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 0.83 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 39' ' ' ARG . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.47 109.999 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.67 110.425 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.82 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.805 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 1.53 110.661 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.25 111.103 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 79' ' ' THR . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 0.97 110.545 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 66' ' ' THR . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.65 111.02 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.84 112.28 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.46 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 1.51 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 1.79 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.22 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.36 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.91 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.407 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.13 110.243 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 68' ' ' VAL . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.912 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.24 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.18 110.526 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 0.34 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.88 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.35 111.014 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 16' ' ' ILE . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.05 109.717 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 0.54 111.357 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.15 111.719 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 86' ' ' VAL . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.68 112.166 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.03 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 1.65 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 92' ' ' ARG . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 4.45 110.795 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 0.97 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD23 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 1.63 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.86 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 1' ' ' VAL . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.593 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.892 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -75.39 -47.89 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 129.09 17.5 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.762 -0.732 . . . . 2.85 111.914 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.17 -34.65 75.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.506 0.194 . . . . 6.7 111.114 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.909 -0.567 . . . . 7.01 109.772 178.124 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.188 -0.365 . . . . 7.54 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.5 p -81.47 39.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.117 0.484 . . . . 6.58 111.269 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 3' ' ' PHE . 7.5 p -73.49 139.19 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.854 -0.612 . . . . 3.59 110.599 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -61.67 -40.1 93.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.992 -0.549 . . . . 2.66 110.475 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' H ' HG22 ' A' ' 1' ' ' VAL . 91.7 t80 73.75 -51.17 0.69 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.37 -0.832 . . . . 1.16 110.717 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.64 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.65 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.09 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 1.45 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 4' ' ' ALA . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 3.56 110.553 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 2.75 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 0.47 111.254 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 2.44 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.43 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 1.96 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.64 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.52 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' ALA . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 0.99 110.441 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' HE3' ' A' ' 22' ' ' LYS . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.04 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.03 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 0.76 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' ILE . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 4.68 109.728 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HE3' HG13 ' A' ' 17' ' ' VAL . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 1.91 110.706 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.14 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 20' ' ' ALA . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.66 110.723 176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 29' ' ' MET . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.19 110.327 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 0.66 111.618 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 0.55 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.06 111.102 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.09 111.944 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.43 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.67 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 0.55 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 1.85 111.171 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.06 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 0.31 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 61' ' ' TYR . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.4 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 0.34 110.957 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 0.33 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 63' ' ' PHE . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.14 110.874 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' HB2' ' H ' ' A' ' 67' ' ' SER . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.33 111.54 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 0.47 109.614 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 3.98 110.932 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.86 112.642 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 0.62 111.23 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 1.59 111.176 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 35' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.36 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' HG11 ' A' ' 60' ' ' VAL . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.67 111.047 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.03 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.09 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 0.42 110.796 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.04 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.37 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.28 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.48 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 0.36 110.364 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46 112.117 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.669 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 0.5 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HG12 ' A' ' 36' ' ' ILE . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 0.83 110.165 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.47 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.713 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.67 110.698 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.82 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 69' ' ' GLU . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 1.53 111.493 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' A' ' 40' ' ' ASN . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.25 111.467 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 0.97 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.624 ' H ' HG23 ' A' ' 66' ' ' THR . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.65 110.46 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 38' ' ' ALA . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.56 110.437 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.811 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.84 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.46 110.384 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' HA ' ' A' ' 4' ' ' ALA . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 1.51 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 80' ' ' VAL . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 1.79 111.351 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.22 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.36 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.91 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.13 112.062 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.25 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.811 HG23 ' HA2' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.24 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.18 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 0.34 110.554 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 74' ' ' LEU . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 0.88 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 0.35 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 16' ' ' ILE . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.05 109.915 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 0.54 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.15 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.68 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.03 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 1.65 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 4.45 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.594 HD12 HD13 ' A' ' 96' ' ' LEU . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 0.97 110.251 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.745 HD22 ' HD3' ' A' ' 99' ' ' LYS . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 1.63 111.432 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 93' ' ' ILE . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.265 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -67.09 -34.13 85.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.23 -61.14 4.19 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 112.149 -0.38 . . . . 2.85 112.149 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.745 ' HD3' HD22 ' A' ' 94' ' ' LEU . 8.3 mtmp? 69.5 -51.83 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.655 0.782 . . . . 6.7 111.924 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.165 -0.922 . . . . 7.01 110.733 179.204 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.091 -0.403 . . . . 7.54 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 t -78.61 132.18 37.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.925 0.393 . . . . 6.58 110.618 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 96' ' ' LEU . 54.6 t -65.07 -25.23 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.636 . . . . 3.59 110.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.98 59.47 0.86 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.539 -0.755 . . . . 2.66 109.109 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -73.41 42.06 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.559 -1.2 . . . . 1.16 112.852 -172.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.673 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.64 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 1.65 110.046 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.09 111.47 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 1.45 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 3.56 110.979 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 5' ' ' PHE . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 2.75 110.628 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.47 111.212 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 2.44 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 1.96 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.64 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.52 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 85' ' ' VAL . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 0.99 109.529 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.04 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.413 ' HB3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.03 110.565 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 0.76 111.293 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 4.68 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 25' ' ' GLN . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 1.91 111.629 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.14 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 0.66 111.127 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 22' ' ' LYS . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.19 110.837 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 0.66 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.604 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.06 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.09 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.751 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.43 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.67 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 0.55 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 1.85 111.15 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 93' ' ' ILE . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.06 110.527 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 0.31 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 0.4 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 82' ' ' ALA . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.34 110.25 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 0.33 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.14 110.829 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.762 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.33 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 0.47 111.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 3.98 111.404 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.86 112.685 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 0.62 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 1.59 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 60' ' ' VAL . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.67 111.39 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.03 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.09 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.42 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.04 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.37 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.28 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.48 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.751 HD11 ' HA2' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 0.36 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 50' ' ' GLU . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 0.5 110.043 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 0.83 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.47 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.67 110.202 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.82 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.77 HG22 ' HG2' ' A' ' 69' ' ' GLU . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 1.53 110.425 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.25 110.788 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.97 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.77 ' HG2' HG22 ' A' ' 66' ' ' THR . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.65 111.141 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 HD21 ' A' ' 83' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.56 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.84 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.46 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 1.51 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.633 HD13 HD22 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 1.79 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.22 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.36 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.91 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.13 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.25 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HA2' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.24 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.18 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 0.34 110.645 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.88 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 0.35 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.557 ' HA ' HG13 ' A' ' 16' ' ' ILE . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.05 109.548 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.15 110.028 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.68 112.153 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.03 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.65 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 4.45 110.036 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 85' ' ' VAL . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.97 110.573 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 1.63 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.86 110.772 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 1' ' ' VAL . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 1.57 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.26 -69.67 2.22 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.06 -133.53 3.16 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.985 -0.626 . . . . 2.85 112.047 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.78 -48.52 66.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.704 0.288 . . . . 6.7 110.969 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 116.071 -0.513 . . . . 7.01 110.03 -176.166 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.019 -0.433 . . . . 7.54 112.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.3 m -79.17 47.86 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 6.58 111.312 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t 54.05 -120.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.823 -0.626 . . . . 3.59 110.502 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -168.58 130.68 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.304 -0.999 . . . . 2.66 108.304 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.7 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -128.95 32.53 4.74 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.537 -0.301 . . . . 1.16 110.949 -176.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.64 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 1.65 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.09 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 73' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 1.45 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 3.56 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 2.75 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.47 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 7' ' ' LEU . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 2.44 110.54 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.43 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 1.96 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.64 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.52 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 85' ' ' VAL . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.99 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.04 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 76' ' ' ARG . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.03 110.822 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 0.76 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 4.68 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 1.91 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.588 HG22 ' HE3' ' A' ' 28' ' ' LYS . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 0.66 110.266 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.19 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.66 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 0.55 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.06 111.379 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.61 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.09 111.507 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.43 112.156 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.67 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.55 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 1.85 110.621 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.06 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 0.31 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 0.4 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.34 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 0.33 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.14 111.457 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.33 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 0.47 110.853 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 3.98 111.086 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.86 112.527 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 42' ' ' ARG . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.615 HG21 ' HB1' ' A' ' 20' ' ' ALA . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.62 110.618 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 1.59 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.57 HG13 HG12 ' A' ' 24' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.36 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.67 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.03 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CD2' ' HG2' ' A' ' 28' ' ' LYS . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 0.42 110.806 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.04 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.37 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.28 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.48 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 0.36 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 0.83 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.47 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.67 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.82 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 1.53 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.25 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.97 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.65 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.56 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.84 112.138 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.46 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 1.51 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 1.79 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.22 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HG2' ' SD ' ' A' ' 18' ' ' MET . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.36 109.214 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.91 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.13 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.25 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.24 110.711 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.18 110.715 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.34 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 0.88 110.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 0.35 110.706 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.05 109.608 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.54 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.15 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.574 ' HB3' HG22 ' A' ' 93' ' ' ILE . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.68 112.833 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.03 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 1.65 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 4.45 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 0.97 110.786 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 1.63 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 0.86 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.7 HD11 ' HD2' ' A' ' 3' ' ' PHE . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 1.57 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . -165.0 110.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' PRO . . . 175.18 -116.8 0.59 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.311 -0.715 . . . . 2.85 111.311 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -60.72 140.13 57.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.108 -0.33 . . . . 6.7 110.108 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.548 0.53 . . . . 7.01 109.826 -175.087 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.905 -0.478 . . . . 7.54 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.6 m 59.4 44.48 15.06 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.391 0.615 . . . . 6.58 110.833 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 96' ' ' LEU . 6.1 p -78.16 140.92 16.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.444 -0.798 . . . . 3.59 111.127 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.81 -36.76 2.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.03 -0.532 . . . . 2.66 109.63 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 71.67 -54.37 0.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.657 -1.156 . . . . 1.16 112.433 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.634 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.64 111.423 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 1.65 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.09 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 1.45 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 3.56 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.75 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 0.47 110.519 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 2.44 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.43 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 1.96 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.64 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.52 110.419 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 0.99 110.476 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.04 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.03 108.87 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 23' ' ' SER . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' H ' ' HB3' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 0.76 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 4.68 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 18' ' ' MET . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 1.91 110.886 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.467 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.14 110.92 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 0.66 110.144 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.19 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.66 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 0.55 110.7 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.06 110.636 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.09 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.977 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.43 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.67 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 0.55 111.444 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.85 110.513 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.06 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 0.31 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.632 HG12 ' HB3' ' A' ' 61' ' ' TYR . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 0.4 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 0.34 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.33 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.14 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.33 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.47 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 3.98 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.86 112.403 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 0.62 110.786 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.59 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.36 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.631 ' HG2' HG11 ' A' ' 60' ' ' VAL . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.094 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.03 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.09 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 0.42 111.542 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.04 112.092 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.37 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.28 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.48 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.977 HD11 ' HA2' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 0.36 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 0.5 109.744 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HB3' HG12 ' A' ' 36' ' ' ILE . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 0.83 110.699 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.47 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.67 109.887 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.82 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 1.53 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.25 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.97 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.65 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 83' ' ' LEU . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 0.56 110.403 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.84 112.825 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' GLU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.46 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.51 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.546 HD12 HG21 ' A' ' 80' ' ' VAL . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.22 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.36 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.91 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.13 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.25 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 74' ' ' LEU . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.24 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.18 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 0.34 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 70' ' ' LEU . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 0.88 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.35 111.046 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.05 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 0.54 109.984 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.15 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 93' ' ' ILE . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.68 112.169 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.03 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 1.65 111.917 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 4.45 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 0.97 111.125 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 1.63 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.86 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 1' ' ' VAL . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.71 121.75 1.08 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.2 114.81 0.34 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.099 -0.8 . . . . 2.85 111.099 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.6 128.4 35.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.017 0.437 . . . . 6.7 110.632 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.682 -0.675 . . . . 7.01 110.157 -179.096 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.843 -0.503 . . . . 7.54 111.843 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 50.7 m 57.32 37.36 28.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.457 0.303 . . . . 6.58 110.639 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 64' ' ' GLU . 31.5 m 41.08 -147.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.301 1.04 . . . . 3.59 112.297 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.31 129.46 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.162 -0.31 . . . . 2.66 110.162 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 -166.85 26.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.605 -0.27 . . . . 1.16 111.631 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 0.64 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 1.65 109.944 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.09 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 74' ' ' LEU . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.974 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HG3' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 3.56 110.531 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 90' ' ' GLU . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 2.75 110.277 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 0.47 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 2.44 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.43 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 90' ' ' GLU . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 1.96 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.64 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.52 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 HG22 ' A' ' 85' ' ' VAL . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.99 110.506 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.04 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.03 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 0.76 110.608 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 4.68 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 1.91 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.14 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' ASP . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 0.66 110.537 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.19 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.66 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.55 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.06 110.729 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.09 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.43 111.54 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.67 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 0.55 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 94' ' ' LEU . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.06 109.648 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 0.31 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 0.4 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' HB1' ' A' ' 82' ' ' ALA . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 0.34 110.191 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 0.33 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.14 110.362 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.33 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 0.47 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 3.98 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.86 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 0.62 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 1.59 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 24' ' ' ILE . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 0.36 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.67 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.09 110.926 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.42 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.04 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.37 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.28 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.48 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 HD11 ' HA2' ' A' ' 30' ' ' GLY . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.36 109.917 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 0.83 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.47 109.883 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.67 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' HG22 ' A' ' 1' ' ' VAL . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 1.53 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.25 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.97 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.65 110.605 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 83' ' ' LEU . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 0.56 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.84 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.46 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 1.51 110.28 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 7' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 1.79 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.22 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HD3' ' HD2' ' A' ' 77' ' ' PRO . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.36 109.956 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.633 ' HD2' ' HD3' ' A' ' 76' ' ' ARG . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.91 112.888 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.52 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.13 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.25 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.464 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.24 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.18 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 0.34 110.731 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 70' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 0.88 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 0.35 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 16' ' ' ILE . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.05 109.971 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 0.54 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 94' ' ' LEU . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.68 112.33 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA3' HG23 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 9' ' ' LYS . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.03 110.852 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 1.65 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 4.45 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 0.97 111.198 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.644 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 1.63 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.86 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 1.57 111.847 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.17 56.93 0.5 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 141.45 3.41 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.154 -0.546 . . . . 2.85 111.736 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 139.87 15.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.138 -0.319 . . . . 6.7 110.138 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.757 -0.639 . . . . 7.01 109.963 -179.171 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.216 -0.354 . . . . 7.54 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.5 p -75.38 134.24 41.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.597 0.237 . . . . 6.58 110.833 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.428 HG21 ' OH ' ' A' ' 61' ' ' TYR . 15.7 m -135.2 155.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 3.59 111.635 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -149.88 -44.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 2.66 110.657 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' HD2' HD11 ' A' ' 96' ' ' LEU . 1.6 p90 45.78 31.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.062 1.345 . . . . 1.16 114.1 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 0.64 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 1.65 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CG ' ' HG3' ' A' ' 92' ' ' ARG . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.09 111.775 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 1.45 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 3.56 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 2.75 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.47 110.669 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 2.44 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.43 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 1.96 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.64 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.52 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.04 110.056 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.03 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 0.76 110.332 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 4.68 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 1.91 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.14 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 0.66 110.079 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.19 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.66 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 0.55 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.06 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.09 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.866 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.43 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.67 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 0.55 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 1.85 110.881 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD22 ' HA ' ' A' ' 94' ' ' LEU . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.06 110.351 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 0.31 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 61' ' ' TYR . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 0.4 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 0.34 110.983 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.33 110.353 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.14 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.33 110.558 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 0.47 109.552 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 3.98 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.86 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.62 111.308 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 1.59 112.293 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 35' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.36 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.646 ' HG2' HG11 ' A' ' 60' ' ' VAL . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.67 111.399 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.03 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.09 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 0.42 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.04 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.37 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.28 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.48 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.866 HD11 ' HA2' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 0.36 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' HG3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46 111.538 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 ' HG2' ' A' ' 50' ' ' GLU . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.5 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.634 ' HB3' HG12 ' A' ' 36' ' ' ILE . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 0.83 110.474 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.47 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.636 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.66 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.82 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 69' ' ' GLU . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 1.53 110.439 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.25 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 79' ' ' THR . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.97 110.201 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 66' ' ' THR . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.65 110.822 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 HD21 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.56 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.84 112.257 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.46 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 1.51 110.675 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 80' ' ' VAL . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 1.79 110.892 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.22 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.36 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.91 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.13 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 68' ' ' VAL . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.25 111.521 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 HD12 ' A' ' 74' ' ' LEU . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.24 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.18 111.609 -174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.34 111.488 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 0.35 110.773 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.05 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.54 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.15 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.68 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.03 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 1.65 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' ' CG ' ' A' ' 6' ' ' GLU . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 4.45 110.345 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.97 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 1.63 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 0.86 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 1.57 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.38 29.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.76 -150.02 9.68 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.344 -0.703 . . . . 2.85 111.344 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -173.6 117.71 0.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.009 0.433 . . . . 6.7 110.83 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HG2' ' HG3' ' A' ' 59' ' ' PRO . 66.8 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.471 -0.776 . . . . 7.01 110.005 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.779 -0.528 . . . . 7.54 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.1 t -65.77 131.26 45.87 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 6.58 109.953 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.1 m -65.52 133.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.423 . . . . 3.59 111.095 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 10.6 t70 -123.57 -72.86 0.66 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.995 -0.548 . . . . 2.66 110.958 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.538 ' HE1' HD13 ' A' ' 36' ' ' ILE . 81.4 t80 161.93 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.646 0.778 . . . . 1.16 110.092 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 0.64 112.093 -171.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 1.65 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.09 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 83' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 1.45 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 4' ' ' ALA . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 3.56 110.707 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 2.75 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.47 111.567 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 2.44 111.235 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.43 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 1.96 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.64 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.52 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 85' ' ' VAL . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 0.99 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.04 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.03 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 0.76 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 4.68 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 1.91 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.14 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.587 HG22 ' HE3' ' A' ' 28' ' ' LYS . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.66 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.19 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.704 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 0.66 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 0.55 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.06 111.59 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.09 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.43 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.67 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 58' ' ' ILE . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 0.55 110.299 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.637 ' HG3' HD21 ' A' ' 94' ' ' LEU . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 1.85 110.228 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 94' ' ' LEU . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.06 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 84' ' ' ALA . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 0.31 109.957 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.538 HD13 ' HE1' ' A' ' 3' ' ' PHE . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 0.4 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 82' ' ' ALA . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 0.34 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 0.33 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 40' ' ' ASN . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.14 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.33 111.103 176.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 0.47 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 3.98 110.853 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.86 111.523 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.62 110.304 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 1.59 112.018 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 0.36 111.611 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.67 111.732 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.03 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.09 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 0.42 111.066 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.596 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.04 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.37 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.28 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.48 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 32' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 0.36 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46 112.043 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 50' ' ' GLU . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.5 110.802 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 36' ' ' ILE . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.83 110.639 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.47 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.943 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.67 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.82 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 1.53 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.25 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 79' ' ' THR . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 0.97 110.809 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.65 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 0.56 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.84 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.46 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 4' ' ' ALA . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 1.51 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 1.79 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.22 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.36 110.088 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.91 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.419 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.13 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 68' ' ' VAL . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.25 110.849 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.24 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.18 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 0.34 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 70' ' ' LEU . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 0.88 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.218 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.954 HG23 HG12 ' A' ' 16' ' ' ILE . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.05 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.54 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.15 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HG3' HD13 ' A' ' 94' ' ' LEU . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.68 112.208 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.03 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 1.65 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 4.45 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG23 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.97 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD21 ' HG3' ' A' ' 33' ' ' LYS . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.86 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.86 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 3' ' ' PHE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 1.57 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.21 57.77 0.88 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.19 20.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.442 -0.409 . . . . 2.85 113.452 -171.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -175.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 6.7 110.553 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.085 -0.96 . . . . 7.01 109.463 -176.816 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.169 -0.372 . . . . 7.54 112.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 p -85.58 118.93 25.4 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.716 -0.285 . . . . 6.58 110.275 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' HB ' HD23 ' A' ' 96' ' ' LEU . 9.2 m 35.01 55.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 124.02 0.825 . . . . 3.59 112.485 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.09 142.45 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.596 -0.729 . . . . 2.66 111.188 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.526 ' CD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -149.6 35.43 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.773 -0.648 . . . . 1.16 110.098 176.015 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 0.64 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 1.65 110.123 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.09 111.164 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 1.45 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 5' ' ' PHE . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 3.56 110.723 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 9' ' ' LYS . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 2.75 110.528 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 0.47 110.886 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 2.44 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.43 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 1.96 111.81 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.64 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.52 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 85' ' ' VAL . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 0.99 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.85 HG12 ' HB3' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.565 ' HB3' HD23 ' A' ' 74' ' ' LEU . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.03 111.3 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 0.76 110.51 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 4.68 110.659 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 1.91 110.057 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.14 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 20' ' ' ALA . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.19 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.66 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.752 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.06 111.416 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.09 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.649 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.43 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.67 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 0.55 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 1.85 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.06 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 49' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 0.31 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 0.4 110.0 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CB ' ' A' ' 82' ' ' ALA . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.603 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 0.33 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.14 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.33 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.47 111.858 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 3.98 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.86 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 0.62 110.906 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 1.59 112.125 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 35' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.67 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.09 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 0.42 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.04 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.37 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.28 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.48 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' HA2' ' A' ' 30' ' ' GLY . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 0.36 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 35' ' ' ILE . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 0.5 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.47 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.67 109.376 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.82 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 69' ' ' GLU . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 1.53 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.25 111.42 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 79' ' ' THR . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 0.97 110.156 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' H ' HG23 ' A' ' 66' ' ' THR . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.65 110.689 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 0.56 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.84 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.46 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 1.51 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 1.79 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.22 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' HD2' ' A' ' 77' ' ' PRO . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.36 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD2' ' HD2' ' A' ' 76' ' ' ARG . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.91 111.632 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.13 108.874 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 HG22 ' A' ' 68' ' ' VAL . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.25 111.422 -176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.24 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.18 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 0.34 110.781 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 0.88 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 0.35 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.825 ' HA ' HG13 ' A' ' 16' ' ' ILE . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.556 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 0.54 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.15 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.68 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.03 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 1.65 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 4.45 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 0.97 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 0.86 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 3' ' ' PHE . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 1.57 110.211 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -98.81 45.82 1.56 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.53 131.86 1.41 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.562 -0.828 . . . . 2.85 112.393 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.9 56.73 4.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.491 . . . . 6.7 110.85 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.104 -0.95 . . . . 7.01 109.308 -179.195 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD1' HD11 ' A' ' 93' ' ' ILE . 86.7 t80 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.987 0.422 . . . . 1.16 110.836 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.478 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.64 111.757 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 1.65 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.09 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.461 HD21 HD11 ' A' ' 74' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 1.45 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 3.56 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 91' ' ' SER . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 2.75 110.173 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 0.47 110.835 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 2.44 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.43 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' LYS . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 1.96 111.136 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.64 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HD2' ' HB ' ' A' ' 86' ' ' VAL . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.52 109.716 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 10' ' ' ALA . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.99 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.04 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.03 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 0.76 110.327 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 4.68 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.14 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 49' ' ' ILE . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 0.66 110.543 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 25' ' ' GLN . 6.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.19 111.358 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.66 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.06 112.401 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.09 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.43 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.67 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 0.55 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 1.85 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 94' ' ' LEU . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.06 110.51 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 0.31 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 0.34 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 0.33 110.834 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.14 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.33 111.477 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 0.47 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 3.98 110.748 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.86 112.63 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.591 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 1.59 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 24' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 0.36 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 60' ' ' VAL . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.67 111.337 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.03 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.09 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 0.42 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.04 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.37 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.48 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 0.36 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 50' ' ' GLU . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 0.5 110.457 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 0.83 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.47 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.67 110.273 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.82 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 1.53 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 0.97 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' H ' HG23 ' A' ' 66' ' ' THR . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.65 110.328 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 HD23 ' A' ' 83' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 0.56 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.84 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.46 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 4' ' ' ALA . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 1.51 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.66 HD21 HD22 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 1.79 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.22 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.36 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.91 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.13 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.25 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.24 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.18 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.34 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.66 HD22 HD21 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 0.88 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.35 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.05 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HB ' ' HD2' ' A' ' 15' ' ' LYS . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 0.54 109.936 -176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.15 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.764 ' HG2' HD23 ' A' ' 94' ' ' LEU . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.68 112.322 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.03 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.682 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 1.65 111.638 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 4.45 109.497 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' CD1' ' A' ' 3' ' ' PHE . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 0.97 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 88' ' ' PRO . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 1.63 112.222 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 0.86 110.335 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.901 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.586 ' HE1' HD13 ' A' ' 36' ' ' ILE . 58.1 t80 . . . . . 0 C--O 1.222 -0.344 0 N-CA-C 111.972 0.36 . . . . 1.16 111.972 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 0.64 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 1.65 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.09 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 1.45 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 3.56 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 2.75 110.766 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.47 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.61 ' HB2' HD12 ' A' ' 16' ' ' ILE . 52.4 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 2.44 111.619 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.43 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 1.96 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.64 112.286 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.52 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 85' ' ' VAL . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.99 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.04 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.03 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.76 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 4.68 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 1.91 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.14 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 49' ' ' ILE . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 0.66 110.283 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.19 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 0.66 111.295 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.55 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.06 110.638 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.09 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.43 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.67 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 84' ' ' ALA . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 0.55 109.732 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 1.85 111.685 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.892 HD21 ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.06 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 0.31 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.33 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.14 110.849 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.805 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.33 111.374 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 0.47 109.472 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 3.98 110.446 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.86 112.72 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 0.62 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 39' ' ' ARG . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 1.59 110.91 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 24' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.36 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.67 111.408 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.03 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.09 112.084 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 0.42 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.04 110.598 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.37 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.48 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 0.36 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46 112.012 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 50' ' ' GLU . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.5 110.578 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 0.83 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 39' ' ' ARG . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.47 109.999 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.67 110.425 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.82 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.805 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 1.53 110.661 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.25 111.103 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 79' ' ' THR . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 0.97 110.545 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 66' ' ' THR . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.65 111.02 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.84 112.28 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.46 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 1.51 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 1.79 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.22 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.36 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.91 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.407 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.13 110.243 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 68' ' ' VAL . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.912 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.24 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.18 110.526 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 0.34 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.88 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.35 111.014 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 16' ' ' ILE . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.05 109.717 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 0.54 111.357 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.15 111.719 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 86' ' ' VAL . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.68 112.166 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.03 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 1.65 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 92' ' ' ARG . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 4.45 110.795 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 0.97 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD23 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 1.63 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.86 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.593 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.892 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.426 ' CZ ' HD11 ' A' ' 7' ' ' LEU . 91.7 t80 . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 120.815 0.341 . . . . 1.16 110.717 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.64 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.65 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.09 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 1.45 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 4' ' ' ALA . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 3.56 110.553 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 2.75 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 0.47 111.254 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 2.44 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.43 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 1.96 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.64 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.52 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' ALA . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 0.99 110.441 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' HE3' ' A' ' 22' ' ' LYS . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.04 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.03 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 0.76 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' ILE . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 4.68 109.728 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HE3' HG13 ' A' ' 17' ' ' VAL . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 1.91 110.706 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.14 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 20' ' ' ALA . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.66 110.723 176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 29' ' ' MET . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.19 110.327 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 0.66 111.618 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 0.55 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.06 111.102 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.09 111.944 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.43 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.67 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 0.55 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 1.85 111.171 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.06 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 0.31 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 61' ' ' TYR . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.4 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 0.34 110.957 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 0.33 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 63' ' ' PHE . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.14 110.874 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.529 ' HB2' ' H ' ' A' ' 67' ' ' SER . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.33 111.54 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 0.47 109.614 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 3.98 110.932 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.86 112.642 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 0.62 111.23 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 1.59 111.176 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 35' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.36 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' HG11 ' A' ' 60' ' ' VAL . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.67 111.047 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.667 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.03 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.09 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 0.42 110.796 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.04 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.37 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.28 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.48 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 0.36 110.364 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46 112.117 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.669 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 0.5 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HG12 ' A' ' 36' ' ' ILE . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 0.83 110.165 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.47 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.713 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.67 110.698 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.82 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 69' ' ' GLU . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 1.53 111.493 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' A' ' 40' ' ' ASN . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.25 111.467 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 0.97 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.624 ' H ' HG23 ' A' ' 66' ' ' THR . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.65 110.46 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 38' ' ' ALA . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.56 110.437 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.811 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.84 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.46 110.384 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' HA ' ' A' ' 4' ' ' ALA . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 1.51 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 80' ' ' VAL . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 1.79 111.351 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.22 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.36 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.91 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.13 112.062 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.25 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.811 HG23 ' HA2' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.24 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.18 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 0.34 110.554 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 74' ' ' LEU . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 0.88 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 0.35 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 16' ' ' ILE . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.05 109.915 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 0.54 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.15 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.68 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.03 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 1.65 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 4.45 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.594 HD12 HD13 ' A' ' 96' ' ' LEU . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 0.97 110.251 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.6 HD23 HD12 ' A' ' 34' ' ' LEU . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 1.63 111.432 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 93' ' ' ILE . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.265 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.31 0 N-CA-C 112.852 0.686 . . . . 1.16 112.852 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.673 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.64 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 1.65 110.046 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.09 111.47 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 1.45 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 3.56 110.979 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 5' ' ' PHE . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 2.75 110.628 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.47 111.212 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 2.44 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 1.96 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.64 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.52 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 85' ' ' VAL . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 0.99 109.529 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.04 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.413 ' HB3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.03 110.565 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 0.76 111.293 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 4.68 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 25' ' ' GLN . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 1.91 111.629 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.14 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 0.66 111.127 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 22' ' ' LYS . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.19 110.837 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 0.66 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.604 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.06 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.09 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.751 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.43 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.67 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 0.55 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 1.85 111.15 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 93' ' ' ILE . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.06 110.527 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 0.31 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 0.4 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 82' ' ' ALA . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.34 110.25 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 0.33 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.14 110.829 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.762 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.33 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 0.47 111.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 3.98 111.404 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.86 112.685 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 0.62 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 1.59 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 60' ' ' VAL . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.67 111.39 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.03 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.09 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.42 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.04 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.37 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.28 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.48 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.751 HD11 ' HA2' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 0.36 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 50' ' ' GLU . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 0.5 110.043 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 0.83 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.47 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.67 110.202 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.82 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.77 HG22 ' HG2' ' A' ' 69' ' ' GLU . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 1.53 110.425 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.25 110.788 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.97 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.77 ' HG2' HG22 ' A' ' 66' ' ' THR . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.65 111.141 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 HD21 ' A' ' 83' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.56 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.84 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.46 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 1.51 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.633 HD13 HD22 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 1.79 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.22 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.36 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.91 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.13 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.25 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HA2' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.24 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.18 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 0.34 110.645 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.88 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 0.35 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.557 ' HA ' HG13 ' A' ' 16' ' ' ILE . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.05 109.548 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.15 110.028 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.68 112.153 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.03 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.65 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 4.45 110.036 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 85' ' ' VAL . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.97 110.573 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 1.63 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.86 110.772 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' H ' HD12 ' A' ' 96' ' ' LEU . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 1.57 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.7 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 120.704 0.288 . . . . 1.16 110.949 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.64 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 1.65 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.09 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 73' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 1.45 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 3.56 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 2.75 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.47 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 7' ' ' LEU . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 2.44 110.54 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.43 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 1.96 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.64 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.52 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 85' ' ' VAL . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.99 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.04 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 76' ' ' ARG . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.03 110.822 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 0.76 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 4.68 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 1.91 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.588 HG22 ' HE3' ' A' ' 28' ' ' LYS . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 0.66 110.266 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.19 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.66 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 0.55 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.06 111.379 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.61 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.09 111.507 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.43 112.156 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.67 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.55 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 1.85 110.621 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.06 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 0.31 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 0.4 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.34 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 0.33 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.14 111.457 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.33 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 0.47 110.853 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 3.98 111.086 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.86 112.527 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 42' ' ' ARG . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.615 HG21 ' HB1' ' A' ' 20' ' ' ALA . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.62 110.618 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 1.59 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.57 HG13 HG12 ' A' ' 24' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.36 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.67 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.03 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CD2' ' HG2' ' A' ' 28' ' ' LYS . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 0.42 110.806 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.04 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.37 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.28 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.48 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 0.36 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 0.83 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.47 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.67 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.82 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 1.53 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.25 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.97 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.65 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.56 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.84 112.138 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.46 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 1.51 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 1.79 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.22 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HG2' ' SD ' ' A' ' 18' ' ' MET . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.36 109.214 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.91 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.13 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.25 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.24 110.711 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.18 110.715 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.34 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 0.88 110.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 0.35 110.706 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.05 109.608 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.54 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.15 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.574 ' HB3' HG22 ' A' ' 93' ' ' ILE . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.68 112.833 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.03 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 1.65 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 4.45 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 0.97 110.786 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 1.63 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 0.86 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.7 HD11 ' HD2' ' A' ' 3' ' ' PHE . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 1.57 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . . . . . . 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 . . . . . 0 N--CA 1.464 0.23 0 N-CA-C 112.433 0.531 . . . . 1.16 112.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.634 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.64 111.423 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 1.65 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.09 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 1.45 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 3.56 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.75 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 0.47 110.519 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 2.44 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.43 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 1.96 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.64 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.52 110.419 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 0.99 110.476 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.04 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.03 108.87 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 23' ' ' SER . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.481 ' H ' ' HB3' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 0.76 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 4.68 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 18' ' ' MET . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 1.91 110.886 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.467 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.14 110.92 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 0.66 110.144 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.19 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.66 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 0.55 110.7 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.06 110.636 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.09 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.977 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.43 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.67 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 0.55 111.444 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.85 110.513 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.06 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 0.31 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.632 HG12 ' HB3' ' A' ' 61' ' ' TYR . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 0.4 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 0.34 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.33 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.14 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.33 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.47 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 3.98 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.86 112.403 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 0.62 110.786 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.59 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.36 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.631 ' HG2' HG11 ' A' ' 60' ' ' VAL . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.094 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.03 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.09 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 0.42 111.542 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.04 112.092 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.37 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.28 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.48 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.977 HD11 ' HA2' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 0.36 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 0.5 109.744 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HB3' HG12 ' A' ' 36' ' ' ILE . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 0.83 110.699 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.47 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.67 109.887 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.82 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 1.53 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.25 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.97 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.65 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 83' ' ' LEU . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 0.56 110.403 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.84 112.825 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' GLU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.46 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.51 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.546 HD12 HG21 ' A' ' 80' ' ' VAL . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.22 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.36 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.91 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.13 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.25 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 74' ' ' LEU . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.24 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.18 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 0.34 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 70' ' ' LEU . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 0.88 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.35 111.046 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.05 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 0.54 109.984 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.15 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 93' ' ' ILE . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.68 112.169 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.03 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 1.65 111.917 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 4.45 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 0.97 111.125 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 1.63 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.86 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.515 HD23 HD12 ' A' ' 93' ' ' ILE . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 . . . . . 0 N--CA 1.457 -0.11 0 N-CA-C 111.631 0.234 . . . . 1.16 111.631 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 0.64 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 1.65 109.944 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.09 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 74' ' ' LEU . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.974 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HG3' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 3.56 110.531 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 90' ' ' GLU . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 2.75 110.277 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 0.47 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 2.44 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.43 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 90' ' ' GLU . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 1.96 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.64 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.52 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 HG22 ' A' ' 85' ' ' VAL . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.99 110.506 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.04 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.03 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 0.76 110.608 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 4.68 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 1.91 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.14 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' ASP . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 0.66 110.537 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.19 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.66 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.55 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.06 110.729 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.09 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.43 111.54 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.67 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 0.55 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 94' ' ' LEU . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.06 109.648 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 0.31 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 0.4 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' HB1' ' A' ' 82' ' ' ALA . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 0.34 110.191 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 0.33 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.14 110.362 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.33 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 0.47 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 3.98 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.86 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 0.62 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 1.59 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 24' ' ' ILE . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 0.36 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.67 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.09 110.926 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.42 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.04 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.37 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.28 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.48 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.466 HD11 ' HA2' ' A' ' 30' ' ' GLY . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.36 109.917 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 0.83 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.47 109.883 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.67 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 1.53 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.25 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.97 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.65 110.605 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 83' ' ' LEU . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 0.56 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.84 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.46 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 1.51 110.28 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 7' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 1.79 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.22 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HD3' ' HD2' ' A' ' 77' ' ' PRO . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.36 109.956 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.633 ' HD2' ' HD3' ' A' ' 76' ' ' ARG . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.91 112.888 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.52 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.13 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.25 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.464 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.24 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.18 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 0.34 110.731 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 70' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 0.88 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 0.35 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 16' ' ' ILE . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.05 109.971 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 0.54 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 94' ' ' LEU . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.68 112.33 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA3' HG23 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 9' ' ' LYS . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.03 110.852 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 1.65 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 4.45 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 0.97 111.198 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.644 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 1.63 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.86 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 1.57 111.847 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.645 ' HD2' HD11 ' A' ' 96' ' ' LEU . 1.6 p90 . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 114.1 1.148 . . . . 1.16 114.1 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 0.64 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 1.65 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CG ' ' HG3' ' A' ' 92' ' ' ARG . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.09 111.775 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 1.45 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 3.56 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 2.75 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.47 110.669 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 2.44 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.43 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 1.96 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.64 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.52 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.04 110.056 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.03 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 0.76 110.332 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 4.68 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 1.91 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.14 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 0.66 110.079 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.19 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.66 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 0.55 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.06 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.09 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.866 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.43 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.67 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 0.55 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 1.85 110.881 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.681 HD22 ' HA ' ' A' ' 94' ' ' LEU . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.06 110.351 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 0.31 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 61' ' ' TYR . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 0.4 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 0.34 110.983 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.33 110.353 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.14 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.33 110.558 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 0.47 109.552 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 3.98 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.86 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.62 111.308 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 1.59 112.293 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 35' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.36 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.646 ' HG2' HG11 ' A' ' 60' ' ' VAL . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.67 111.399 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.56 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.03 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.09 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 0.42 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.04 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.37 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.28 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.48 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.866 HD11 ' HA2' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 0.36 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46 111.538 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 ' HG2' ' A' ' 50' ' ' GLU . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.5 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.634 ' HB3' HG12 ' A' ' 36' ' ' ILE . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 0.83 110.474 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.47 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.636 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.66 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.82 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 69' ' ' GLU . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 1.53 110.439 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.25 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 79' ' ' THR . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.97 110.201 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 66' ' ' THR . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.65 110.822 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 HD21 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.56 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.84 112.257 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.46 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 1.51 110.675 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 80' ' ' VAL . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 1.79 110.892 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.22 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.36 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.91 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.13 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 68' ' ' VAL . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.25 111.521 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 HD12 ' A' ' 74' ' ' LEU . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.24 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.18 111.609 -174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.34 111.488 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 0.35 110.773 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.05 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.54 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.15 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.68 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.03 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 1.65 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' ' CG ' ' A' ' 6' ' ' GLU . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 4.45 110.345 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.97 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 1.63 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 0.86 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 1.57 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.538 ' HE1' HD13 ' A' ' 36' ' ' ILE . 81.4 t80 . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.938 0.399 . . . . 1.16 110.092 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 0.64 112.093 -171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 1.65 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.09 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 83' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 1.45 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 4' ' ' ALA . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 3.56 110.707 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 2.75 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.47 111.567 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.579 HE21 HD12 ' A' ' 16' ' ' ILE . 68.6 mm-40 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 2.44 111.235 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.43 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 1.96 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.64 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.52 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 85' ' ' VAL . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 0.99 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.04 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.03 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 0.76 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 4.68 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 1.91 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.14 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.587 HG22 ' HE3' ' A' ' 28' ' ' LYS . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.66 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.19 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.704 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 0.66 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 0.55 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.06 111.59 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.09 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.43 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.67 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 58' ' ' ILE . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 0.55 110.299 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.637 ' HG3' HD21 ' A' ' 94' ' ' LEU . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 1.85 110.228 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 94' ' ' LEU . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.06 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 84' ' ' ALA . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 0.31 109.957 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.538 HD13 ' HE1' ' A' ' 3' ' ' PHE . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 0.4 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 82' ' ' ALA . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 0.34 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 0.33 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 40' ' ' ASN . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.14 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.33 111.103 176.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 0.47 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 3.98 110.853 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.86 111.523 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.62 110.304 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 1.59 112.018 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 0.36 111.611 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.67 111.732 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.03 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.09 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 0.42 111.066 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.596 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.04 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.37 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.28 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.48 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 32' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 0.36 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46 112.043 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 50' ' ' GLU . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.5 110.802 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 36' ' ' ILE . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.83 110.639 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.47 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.943 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.67 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.82 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 1.53 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.25 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 79' ' ' THR . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 0.97 110.809 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.65 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 0.56 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.84 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.46 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 4' ' ' ALA . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 1.51 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 1.79 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.22 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.36 110.088 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.91 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.419 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.13 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 68' ' ' VAL . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.25 110.849 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.24 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.18 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 0.34 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 70' ' ' LEU . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 0.88 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.218 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.954 HG23 HG12 ' A' ' 16' ' ' ILE . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.05 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.54 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.15 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HG3' HD13 ' A' ' 94' ' ' LEU . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.68 112.208 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.03 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 1.65 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 4.45 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.616 HG23 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.97 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD21 ' HG3' ' A' ' 33' ' ' LYS . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.86 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.86 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 3' ' ' PHE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 1.57 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.526 ' CD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 121.233 0.54 . . . . 1.16 110.098 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 0.64 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 1.65 110.123 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.09 111.164 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 1.45 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 5' ' ' PHE . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 3.56 110.723 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 9' ' ' LYS . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 2.75 110.528 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 0.47 110.886 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 2.44 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.43 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 1.96 111.81 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.64 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.52 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 85' ' ' VAL . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 0.99 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.85 HG12 ' HB3' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.565 ' HB3' HD23 ' A' ' 74' ' ' LEU . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.03 111.3 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 0.76 110.51 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 4.68 110.659 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 1.91 110.057 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.14 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 20' ' ' ALA . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.19 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.66 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.752 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.06 111.416 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.09 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.649 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.43 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.67 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 0.55 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 1.85 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.06 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 49' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 0.31 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 0.4 110.0 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CB ' ' A' ' 82' ' ' ALA . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.603 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 0.33 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.14 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.33 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.47 111.858 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 3.98 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.86 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 0.62 110.906 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 1.59 112.125 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 35' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.67 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.575 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.09 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 0.42 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.04 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.37 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.28 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.48 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' HA2' ' A' ' 30' ' ' GLY . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 0.36 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 35' ' ' ILE . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 0.5 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.47 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.67 109.376 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.82 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 69' ' ' GLU . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 1.53 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.25 111.42 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 79' ' ' THR . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 0.97 110.156 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' H ' HG23 ' A' ' 66' ' ' THR . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.65 110.689 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 0.56 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.84 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.46 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 1.51 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 1.79 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.22 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' HD2' ' A' ' 77' ' ' PRO . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.36 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD2' ' HD2' ' A' ' 76' ' ' ARG . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.91 111.632 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.13 108.874 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 HG22 ' A' ' 68' ' ' VAL . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.25 111.422 -176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.24 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.18 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 0.34 110.781 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 0.88 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 0.35 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.825 ' HA ' HG13 ' A' ' 16' ' ' ILE . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.556 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 0.54 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.15 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.68 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.03 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 1.65 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 4.45 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 0.97 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 0.86 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 3' ' ' PHE . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 1.57 110.211 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.971 0 N-CA-C 112.715 -0.154 . . . . 7.54 112.715 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 48.4 m -148.75 61.13 1.07 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.789 -0.449 . . . . 6.58 109.789 177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 1' ' ' VAL . 7.1 p 46.41 49.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 122.542 1.163 . . . . 3.59 110.801 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -62.31 120.56 11.22 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.482 -1.235 . . . . 2.66 111.069 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.59 ' CD1' HD11 ' A' ' 93' ' ' ILE . 86.7 t80 -60.44 -48.94 79.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.51 -0.768 . . . . 1.16 110.836 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.478 ' CB ' HD11 ' A' ' 73' ' ' LEU . . . -61.44 -47.01 87.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.64 111.757 -177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -61.49 -49.34 77.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.528 -0.306 . . . . 1.65 110.887 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -63.92 -38.12 89.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 2.09 111.299 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.461 HD21 HD11 ' A' ' 74' ' ' LEU . 18.5 tp -68.39 -47.12 68.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.803 -0.359 . . . . 1.45 111.25 -176.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -66.93 -33.93 76.66 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.71 -0.396 . . . . 3.56 110.453 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.682 ' HE3' ' HA ' ' A' ' 91' ' ' SER . 38.9 ttpt -65.22 -40.62 94.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 2.75 110.173 176.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -62.82 -37.73 87.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.028 0.442 . . . . 0.47 110.835 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.35 -39.53 92.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.979 -0.555 . . . . 2.44 110.154 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.69 -50.61 14.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.677 -0.692 . . . . 1.43 111.835 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 9' ' ' LYS . 8.4 t -115.04 46.19 1.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.422 0.629 . . . . 1.96 111.136 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.88 -134.4 1.67 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.939 -0.648 . . . . 0.64 112.127 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HD2' ' HB ' ' A' ' 86' ' ' VAL . 1.2 tmtp? -159.64 115.8 2.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.716 -0.475 . . . . 3.52 109.716 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' A' ' 10' ' ' ALA . 40.6 mm -123.8 126.66 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.991 -0.55 . . . . 0.99 110.736 -176.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.3 t -90.53 132.09 36.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.586 -0.524 . . . . 1.04 109.586 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -125.56 125.75 43.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.843 0.354 . . . . 2.03 110.766 -177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 162.03 -121.52 1.03 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.69 -0.564 . . . . 1.71 111.69 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -164.82 -61.54 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.327 -0.249 . . . . 0.76 110.327 175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -67.1 -39.18 86.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.358 . . . . 4.68 111.111 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -60.97 -40.08 92.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 1.91 110.25 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -66.88 -35.61 80.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.743 -0.662 . . . . 1.14 111.045 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 49' ' ' ILE . 67.7 mt -59.21 -39.43 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.979 0.418 . . . . 0.66 110.543 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.416 HE21 ' HB2' ' A' ' 25' ' ' GLN . 6.3 tt0 -59.94 -37.33 79.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.885 -0.598 . . . . 2.19 111.358 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -68.98 -36.01 77.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.66 110.459 176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.31 78.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.25 -0.432 . . . . 0.55 110.788 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 60.7 mtpt -66.85 -48.44 68.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.881 -0.6 . . . . 2.06 112.401 -176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptp -147.53 24.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.811 -0.355 . . . . 3.09 111.647 -171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.54 -149.6 21.92 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 119.928 -1.13 . . . . 1.43 112.994 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -163.84 41.2 0.32 Allowed Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.718 -0.741 . . . . 1.67 111.353 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.27 138.11 56.63 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.785 -0.45 . . . . 0.55 109.785 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -68.4 -39.16 81.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.75 0.309 . . . . 1.85 110.485 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 94' ' ' LEU . 56.0 tp -141.76 138.33 32.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.571 -0.286 . . . . 1.06 110.51 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -125.45 126.05 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.556 -0.535 . . . . 0.31 109.556 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD12 HD11 ' A' ' 83' ' ' LEU . 65.2 mt -112.45 131.2 64.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.436 -0.347 . . . . 0.4 110.798 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.0 m -123.36 136.63 59.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.43 -0.35 . . . . 0.34 110.544 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.81 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -63.86 141.01 58.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.471 -0.331 . . . . 0.33 110.834 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -61.71 -43.47 98.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.004 0.43 . . . . 4.14 110.581 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.468 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 7.2 m120 -88.81 35.21 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.253 -0.431 . . . . 2.33 111.477 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.09 161.48 16.5 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.343 -0.614 . . . . 0.47 109.343 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 49.4 mtp180 -66.34 135.11 94.73 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 120.995 -0.282 . . . . 3.98 110.748 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 68.4 Cg_exo -53.71 -36.13 80.68 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.243 2.629 . . . . 0.86 112.63 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -58.27 -43.4 87.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.996 0.427 . . . . 2.48 110.603 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.66 -49.34 52.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.69 -0.686 . . . . 0.62 110.591 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -62.51 -54.17 43.84 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.395 0.517 . . . . 1.59 112.395 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -61.5 -37.6 84.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.977 0.417 . . . . 2.6 111.218 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -64.91 -52.39 56.73 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.858 -0.61 . . . . 1.21 111.073 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.692 HG12 HG12 ' A' ' 24' ' ' ILE . 66.4 mt -66.16 -50.23 70.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.4 -0.364 . . . . 0.36 111.774 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 60' ' ' VAL . 94.7 mt-10 -57.3 -43.52 83.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.459 -0.337 . . . . 1.67 111.337 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -68.81 -50.57 49.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.573 -0.285 . . . . 1.03 111.038 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.525 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 6.6 m-30 -59.99 -42.27 93.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 1.09 111.279 -177.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.5 -45.25 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.481 -0.327 . . . . 0.42 110.832 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -59.33 -43.68 92.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.575 -0.284 . . . . 4.04 111.654 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.4 pp -65.72 -33.61 76.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.848 0.356 . . . . 1.37 110.66 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -77.3 -9.62 58.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 1.28 111.516 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.03 25.07 60.46 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.082 -0.58 . . . . 0.48 111.937 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.29 119.47 66.5 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.746 -0.465 . . . . 0.36 109.746 175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.95 125.43 13.64 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.91 2.407 . . . . 0.46 112.378 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG11 ' HG2' ' A' ' 50' ' ' GLU . 40.9 t -102.73 140.45 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.626 -0.715 . . . . 0.5 110.457 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.545 ' HB3' HG12 ' A' ' 36' ' ' ILE . 40.8 t80 -123.56 133.75 53.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.782 -0.451 . . . . 0.83 109.782 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -86.87 120.5 28.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.296 -0.411 . . . . 2.47 110.065 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.81 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 29.6 t80 -67.46 128.97 38.43 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.574 -0.284 . . . . 0.67 110.273 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.59 62.1 1.39 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.984 -0.553 . . . . 2.46 111.135 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.57 -168.11 41.21 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.955 -0.641 . . . . 0.82 112.635 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 13.3 t -99.99 170.0 8.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.878 0.37 . . . . 1.53 110.874 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.7 p -61.26 -33.96 74.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.552 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.78 -47.65 90.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.063 0.459 . . . . 0.97 110.666 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' H ' HG23 ' A' ' 66' ' ' THR . 51.4 mt-10 -63.88 -40.46 96.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.797 -0.638 . . . . 2.65 110.328 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.51 HD21 HD23 ' A' ' 83' ' ' LEU . 24.0 tp -60.96 -48.23 82.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.748 -0.66 . . . . 0.56 110.4 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -56.77 -44.56 91.77 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.922 -0.581 . . . . 0.84 112.307 177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -62.05 -38.61 89.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.633 0.254 . . . . 1.46 111.531 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.478 HD11 ' CB ' ' A' ' 4' ' ' ALA . 26.6 tp -68.66 -47.23 67.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.732 -0.213 . . . . 1.51 111.573 -176.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.66 HD21 HD22 ' A' ' 83' ' ' LEU . 7.5 mp -79.41 -41.07 28.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.682 0.277 . . . . 1.79 111.367 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.43 32.57 1.93 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.872 -0.68 . . . . 2.22 111.868 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -113.5 98.41 46.7 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.068 -0.715 . . . . 4.36 109.068 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.54 43.2 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 123.195 2.597 . . . . 1.91 112.508 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -144.79 34.44 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.796 -0.638 . . . . 3.13 110.371 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 34.0 p 47.88 73.16 0.22 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.865 -0.607 . . . . 1.25 112.067 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 71' ' ' GLY . 8.8 p -68.74 122.68 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.122 0.487 . . . . 1.24 110.513 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.5 t -82.66 -37.03 25.43 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.54 -0.755 . . . . 1.18 111.139 -173.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -149.81 147.58 28.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.34 111.054 -175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.66 HD22 HD21 ' A' ' 74' ' ' LEU . 2.2 pp -135.43 137.91 42.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.101 -0.5 . . . . 0.88 110.061 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.08 115.42 30.19 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.107 0.479 . . . . 0.35 110.867 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 31.5 t -82.9 77.61 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.327 -0.852 . . . . 1.05 109.19 172.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.466 ' HB ' ' HD2' ' A' ' 15' ' ' LYS . 21.4 t -68.57 -48.92 69.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.394 -0.821 . . . . 0.54 109.936 -176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.71 100.49 31.2 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.757 -0.656 . . . . 2.15 110.583 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.764 ' HG2' HD23 ' A' ' 94' ' ' LEU . 13.6 Cg_exo -70.61 -37.91 6.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.984 2.456 . . . . 1.68 112.322 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.72 -121.84 11.32 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.937 -0.649 . . . . 1.49 112.124 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -67.6 -30.24 69.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.219 0.533 . . . . 3.03 109.859 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.682 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 44.9 t -59.93 131.57 51.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.644 -0.707 . . . . 1.65 111.638 -178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.0 30.4 5.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.387 -0.824 . . . . 4.45 109.497 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.59 HD11 ' CD1' ' A' ' 3' ' ' PHE . 10.9 tp -60.53 -25.55 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.845 -0.616 . . . . 0.97 110.549 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.764 HD23 ' HG2' ' A' ' 88' ' ' PRO . 1.1 pp -64.67 -13.05 52.41 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 115.527 -0.761 . . . . 1.63 112.222 177.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.11 -37.11 86.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.111 0.481 . . . . 0.86 110.335 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.3 -29.48 62.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.588 -0.733 . . . . 1.57 110.901 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -125.09 55.01 0.73 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 121.147 -0.549 . . . . 1.79 111.868 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.39 44.07 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.268 -0.733 . . . . 2.85 111.268 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -164.78 129.46 2.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.421 -0.585 . . . . 6.7 109.421 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 . . . . . 0 C--O 1.243 0.761 0 N-CA-C 108.319 -0.993 . . . . 7.01 108.319 -177.593 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.927 0 N-CA-C 111.522 -0.631 . . . . 7.54 111.522 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.1 p -160.35 139.68 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.808 -0.441 . . . . 6.58 109.808 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.486 ' HA ' HD21 ' A' ' 96' ' ' LEU . 3.2 t -111.95 40.74 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.474 0.654 . . . . 3.59 109.958 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.2 -44.14 14.23 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.955 -0.566 . . . . 2.66 110.259 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.586 ' HE1' HD13 ' A' ' 36' ' ' ILE . 58.1 t80 72.66 -50.99 0.71 Allowed 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 115.036 -0.984 . . . . 1.16 111.972 -177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 73' ' ' LEU . . . -60.53 -50.34 73.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.827 0.306 . . . . 0.64 111.827 -174.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -64.84 -46.72 80.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.086 0.469 . . . . 1.65 110.356 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -62.34 -39.78 94.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.439 -0.8 . . . . 2.09 111.539 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.84 -47.2 78.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.948 0.404 . . . . 1.45 110.682 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.09 -36.32 81.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.143 -0.48 . . . . 3.56 111.001 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.591 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 2.4 mmpt? -61.77 -44.19 97.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.393 -0.367 . . . . 2.75 110.766 174.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -62.47 -42.58 99.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.731 -0.668 . . . . 0.47 111.02 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.61 ' HB2' HD12 ' A' ' 16' ' ' ILE . 52.4 tt0 -71.27 -47.79 54.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.235 -0.439 . . . . 2.44 111.619 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.17 -49.95 21.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.171 -0.468 . . . . 1.43 112.097 -172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 57.6 m -84.05 -45.75 12.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 1.96 111.493 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -90.05 -121.39 2.21 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.714 -0.755 . . . . 0.64 112.286 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -163.6 135.4 4.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.844 0.354 . . . . 3.52 110.633 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.647 HG12 HG22 ' A' ' 85' ' ' VAL . 64.4 mt -126.95 120.54 55.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.99 110.111 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.23 106.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.113 -0.328 . . . . 1.04 110.113 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.4 ptp -84.13 130.22 34.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.395 -0.366 . . . . 2.03 110.366 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 128.83 2.01 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.017 -0.611 . . . . 1.71 111.699 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -66.17 -56.78 9.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.7 0.286 . . . . 0.76 111.203 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -66.35 -35.48 80.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 4.68 110.623 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -63.19 -39.24 94.07 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.842 -0.617 . . . . 1.91 110.665 178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.1 t -65.21 -42.35 93.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.186 -0.461 . . . . 1.14 110.628 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 49' ' ' ILE . 52.3 mt -59.55 -42.26 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 121.121 0.486 . . . . 0.66 110.283 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -59.44 -46.98 87.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.624 -0.716 . . . . 2.19 111.045 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 3.8 m-85 -66.1 -36.48 83.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.192 -0.458 . . . . 0.66 111.295 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.98 -45.68 87.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.35 . . . . 0.55 111.149 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.0 mtmp? -66.43 -42.96 86.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.06 0.457 . . . . 2.06 110.638 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 60.4 mtt -69.05 -36.31 77.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.924 -0.58 . . . . 3.09 111.273 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.4 46.09 4.47 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.637 -0.792 . . . . 1.43 111.353 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -129.02 35.81 2.53 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 121.046 -0.597 . . . . 1.67 111.655 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 84' ' ' ALA . . . -141.65 134.72 29.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.732 -0.47 . . . . 0.55 109.732 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 32.1 mmmt -91.11 -41.82 10.82 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 111.685 0.254 . . . . 1.85 111.685 -175.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.892 HD21 ' HA3' ' A' ' 97' ' ' GLY . 0.9 OUTLIER -138.31 118.76 13.8 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.504 -0.478 . . . . 1.06 110.317 -177.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.1 mt -101.52 132.68 46.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.712 0.291 . . . . 0.31 110.706 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' HE1' ' A' ' 3' ' ' PHE . 75.0 mt -120.9 131.13 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.217 -0.447 . . . . 0.4 110.231 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 m -124.82 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.377 -0.374 . . . . 0.34 111.234 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.65 135.8 50.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.278 -0.419 . . . . 0.33 110.233 177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.544 ' HD2' ' HA ' ' A' ' 64' ' ' GLU . 84.5 mtt180 -62.65 -37.1 85.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.702 0.287 . . . . 4.14 110.849 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.805 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 8.7 m120 -88.56 31.68 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.198 -0.455 . . . . 2.33 111.374 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.48 172.53 7.69 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.472 -0.566 . . . . 0.47 109.472 173.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 98.0 mtt180 -63.46 126.81 90.27 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.809 0.338 . . . . 3.98 110.446 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 53.0 Cg_exo -58.43 -42.11 58.69 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.124 2.549 . . . . 0.86 112.72 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -59.1 -42.15 89.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 2.48 110.217 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' HG13 ' A' ' 49' ' ' ILE . 42.7 mm -63.42 -48.34 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.395 -0.821 . . . . 0.62 111.003 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 39' ' ' ARG . 9.5 mtpm? -59.37 -49.93 75.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.415 -0.357 . . . . 1.59 110.91 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -59.39 -39.82 84.58 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.407 -0.36 . . . . 2.6 111.5 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -65.33 -52.32 54.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.157 0.503 . . . . 1.21 110.647 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.818 HG12 HG12 ' A' ' 24' ' ' ILE . 62.6 mt -63.08 -51.79 67.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.36 111.812 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' HG2' HG11 ' A' ' 60' ' ' VAL . 92.8 mt-10 -57.88 -45.81 85.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.557 -0.292 . . . . 1.67 111.408 -177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.652 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 26.1 t80 -63.17 -50.72 69.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.433 -0.349 . . . . 1.03 111.003 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -65.29 -41.1 94.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.084 0.402 . . . . 1.09 112.084 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.51 99.07 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.726 0.298 . . . . 0.42 110.439 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -60.95 -37.89 83.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.861 -0.609 . . . . 4.04 110.598 178.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 77.9 mt -61.94 -48.54 79.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.926 0.393 . . . . 1.37 110.634 178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.6 m -67.07 -32.63 73.94 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.919 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 102.89 32.01 4.89 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.732 -0.667 . . . . 0.48 111.714 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -101.45 123.15 45.48 Favored Pre-proline 0 C--N 1.324 -0.52 0 N-CA-C 110.266 -0.272 . . . . 0.36 110.266 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 20.4 Cg_exo -65.29 135.79 44.58 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.748 2.299 . . . . 0.46 112.012 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 50' ' ' GLU . 41.8 t -117.71 123.22 71.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.975 -0.557 . . . . 0.5 110.578 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.436 ' HB3' HG12 ' A' ' 36' ' ' ILE . 62.5 t80 -100.28 131.0 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.801 -0.444 . . . . 0.83 109.801 174.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.403 ' HG2' ' HG3' ' A' ' 39' ' ' ARG . 26.1 tt0 -94.37 120.06 34.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.108 0.48 . . . . 2.47 109.999 178.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 20.0 t80 -77.17 123.46 26.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.649 -0.705 . . . . 0.67 110.425 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' HA ' ' HD2' ' A' ' 39' ' ' ARG . 34.8 mt-10 -76.77 60.05 1.66 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.344 -0.389 . . . . 2.46 110.763 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -173.95 164.31 35.63 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 120.938 -0.649 . . . . 0.82 111.876 -177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.805 ' HA ' ' HB2' ' A' ' 40' ' ' ASN . 10.6 t -78.12 163.66 25.66 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.804 0.335 . . . . 1.53 110.661 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -58.58 -33.59 70.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.909 -0.587 . . . . 1.25 111.103 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG22 HG22 ' A' ' 79' ' ' THR . 15.3 t -59.72 -47.19 92.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.099 0.476 . . . . 0.97 110.545 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' H ' HG23 ' A' ' 66' ' ' THR . 6.4 mm-40 -64.77 -42.78 94.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.637 -0.71 . . . . 2.65 111.02 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 tp -61.23 -46.01 92.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.15 -0.477 . . . . 0.56 110.846 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -62.73 -46.39 93.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.98 -0.629 . . . . 0.84 112.28 178.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 42.2 m -61.02 -36.29 79.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.876 0.37 . . . . 1.46 110.903 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 4' ' ' ALA . 39.2 tp -66.33 -42.45 88.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 1.51 110.417 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.33 -54.29 45.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.143 0.497 . . . . 1.79 110.488 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.99 -48.41 0.79 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.329 -0.708 . . . . 2.22 111.329 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -68.56 127.05 93.28 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.303 -0.629 . . . . 4.36 109.303 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.0 42.16 0.82 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.824 2.349 . . . . 1.91 112.95 -176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.407 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 22.0 m170 -105.8 142.02 36.24 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.741 -0.663 . . . . 3.13 110.243 175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 HG22 HG22 ' A' ' 68' ' ' VAL . 15.7 p -76.54 79.05 3.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.109 -0.496 . . . . 1.25 110.912 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.3 t -71.05 118.12 15.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.145 -0.48 . . . . 1.24 110.599 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.5 m -80.89 -39.52 26.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.904 -0.589 . . . . 1.18 110.526 -177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -154.91 150.33 27.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.089 -0.96 . . . . 0.34 109.676 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.489 HD11 HD12 ' A' ' 36' ' ' ILE . 4.0 pp -147.55 149.28 32.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.829 0.347 . . . . 0.88 110.607 -177.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.484 ' HB1' ' HB1' ' A' ' 32' ' ' ALA . . . -120.15 116.48 25.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.095 -0.502 . . . . 0.35 111.014 -178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.647 HG22 HG12 ' A' ' 16' ' ' ILE . 21.4 t -79.31 121.75 33.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-N 115.979 -0.555 . . . . 1.05 109.717 176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' PRO . 32.7 t -93.94 -44.15 13.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.757 -0.656 . . . . 0.54 111.357 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 54.3 m-20 -118.64 75.32 12.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 2.15 111.719 -176.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 86' ' ' VAL . 14.2 Cg_endo -92.46 47.93 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.556 2.838 . . . . 1.68 112.166 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.41 -51.45 42.87 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.883 -0.675 . . . . 1.49 112.853 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.3 -39.41 13.49 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.946 0.403 . . . . 3.03 110.664 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.0 p -66.44 131.44 46.06 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.99 -0.55 . . . . 1.65 110.879 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HA ' ' HD3' ' A' ' 92' ' ' ARG . 18.3 mmt180 -87.27 32.31 0.7 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.195 0.522 . . . . 4.45 110.795 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.5 tp -68.13 -27.45 37.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.866 -0.606 . . . . 0.97 111.069 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.544 HD23 HD23 ' A' ' 34' ' ' LEU . 69.8 mt -65.99 -24.43 66.77 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.152 -0.476 . . . . 1.63 110.95 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.77 -37.35 70.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 0.86 110.825 177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 1' ' ' VAL . 96.9 mt -75.96 -31.83 59.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.593 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.892 ' HA3' HD21 ' A' ' 34' ' ' LEU . . . -75.39 -47.89 11.82 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.932 -0.651 . . . . 1.79 112.401 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 129.09 17.5 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.762 -0.732 . . . . 2.85 111.914 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.17 -34.65 75.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.506 0.194 . . . . 6.7 111.114 -177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.909 -0.567 . . . . 7.01 109.772 178.124 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.188 -0.365 . . . . 7.54 112.188 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 4.5 p -81.47 39.28 0.52 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.117 0.484 . . . . 6.58 111.269 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 3' ' ' PHE . 7.5 p -73.49 139.19 19.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.854 -0.612 . . . . 3.59 110.599 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 3' ' ' PHE . 0.9 OUTLIER -61.67 -40.1 93.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.992 -0.549 . . . . 2.66 110.475 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.525 ' H ' HG22 ' A' ' 1' ' ' VAL . 91.7 t80 73.75 -51.17 0.69 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.37 -0.832 . . . . 1.16 110.717 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.74 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -59.03 -45.63 90.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.64 110.6 177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -57.47 -44.86 85.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.867 -0.606 . . . . 1.65 110.905 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -60.41 -48.53 81.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.669 -0.241 . . . . 2.09 111.458 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.426 HD11 ' CZ ' ' A' ' 3' ' ' PHE . 36.6 mt -63.78 -43.42 96.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.635 -0.257 . . . . 1.45 111.244 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 4' ' ' ALA . 64.7 mtp85 -63.33 -43.1 98.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.364 . . . . 3.56 110.553 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -65.93 -45.12 83.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.728 -0.669 . . . . 2.75 110.34 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' A' ' 16' ' ' ILE . . . -66.86 -32.53 73.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.037 -0.529 . . . . 0.47 111.254 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -69.85 -46.55 65.32 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.086 0.402 . . . . 2.44 112.086 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -85.41 -43.58 13.51 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.546 -0.462 . . . . 1.43 111.85 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 m -73.58 -45.68 51.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.861 0.362 . . . . 1.96 111.251 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.6 -118.81 4.18 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.895 -0.669 . . . . 0.64 112.306 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -163.22 130.0 3.41 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.057 -0.349 . . . . 3.52 110.057 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' ALA . 58.3 mt -135.65 123.79 37.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.437 -0.347 . . . . 0.99 110.441 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.418 HG13 ' HE3' ' A' ' 22' ' ' LYS . 61.3 t -82.09 121.61 35.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.241 -0.436 . . . . 1.04 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 30.6 ttp -110.14 125.92 53.52 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.822 0.344 . . . . 2.03 111.112 -175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 157.51 -126.57 1.76 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.96 -0.638 . . . . 1.71 112.13 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -160.81 -57.96 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.786 -0.45 . . . . 0.76 109.786 177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.452 ' HA ' HD12 ' A' ' 24' ' ' ILE . 23.1 tpt85 -63.12 -39.1 93.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.71 -0.677 . . . . 4.68 109.728 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.418 ' HE3' HG13 ' A' ' 17' ' ' VAL . 27.5 mtpp -61.04 -41.17 96.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.309 -0.86 . . . . 1.91 110.706 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.8 m -64.97 -38.94 92.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.949 -0.569 . . . . 1.14 110.347 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 20' ' ' ALA . 82.1 mt -60.46 -39.58 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.66 110.723 176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 29' ' ' MET . 4.3 tp-100 -57.16 -48.74 77.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.991 -0.55 . . . . 2.19 110.327 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 9.5 m-85 -67.72 -32.43 73.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 0.66 111.618 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.92 -39.77 94.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.753 0.311 . . . . 0.55 110.951 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 8.4 mtmp? -72.09 -49.48 36.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.341 -0.39 . . . . 2.06 111.102 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.458 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 26.7 ptm -75.65 -28.86 58.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.989 -0.55 . . . . 3.09 111.944 -175.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.34 124.56 0.82 Allowed Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.402 -0.679 . . . . 1.43 111.402 -173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 168.57 -43.09 0.22 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.614 -0.803 . . . . 1.67 111.942 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.61 129.48 39.92 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.044 -0.354 . . . . 0.55 110.044 176.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 30.6 mmmt -86.38 -36.37 19.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.563 -0.289 . . . . 1.85 111.171 -176.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.6 HD12 HD23 ' A' ' 94' ' ' LEU . 1.0 OUTLIER -141.32 114.54 8.69 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.808 -0.357 . . . . 1.06 110.217 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 64.7 mt -99.78 128.77 51.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.049 -0.352 . . . . 0.31 110.049 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 61' ' ' TYR . 56.1 mt -115.15 130.64 69.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.4 110.156 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.9 m -118.59 134.62 61.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.737 -0.211 . . . . 0.34 110.957 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -82.3 139.87 33.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.579 -0.282 . . . . 0.33 111.051 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 63' ' ' PHE . 99.4 mtt180 -59.58 -44.67 93.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.675 0.274 . . . . 4.14 110.874 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.529 ' HB2' ' H ' ' A' ' 67' ' ' SER . 7.1 m120 -80.53 42.86 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 2.33 111.54 178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.16 162.82 21.78 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.614 -0.513 . . . . 0.47 109.614 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 20.4 mmt85 -51.62 122.01 19.58 Favored Pre-proline 0 C--N 1.329 -0.316 0 O-C-N 123.355 0.41 . . . . 3.98 110.932 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.5 Cg_endo -57.29 -40.38 82.66 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.151 2.567 . . . . 0.86 112.642 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.9 -43.34 98.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.278 -0.419 . . . . 2.48 110.408 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.5 mm -62.08 -51.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.528 -0.76 . . . . 0.62 111.23 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 50' ' ' GLU . 50.1 mtmt -57.15 -53.68 55.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.365 -0.379 . . . . 1.59 111.176 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.74 -39.48 93.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.062 -0.517 . . . . 2.6 111.736 -176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.26 -45.19 92.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.845 0.355 . . . . 1.21 110.326 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.424 HG21 HG21 ' A' ' 35' ' ' ILE . 72.5 mt -64.96 -47.81 86.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.907 -0.588 . . . . 0.36 111.135 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.669 ' HG2' HG11 ' A' ' 60' ' ' VAL . 35.9 mt-10 -57.09 -44.18 82.9 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.819 0.342 . . . . 1.67 111.047 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.667 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 27.3 t80 -63.81 -51.73 63.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.857 -0.611 . . . . 1.03 110.77 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -61.97 -43.98 97.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 1.09 111.629 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.57 -43.61 98.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.075 -0.511 . . . . 0.42 110.796 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -61.51 -39.88 92.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.653 0.264 . . . . 4.04 111.019 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 81.4 mt -61.04 -44.84 96.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.989 0.423 . . . . 1.37 110.526 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.4 t -70.29 -38.01 74.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.769 -0.65 . . . . 1.28 110.58 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 106.44 32.57 3.64 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.387 -0.685 . . . . 0.48 111.387 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 75.3 mt -102.25 125.45 36.39 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.664 -0.268 . . . . 0.36 110.364 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -67.02 134.87 35.66 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 123.09 2.527 . . . . 0.46 112.117 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.669 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -117.98 118.71 59.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.147 -0.478 . . . . 0.5 110.52 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.679 ' HB3' HG12 ' A' ' 36' ' ' ILE . 20.3 t80 -88.54 125.56 34.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.226 0.536 . . . . 0.83 110.165 175.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -83.73 109.68 17.69 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.464 -0.789 . . . . 2.47 109.111 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.713 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 11.8 t80 -71.61 107.74 4.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.088 0.47 . . . . 0.67 110.698 -176.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.88 59.06 1.21 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.434 -0.803 . . . . 2.46 111.231 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.89 -146.0 4.44 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.917 -0.583 . . . . 0.82 111.974 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.624 HG23 ' H ' ' A' ' 69' ' ' GLU . 8.2 t -127.4 151.23 49.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.267 0.556 . . . . 1.53 111.493 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.529 ' H ' ' HB2' ' A' ' 40' ' ' ASN . 5.0 p -63.75 -23.17 67.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.345 -0.843 . . . . 1.25 111.467 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.17 -50.35 64.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 CA-C-O 120.962 0.411 . . . . 0.97 110.54 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.624 ' H ' HG23 ' A' ' 66' ' ' THR . 6.1 mm-40 -64.86 -43.73 92.02 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.711 -0.677 . . . . 2.65 110.46 175.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 38' ' ' ALA . 22.3 tp -60.66 -41.07 94.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.56 110.437 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.811 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -62.68 -49.22 75.12 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.772 -0.649 . . . . 0.84 112.71 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -67.37 -32.87 74.08 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.992 0.425 . . . . 1.46 110.384 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' HA ' ' A' ' 4' ' ' ALA . 5.8 tt -61.87 -48.42 80.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.565 -0.743 . . . . 1.51 110.521 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.558 HD22 HG11 ' A' ' 80' ' ' VAL . 10.2 mp -76.45 -39.27 53.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.353 -0.385 . . . . 1.79 111.351 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.74 51.68 0.49 Allowed Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.736 -0.745 . . . . 2.22 111.506 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -135.45 116.17 11.86 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.568 -0.53 . . . . 4.36 109.568 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -62.18 -50.96 4.04 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 122.559 2.173 . . . . 1.91 111.803 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.562 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.3 OUTLIER -83.16 46.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 3.13 112.062 178.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 72.0 p 55.24 170.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.583 1.153 . . . . 1.25 113.957 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.811 HG23 ' HA2' ' A' ' 71' ' ' GLY . 92.5 t -125.25 124.65 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.416 -0.811 . . . . 1.24 109.355 175.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.7 p -83.6 -40.33 19.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.028 0.442 . . . . 1.18 111.076 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.98 156.19 28.94 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.931 -0.577 . . . . 0.34 110.554 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 74' ' ' LEU . 1.9 pt? -143.93 137.58 27.91 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.226 -0.443 . . . . 0.88 110.191 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -111.66 112.09 23.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.232 -0.44 . . . . 0.35 110.82 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.421 ' HA ' HG12 ' A' ' 16' ' ' ILE . 26.0 t -77.83 117.89 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 1.05 109.915 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.0 t -93.14 -42.15 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.862 -0.608 . . . . 0.54 110.735 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -119.91 86.31 36.1 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 2.15 110.674 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -96.15 41.09 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.192 2.595 . . . . 1.68 112.354 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.17 -62.41 3.53 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.497 -0.859 . . . . 1.49 112.627 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.0 mp0 -72.53 -43.16 63.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.753 0.311 . . . . 3.03 111.363 -177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.8 t -69.09 138.31 54.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.292 -0.413 . . . . 1.65 110.754 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -98.72 33.3 2.33 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.147 0.498 . . . . 4.45 110.292 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.594 HD12 HD13 ' A' ' 96' ' ' LEU . 10.0 tp -64.83 -21.78 30.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.539 -0.755 . . . . 0.97 110.251 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.745 HD22 ' HD3' ' A' ' 99' ' ' LYS . 89.0 mt -58.85 -24.3 61.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.607 -0.724 . . . . 1.63 111.432 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.41 -42.38 96.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.226 -0.443 . . . . 0.86 110.678 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.594 HD13 HD12 ' A' ' 93' ' ' ILE . 5.4 mp -75.51 -30.89 59.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.459 . . . . 1.57 110.265 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -67.09 -34.13 85.57 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.911 -0.661 . . . . 1.79 111.956 177.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.23 -61.14 4.19 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 112.149 -0.38 . . . . 2.85 112.149 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.745 ' HD3' HD22 ' A' ' 94' ' ' LEU . 8.3 mtmp? 69.5 -51.83 0.61 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.655 0.782 . . . . 6.7 111.924 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.165 -0.922 . . . . 7.01 110.733 179.204 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 112.091 -0.403 . . . . 7.54 112.091 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.2 t -78.61 132.18 37.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.925 0.393 . . . . 6.58 110.618 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 96' ' ' LEU . 54.6 t -65.07 -25.23 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.802 -0.636 . . . . 3.59 110.606 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.0 t70 64.98 59.47 0.86 Allowed 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.539 -0.755 . . . . 2.66 109.109 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.633 ' HB2' ' HB2' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -73.41 42.06 0.12 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.559 -1.2 . . . . 1.16 112.852 -172.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.673 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -62.74 -49.3 75.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.22 0.533 . . . . 0.64 110.755 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 6.2 t80 -63.56 -41.45 98.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.029 -0.987 . . . . 1.65 110.046 177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.633 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 33.6 mm-40 -60.19 -51.44 69.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.685 -0.689 . . . . 2.09 111.47 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 73' ' ' LEU . 12.3 mt -64.35 -41.33 96.8 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 120.675 -0.41 . . . . 1.45 111.872 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.4 ptp85 -65.38 -37.47 87.08 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.092 -0.643 . . . . 3.56 110.979 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 5' ' ' PHE . 7.4 mtpm? -69.93 -46.37 65.46 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.78 0.324 . . . . 2.75 110.628 177.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB1' HD11 ' A' ' 16' ' ' ILE . . . -59.51 -40.01 85.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.954 -0.566 . . . . 0.47 111.212 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -66.65 -39.56 88.29 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.168 -0.469 . . . . 2.44 110.368 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.29 -49.89 62.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.915 -0.584 . . . . 1.43 111.565 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.406 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 9.6 t -123.87 42.3 3.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.919 0.866 . . . . 1.96 111.481 -175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -156.03 -134.08 1.77 Allowed Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.914 -0.875 . . . . 0.64 110.914 177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -166.31 123.93 1.4 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 117.213 0.506 . . . . 3.52 111.267 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.557 HG13 ' HA ' ' A' ' 85' ' ' VAL . 3.7 mp -128.87 123.88 59.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.716 -0.675 . . . . 0.99 109.529 176.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -93.44 106.22 17.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.002 0.43 . . . . 1.04 110.548 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.413 ' HB3' HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.39 137.29 32.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.11 -0.495 . . . . 2.03 110.565 179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.13 134.15 2.6 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.694 -0.765 . . . . 1.71 112.164 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -67.94 -49.95 58.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.831 0.348 . . . . 0.76 111.293 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -70.93 -35.18 72.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.098 0.475 . . . . 4.68 110.752 178.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 25' ' ' GLN . 90.6 mttt -64.14 -37.07 86.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.886 -0.597 . . . . 1.91 111.629 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.7 p -70.32 -32.5 70.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.618 -0.433 . . . . 1.14 110.56 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 20' ' ' ALA . 78.9 mt -63.6 -47.91 89.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.822 0.344 . . . . 0.66 111.127 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 22' ' ' LYS . 10.6 pt20 -67.32 -39.8 85.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.57 -0.286 . . . . 2.19 110.837 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.18 -37.09 86.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.533 0.206 . . . . 0.66 111.047 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -65.37 -41.08 94.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.604 176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -64.87 -45.05 87.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.911 -0.586 . . . . 2.06 110.866 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.1 mtm -73.5 -33.71 64.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.856 -0.611 . . . . 3.09 111.421 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.751 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.94 45.15 6.43 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.967 -0.635 . . . . 1.43 112.09 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -124.74 53.29 0.77 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.76 -0.734 . . . . 1.67 112.527 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.26 142.62 18.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.679 0.276 . . . . 0.55 110.374 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 71.3 mmtt -81.04 -50.5 9.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.416 -0.356 . . . . 1.85 111.15 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 93' ' ' ILE . 58.9 tp -141.53 125.37 17.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.528 -0.305 . . . . 1.06 110.527 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 65.5 mt -102.58 128.35 55.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.769 -0.456 . . . . 0.31 109.769 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.13 126.82 71.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.98 -0.378 . . . . 0.4 109.98 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.47 HG12 ' CB ' ' A' ' 82' ' ' ALA . 30.6 m -122.85 134.22 66.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.34 110.25 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -64.54 124.24 21.33 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.352 -0.61 . . . . 0.33 109.352 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 7.5 ptm180 -62.19 -26.9 68.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 4.14 110.829 -175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.762 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 3.7 m120 -81.35 -15.81 54.21 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.044 -0.526 . . . . 2.33 111.15 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.51 163.26 11.33 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.527 -0.306 . . . . 0.47 111.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 24.9 mmt85 -48.34 125.32 11.91 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.908 -0.587 . . . . 3.98 111.404 -176.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 50.8 Cg_exo -54.82 -38.94 92.03 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.241 2.627 . . . . 0.86 112.685 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -61.72 -44.03 97.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.232 -0.44 . . . . 2.48 110.922 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.27 -49.29 84.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.639 -0.71 . . . . 0.62 110.663 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -61.94 -46.33 89.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.451 . . . . 1.59 110.956 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -59.05 -43.47 91.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.313 -0.403 . . . . 2.6 111.097 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.81 -50.07 74.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.875 0.369 . . . . 1.21 110.82 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 83.5 mt -62.4 -50.98 77.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.968 -0.56 . . . . 0.36 111.473 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HA ' HG21 ' A' ' 60' ' ' VAL . 56.9 mt-10 -60.88 -43.12 98.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.432 -0.349 . . . . 1.67 111.39 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 28.9 t80 -66.5 -49.57 66.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.463 -0.335 . . . . 1.03 111.011 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -60.77 -46.7 89.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 1.09 110.962 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -63.88 -37.49 87.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 0.42 111.065 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 tpt85 -59.55 -41.74 90.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.865 0.364 . . . . 4.04 110.773 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 70.8 mt -66.43 -42.8 87.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 1.37 110.898 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.6 t -75.67 -36.98 59.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.892 -0.595 . . . . 1.28 110.99 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.48 37.41 1.77 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.145 -0.55 . . . . 0.48 112.172 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.751 HD11 ' HA2' ' A' ' 30' ' ' GLY . 65.6 mt -113.41 125.85 29.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.633 0.254 . . . . 0.36 110.353 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.55 133.61 26.36 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.573 2.182 . . . . 0.46 111.908 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG21 ' HA ' ' A' ' 50' ' ' GLU . 49.0 t -118.13 124.97 73.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.005 -0.543 . . . . 0.5 110.043 177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -105.33 129.45 53.67 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.226 -0.443 . . . . 0.83 110.458 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.11 111.72 19.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 2.47 110.202 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.652 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 51.6 t80 -63.78 126.03 26.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.838 -1.074 . . . . 0.67 110.202 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.27 61.32 1.62 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.392 0.615 . . . . 2.46 110.139 177.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.7 157.96 28.57 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-N 115.187 -0.915 . . . . 0.82 111.197 -175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.77 HG22 ' HG2' ' A' ' 69' ' ' GLU . 14.6 t -79.97 172.84 13.24 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.86 0.362 . . . . 1.53 110.425 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -57.46 -36.6 71.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.997 -0.547 . . . . 1.25 110.788 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -64.24 -47.52 89.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 0.97 110.806 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.77 ' HG2' HG22 ' A' ' 66' ' ' THR . 34.6 mm-40 -61.69 -43.45 98.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.888 -0.596 . . . . 2.65 111.141 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD11 HD21 ' A' ' 83' ' ' LEU . 34.0 tp -65.83 -36.05 82.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.357 -0.383 . . . . 0.56 110.351 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . -61.86 -44.19 98.19 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.009 -0.615 . . . . 0.84 111.963 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.7 m -65.35 -42.49 92.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 1.46 110.384 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.896 HD12 HD12 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -61.8 -48.43 80.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.822 -0.626 . . . . 1.51 110.263 -179.602 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.633 HD13 HD22 ' A' ' 83' ' ' LEU . 19.9 tp -69.48 -32.68 71.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 1.79 111.095 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.2 56.29 1.39 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.573 -0.823 . . . . 2.22 112.244 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 45.8 ttp180 -142.35 135.8 14.3 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.901 -0.407 . . . . 4.36 109.901 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.75 42.25 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.702 2.268 . . . . 1.91 111.753 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -157.7 130.57 7.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.3 -0.863 . . . . 3.13 108.871 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.3 p -53.34 122.61 9.95 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 123.691 0.62 . . . . 1.25 111.422 -177.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 HG23 ' HA2' ' A' ' 71' ' ' GLY . 62.9 t -92.68 119.51 40.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.37 -0.377 . . . . 1.24 110.192 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.9 m -81.84 -40.44 22.47 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.29 0.567 . . . . 1.18 109.838 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -161.44 152.28 18.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.266 -0.879 . . . . 0.34 110.645 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.633 HD22 HD13 ' A' ' 74' ' ' LEU . 3.9 pp -144.59 138.82 27.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.15 -0.477 . . . . 0.88 110.354 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.08 114.29 28.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.383 -0.371 . . . . 0.35 110.865 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.557 ' HA ' HG13 ' A' ' 16' ' ' ILE . 46.7 t -79.88 105.26 9.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.548 -0.538 . . . . 1.05 109.548 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.0 t -90.07 -45.87 15.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.058 -0.519 . . . . 0.54 110.576 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 10.3 t70 -121.78 109.31 34.23 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 116.07 -0.514 . . . . 2.15 110.028 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 87' ' ' ASP . 2.7 Cg_endo -86.23 48.63 2.03 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.705 2.937 . . . . 1.68 112.153 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 13' ' ' THR . . . -62.39 122.8 29.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.927 -0.654 . . . . 1.49 113.039 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 50.27 47.96 22.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.444 0.698 . . . . 3.03 111.934 176.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.0 p -149.64 147.54 28.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.946 0.403 . . . . 1.65 111.072 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 47.5 mtp85 -97.29 41.1 1.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.125 -0.488 . . . . 4.45 110.036 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.454 HG21 HG11 ' A' ' 85' ' ' VAL . 10.6 tp -70.33 -29.78 40.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.966 -0.561 . . . . 0.97 110.573 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.9 mt -72.8 -3.78 27.54 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.946 -0.57 . . . . 1.63 111.516 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.42 -38.91 92.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.813 0.339 . . . . 0.86 110.772 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 1' ' ' VAL . 5.7 mp -68.73 -30.7 69.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.962 -0.563 . . . . 1.57 110.728 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.26 -69.67 2.22 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.831 -0.622 . . . . 1.79 112.51 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.06 -133.53 3.16 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.985 -0.626 . . . . 2.85 112.047 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -67.78 -48.52 66.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.704 0.288 . . . . 6.7 110.969 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-N 116.071 -0.513 . . . . 7.01 110.03 -176.166 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 112.019 -0.433 . . . . 7.54 112.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.3 m -79.17 47.86 0.82 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 6.58 111.312 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t 54.05 -120.41 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 115.823 -0.626 . . . . 3.59 110.502 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -168.58 130.68 1.34 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.304 -0.999 . . . . 2.66 108.304 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.7 ' HD2' HD11 ' A' ' 96' ' ' LEU . 0.5 OUTLIER -128.95 32.53 4.74 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.537 -0.301 . . . . 1.16 110.949 -176.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.909 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -61.47 -50.44 72.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.055 0.455 . . . . 0.64 110.406 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -64.96 -42.29 94.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.476 -0.784 . . . . 1.65 110.66 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -61.64 -47.86 83.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.488 -0.324 . . . . 2.09 111.755 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 73' ' ' LEU . 32.5 tp -62.18 -42.85 99.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.745 0.307 . . . . 1.45 110.489 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -63.57 -41.37 98.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.355 -0.384 . . . . 3.56 110.759 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.13 -41.82 98.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.775 -0.648 . . . . 2.75 110.605 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.98 -41.91 99.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.495 . . . . 0.47 110.834 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 7' ' ' LEU . 66.4 mt-30 -63.52 -35.58 80.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.957 -0.565 . . . . 2.44 110.54 177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.03 -49.92 11.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.667 -0.697 . . . . 1.43 111.637 -175.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 39.7 p -83.18 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.286 0.476 . . . . 1.96 112.286 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -85.75 -121.85 1.21 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 121.121 -0.562 . . . . 0.64 112.352 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -157.72 124.22 4.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.775 0.321 . . . . 3.52 110.527 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 85' ' ' VAL . 47.0 mm -121.82 128.52 75.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.52 . . . . 0.99 109.804 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.528 HG21 ' CZ ' ' A' ' 26' ' ' TYR . 82.6 t -101.22 115.64 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.938 0.399 . . . . 1.04 110.761 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.488 ' SD ' ' HG2' ' A' ' 76' ' ' ARG . 30.5 ttp -84.69 119.24 25.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.908 -0.587 . . . . 2.03 110.822 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 152.25 125.9 1.17 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.825 -0.702 . . . . 1.71 112.16 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.78 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . -64.73 -54.87 24.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.957 0.408 . . . . 0.76 110.924 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.2 ptt-85 -68.98 -28.44 66.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.853 -0.612 . . . . 4.68 111.087 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -66.8 -37.72 85.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.339 -0.391 . . . . 1.91 110.441 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.1 m -63.06 -35.32 79.85 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.314 -0.403 . . . . 1.14 110.474 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.588 HG22 ' HE3' ' A' ' 28' ' ' LYS . 53.3 mt -61.54 -42.98 96.12 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 121.176 0.512 . . . . 0.66 110.266 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -61.97 -44.53 96.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.631 -0.713 . . . . 2.19 110.931 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' A' ' 29' ' ' MET . 14.2 m-85 -67.0 -34.02 76.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.339 -0.391 . . . . 0.66 111.196 177.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.65 91.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.936 0.398 . . . . 0.55 110.25 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.588 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.3 mttt -66.33 -47.82 72.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.735 -0.666 . . . . 2.06 111.379 178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.61 ' HG2' ' HA ' ' A' ' 26' ' ' TYR . 27.0 ptm -73.39 -35.62 65.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 3.09 111.507 -176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 83.83 140.19 4.25 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 1.43 112.156 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.71 -41.84 0.95 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.538 -0.839 . . . . 1.67 112.591 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -60.76 137.73 58.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.55 111.328 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 13.4 mmtm -71.68 -44.1 64.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.026 -0.533 . . . . 1.85 110.621 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 59' ' ' PRO . 40.5 tp -143.25 152.84 42.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.957 -0.565 . . . . 1.06 110.004 -177.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.2 mt -129.08 125.59 62.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 0.31 109.554 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 73.1 mt -107.18 128.55 62.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.725 0.298 . . . . 0.4 110.857 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.2 m -124.4 134.79 65.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 0.34 110.977 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.83 153.31 42.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.392 . . . . 0.33 110.956 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 14.4 mmt85 -65.26 -40.97 94.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.447 -0.342 . . . . 4.14 111.457 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -82.41 16.37 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.629 0.252 . . . . 2.33 111.485 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.85 147.83 40.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.561 -0.29 . . . . 0.47 110.853 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.574 ' HB3' ' OD1' ' A' ' 44' ' ' ASP . 44.7 mmm-85 -56.53 133.2 77.3 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.986 -0.552 . . . . 3.98 111.086 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.9 Cg_exo -58.34 -38.22 91.57 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.498 . . . . 0.86 112.527 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.574 ' OD1' ' HB3' ' A' ' 42' ' ' ARG . 8.3 p-10 -59.72 -37.88 80.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 2.48 110.866 177.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.615 HG21 ' HB1' ' A' ' 20' ' ' ALA . 46.8 mm -65.4 -47.19 87.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.974 -0.557 . . . . 0.62 110.618 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -60.8 -49.5 77.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.509 . . . . 1.59 111.29 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -59.49 -46.14 89.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.101 -0.5 . . . . 2.6 111.51 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' O ' ' HD1' ' A' ' 52' ' ' TYR . 35.7 m-20 -63.51 -48.62 76.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.637 0.256 . . . . 1.21 110.813 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.57 HG13 HG12 ' A' ' 24' ' ' ILE . 56.2 mt -58.19 -54.1 37.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.329 -0.396 . . . . 0.36 111.184 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -61.75 -41.81 98.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.013 0.375 . . . . 1.67 112.013 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 42.9 t80 -62.07 -51.83 66.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.03 110.692 -177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.539 ' CD2' ' HG2' ' A' ' 28' ' ' LYS . 73.1 m-85 -72.53 -39.06 67.84 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.788 -0.642 . . . . 1.09 111.704 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.86 -45.78 93.2 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.258 -0.177 . . . . 0.42 110.806 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -58.78 -36.55 74.6 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.488 -0.324 . . . . 4.04 111.382 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 88.4 mt -62.57 -48.47 79.32 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.046 0.451 . . . . 1.37 110.48 177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.0 m -80.03 0.97 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.738 -0.665 . . . . 1.28 111.593 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.16 36.22 84.87 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.175 -0.536 . . . . 0.48 112.327 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 67.4 mt -103.01 118.34 58.34 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-O 120.792 0.33 . . . . 0.36 110.186 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 22.2 Cg_exo -66.91 133.83 32.55 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.002 2.468 . . . . 0.46 112.498 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -102.62 120.69 52.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.164 -0.471 . . . . 0.5 110.394 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 36' ' ' ILE . 74.4 t80 -104.97 130.18 53.22 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.152 -0.476 . . . . 0.83 109.756 176.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -87.22 129.31 35.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.946 0.403 . . . . 2.47 110.61 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.686 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 28.8 t80 -69.73 127.52 33.24 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.725 -0.671 . . . . 0.67 110.127 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -79.0 61.15 3.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.938 0.399 . . . . 2.46 110.206 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 174.93 -153.8 16.71 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.835 -0.698 . . . . 0.82 112.286 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.7 p -114.09 170.05 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.784 0.325 . . . . 1.53 111.317 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 p -62.47 -33.5 74.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.758 -0.655 . . . . 1.25 110.464 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HA ' HG22 ' A' ' 79' ' ' THR . 87.7 t -63.16 -48.89 85.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.97 110.092 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -61.21 -43.38 98.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.511 -0.768 . . . . 2.65 110.675 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.81 -43.91 78.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.56 110.838 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' HA2' HG12 ' A' ' 80' ' ' VAL . . . -58.68 -44.04 95.94 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.095 -0.574 . . . . 0.84 112.138 177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -65.76 -36.01 82.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.718 0.295 . . . . 1.46 110.391 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.909 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -58.97 -47.12 86.27 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.137 -0.483 . . . . 1.51 110.389 178.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -68.21 -33.71 74.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.957 -0.565 . . . . 1.79 110.526 176.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 81.81 36.11 20.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.92 -0.872 . . . . 2.22 110.92 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' HG2' ' SD ' ' A' ' 18' ' ' MET . 5.8 tpp85 -106.36 134.78 19.63 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.214 -0.661 . . . . 4.36 109.214 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.87 38.48 0.27 Allowed 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 123.291 2.661 . . . . 1.91 114.055 -174.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -172.57 140.34 1.03 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.391 -0.596 . . . . 3.13 109.391 173.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.707 HG22 ' HA ' ' A' ' 68' ' ' VAL . 24.3 p -65.91 126.42 28.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.019 -0.537 . . . . 1.25 111.833 -173.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.401 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.2 p -94.78 127.68 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.204 -0.453 . . . . 1.24 110.711 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.711 ' HB3' ' HB2' ' A' ' 20' ' ' ALA . 8.7 t -84.75 -35.54 22.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.991 -0.55 . . . . 1.18 110.715 -176.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.78 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -158.2 152.0 23.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.34 110.019 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.8 pp -141.32 137.91 32.76 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.159 0.505 . . . . 0.88 110.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -93.84 116.99 29.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.633 -0.712 . . . . 0.35 110.706 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 34' ' ' LEU . 48.3 t -82.38 87.66 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.79 -0.641 . . . . 1.05 109.608 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 48.0 t -60.69 -44.2 96.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.1 -0.5 . . . . 0.54 109.929 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.502 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . 37.0 t70 -161.42 125.87 2.06 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.727 -0.67 . . . . 2.15 109.905 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.574 ' HB3' HG22 ' A' ' 93' ' ' ILE . 33.7 Cg_exo -64.9 -33.21 53.26 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.173 2.582 . . . . 1.68 112.833 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.89 -125.91 8.59 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.538 -0.839 . . . . 1.49 111.678 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -23.24 59.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.613 0.244 . . . . 3.03 111.048 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 48.1 t -66.29 142.49 57.65 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.09 0.472 . . . . 1.65 111.395 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -104.03 44.85 0.99 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.764 -0.653 . . . . 4.45 110.562 177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.574 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.0 tp -64.71 -28.14 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.058 -0.519 . . . . 0.97 110.786 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 97' ' ' GLY . 95.5 mt -64.74 -20.33 66.29 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.034 -0.53 . . . . 1.63 111.882 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.03 97.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.526 -0.306 . . . . 0.86 111.511 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.7 HD11 ' HD2' ' A' ' 3' ' ' PHE . 2.6 pt? -106.79 13.77 27.52 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 1.57 111.203 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . -165.0 110.34 0.41 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.825 -0.702 . . . . 1.79 111.657 177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 59' ' ' PRO . . . 175.18 -116.8 0.59 Allowed Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.311 -0.715 . . . . 2.85 111.311 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -60.72 140.13 57.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.108 -0.33 . . . . 6.7 110.108 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--O 1.249 1.073 0 O-C-N 123.548 0.53 . . . . 7.01 109.826 -175.087 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.905 -0.478 . . . . 7.54 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 33.6 m 59.4 44.48 15.06 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.391 0.615 . . . . 6.58 110.833 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 96' ' ' LEU . 6.1 p -78.16 140.92 16.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.444 -0.798 . . . . 3.59 111.127 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.81 -36.76 2.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.03 -0.532 . . . . 2.66 109.63 176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 62.6 t80 71.67 -54.37 0.68 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.657 -1.156 . . . . 1.16 112.433 178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.634 ' HA ' HD11 ' A' ' 73' ' ' LEU . . . -66.84 -50.66 61.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.587 0.232 . . . . 0.64 111.423 -175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -61.2 -38.38 86.35 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.477 0.656 . . . . 1.65 109.723 175.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.38 -40.93 94.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.043 -0.98 . . . . 2.09 111.092 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 73' ' ' LEU . 13.4 mt -63.14 -42.58 99.49 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.915 -0.314 . . . . 1.45 110.664 175.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -59.47 -50.4 74.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.314 -0.403 . . . . 3.56 110.807 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -65.85 -37.36 85.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 2.75 111.648 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.52 91.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.33 . . . . 0.47 110.519 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.7 -42.05 67.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.11 0.481 . . . . 2.44 110.435 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.37 -51.22 18.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 1.43 112.247 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.0 m -96.16 -48.84 5.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.053 0.39 . . . . 1.96 112.053 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.08 -135.75 1.45 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.866 -0.683 . . . . 0.64 112.679 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 86' ' ' VAL . 62.5 mttp -141.15 115.2 9.21 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.419 -0.215 . . . . 3.52 110.419 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 mm -122.21 128.19 75.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.48 . . . . 0.99 110.476 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 t -120.0 139.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.082 -0.508 . . . . 1.04 109.976 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.445 ' O ' ' HE3' ' A' ' 22' ' ' LYS . 85.8 mtp -67.63 127.43 32.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.87 -0.789 . . . . 2.03 108.87 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' CA ' ' HB2' ' A' ' 23' ' ' SER . . . -100.39 -108.38 3.01 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.412 -0.899 . . . . 1.71 112.682 -173.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.481 ' H ' ' HB3' ' A' ' 82' ' ' ALA . . . 59.79 -112.6 0.58 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.191 -0.504 . . . . 0.76 110.483 -174.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.29 -32.95 72.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.622 0.249 . . . . 4.68 111.225 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' A' ' 18' ' ' MET . 57.5 mtmt -74.7 -25.61 59.26 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.982 0.42 . . . . 1.91 110.886 176.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.467 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 8.7 t -62.31 -27.62 69.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.725 -0.671 . . . . 1.14 110.92 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 24.5 mm -58.96 -43.03 87.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.357 -0.383 . . . . 0.66 110.144 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -62.32 -48.54 79.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.19 110.954 177.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -62.1 -43.96 97.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.66 111.65 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.84 -39.52 83.85 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.019 0.438 . . . . 0.55 110.7 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 24' ' ' ILE . 54.0 tttm -63.48 -49.01 75.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.398 -0.819 . . . . 2.06 110.636 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 65.6 mtt -72.4 -37.73 68.62 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.927 -0.579 . . . . 3.09 111.299 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.977 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.05 40.29 4.92 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.946 -0.645 . . . . 1.43 111.698 -176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 -39.86 4.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.065 -0.588 . . . . 1.67 112.719 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.8 138.2 46.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.614 0.245 . . . . 0.55 111.444 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.572 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 0.1 OUTLIER -77.58 -45.35 25.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.975 0.417 . . . . 1.85 110.513 178.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' ' 59' ' ' PRO . 57.2 tp -141.12 128.92 21.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.135 -0.484 . . . . 1.06 109.88 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.3 mt -109.32 122.9 64.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.61 -0.436 . . . . 0.31 110.246 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.632 HG12 ' HB3' ' A' ' 61' ' ' TYR . 62.5 mt -103.7 130.78 53.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.273 -0.421 . . . . 0.4 110.279 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -120.87 135.58 60.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.847 0.356 . . . . 0.34 110.867 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.98 143.36 52.64 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.03 -0.532 . . . . 0.33 110.343 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -63.21 -52.27 62.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.652 -0.249 . . . . 4.14 111.005 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.76 33.32 0.52 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.265 0.555 . . . . 2.33 111.401 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . . . -88.4 162.94 16.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 0.47 109.947 174.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' NE ' ' HA ' ' A' ' 42' ' ' ARG . 14.2 mmp_? -60.54 131.61 90.78 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.646 0.26 . . . . 3.98 110.625 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 51.6 Cg_exo -58.36 -41.39 66.47 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.146 2.564 . . . . 0.86 112.403 -177.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -58.39 -35.38 71.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.48 111.185 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.15 -53.51 17.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.476 -0.329 . . . . 0.62 110.786 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -57.32 -49.86 74.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 1.59 111.819 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.58 -44.85 96.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.958 -0.565 . . . . 2.6 111.467 -174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.93 -42.36 76.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 1.21 110.766 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.53 -51.83 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.511 -0.313 . . . . 0.36 111.103 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.631 ' HG2' HG11 ' A' ' 60' ' ' VAL . 52.5 mt-10 -61.81 -37.09 83.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.094 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -61.1 -51.57 68.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.907 0.384 . . . . 1.03 110.871 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m-85 -69.41 -42.14 75.45 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.95 -0.568 . . . . 1.09 111.526 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.401 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.6 -48.58 78.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.29 -0.414 . . . . 0.42 111.542 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 50' ' ' GLU . 49.9 mtm180 -62.52 -40.61 97.31 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.092 0.405 . . . . 4.04 112.092 -176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 52' ' ' TYR . 4.5 pp -66.5 -35.11 79.46 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 120.71 -0.396 . . . . 1.37 110.832 -179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.7 m -75.56 -36.36 60.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.178 0.513 . . . . 1.28 110.7 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 110.0 33.18 2.65 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.48 111.742 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.977 HD11 ' HA2' ' A' ' 30' ' ' GLY . 71.9 mt -104.74 122.53 43.15 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.167 -0.309 . . . . 0.36 110.167 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' HD2' ' O ' ' A' ' 33' ' ' LYS . 17.0 Cg_exo -66.26 136.33 43.39 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.728 2.285 . . . . 0.46 111.685 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG11 ' HG2' ' A' ' 50' ' ' GLU . 61.6 t -113.03 126.8 70.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.744 -0.465 . . . . 0.5 109.744 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.632 ' HB3' HG12 ' A' ' 36' ' ' ILE . 29.8 t80 -100.95 123.85 45.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.058 0.456 . . . . 0.83 110.699 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -76.71 112.77 13.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.532 -0.758 . . . . 2.47 109.528 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 13.9 t80 -73.39 123.05 23.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.887 -0.412 . . . . 0.67 109.887 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -77.22 49.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.528 0.68 . . . . 2.46 110.594 177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.53 34.17 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.625 -0.716 . . . . 0.82 112.008 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.7 p -72.87 163.25 28.42 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.447 -0.376 . . . . 1.53 111.05 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.2 p -61.18 -29.65 69.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.966 0.412 . . . . 1.25 110.804 178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 79' ' ' THR . 21.3 t -64.57 -48.41 85.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.886 -0.597 . . . . 0.97 110.29 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 66.4 mm-40 -62.93 -40.39 97.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.856 -0.611 . . . . 2.65 110.792 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 HD22 ' A' ' 83' ' ' LEU . 35.2 tp -63.13 -43.43 98.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.927 0.394 . . . . 0.56 110.403 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.13 -49.78 68.62 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.831 -0.622 . . . . 0.84 112.825 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 69' ' ' GLU . 7.2 t -65.43 -30.49 71.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 1.46 110.736 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.634 HD11 ' HA ' ' A' ' 4' ' ' ALA . 0.3 OUTLIER -63.44 -46.69 85.11 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.468 -0.567 . . . . 1.51 109.468 176.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.546 HD12 HG21 ' A' ' 80' ' ' VAL . 94.3 mt -66.32 -47.16 74.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.078 -0.51 . . . . 1.79 110.767 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.55 -51.62 0.49 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.525 -0.845 . . . . 2.22 113.021 175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -69.64 137.28 88.13 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.092 0.472 . . . . 4.36 111.787 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.48 47.95 2.23 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 123.507 2.804 . . . . 1.91 112.467 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -136.78 142.72 42.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.726 -0.67 . . . . 3.13 110.22 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.633 HG22 HG22 ' A' ' 68' ' ' VAL . 76.7 p -63.49 121.2 13.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.09 -0.505 . . . . 1.25 110.834 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 74' ' ' LEU . 92.0 t -101.77 119.63 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.706 -0.479 . . . . 1.24 109.706 177.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.3 m -72.45 -40.19 67.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.976 -0.556 . . . . 1.18 110.744 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -163.67 156.92 18.66 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.868 -0.605 . . . . 0.34 110.63 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.477 HD22 HD21 ' A' ' 70' ' ' LEU . 2.6 pt? -139.42 139.37 37.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.3 -0.409 . . . . 0.88 110.112 177.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.96 116.3 28.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.35 111.046 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 46.8 t -86.45 99.87 8.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.19 -0.67 . . . . 1.05 109.19 174.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 47.5 t -74.85 -42.17 46.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.242 0.544 . . . . 0.54 109.984 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -148.84 119.26 4.14 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.474 -0.785 . . . . 2.15 110.204 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.539 ' HB3' HG22 ' A' ' 93' ' ' ILE . 43.4 Cg_endo -70.51 -37.95 6.76 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.512 2.141 . . . . 1.68 112.169 -179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -114.79 6.28 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.865 -0.684 . . . . 1.49 112.092 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -69.53 -33.32 72.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.038 0.447 . . . . 3.03 110.75 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 88' ' ' PRO . 6.2 m -69.55 138.53 53.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.952 -0.567 . . . . 1.65 111.917 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -100.39 49.69 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 4.45 110.042 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.539 HG22 ' HB3' ' A' ' 88' ' ' PRO . 10.6 tp -72.76 -24.6 21.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.389 -0.823 . . . . 0.97 111.125 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.9 mt -64.27 -18.78 64.9 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.795 0.331 . . . . 1.63 111.291 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.96 70.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.062 0.458 . . . . 0.86 110.623 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 1' ' ' VAL . 3.4 mm? -78.05 -29.69 49.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.993 -0.549 . . . . 1.57 110.92 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -158.71 121.75 1.08 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.952 -0.642 . . . . 1.79 111.994 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.2 114.81 0.34 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.099 -0.8 . . . . 2.85 111.099 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -74.6 128.4 35.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.017 0.437 . . . . 6.7 110.632 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.682 -0.675 . . . . 7.01 110.157 -179.096 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.843 -0.503 . . . . 7.54 111.843 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 50.7 m 57.32 37.36 28.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.457 0.303 . . . . 6.58 110.639 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 64' ' ' GLU . 31.5 m 41.08 -147.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.301 1.04 . . . . 3.59 112.297 -177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -171.31 129.46 0.71 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.162 -0.31 . . . . 2.66 110.162 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.593 ' HE1' ' HE1' ' A' ' 63' ' ' PHE . 8.6 p90 -166.85 26.91 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.605 -0.27 . . . . 1.16 111.631 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.06 69.81 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.137 0.494 . . . . 0.64 110.632 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.535 ' HA ' ' HG3' ' A' ' 8' ' ' ARG . 7.5 p90 -70.63 -28.0 64.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.886 -0.597 . . . . 1.65 109.944 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -65.88 -42.91 89.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.218 -0.446 . . . . 2.09 110.41 175.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.796 ' HB3' HD12 ' A' ' 74' ' ' LEU . 38.8 mt -62.88 -47.96 81.09 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.421 -0.354 . . . . 1.45 110.974 178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.535 ' HG3' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -67.23 -33.3 75.05 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 120.637 -0.425 . . . . 3.56 110.531 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 90' ' ' GLU . 25.3 ttmm -66.69 -47.33 72.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.92 -0.582 . . . . 2.75 110.277 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -40.08 90.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.89 -0.595 . . . . 0.47 110.633 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -64.5 -41.53 96.38 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.887 -0.597 . . . . 2.44 111.272 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -78.65 -50.17 11.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.238 0.458 . . . . 1.43 112.238 -174.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.567 HG21 ' HG2' ' A' ' 90' ' ' GLU . 6.9 t -90.34 -33.86 15.92 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.945 0.35 . . . . 1.96 111.945 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -95.8 -137.88 9.45 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.54 -0.838 . . . . 0.64 112.932 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -146.45 114.63 6.62 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.722 -0.473 . . . . 3.52 109.722 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD12 HG22 ' A' ' 85' ' ' VAL . 41.9 mm -124.08 122.91 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.326 -0.397 . . . . 0.99 110.506 -177.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.8 t -98.9 110.14 25.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.979 -0.378 . . . . 1.04 109.979 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.8 ptp -92.16 138.47 31.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.855 0.359 . . . . 2.03 111.102 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.98 131.67 2.02 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.023 -0.608 . . . . 1.71 111.939 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -66.66 -49.54 65.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.937 0.399 . . . . 0.76 110.608 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.6 -37.23 79.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.838 -0.619 . . . . 4.68 110.683 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -62.17 -43.06 99.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 1.91 110.742 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -63.91 -39.54 94.4 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 1.14 110.396 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 48' ' ' ASP . 80.3 mt -60.02 -44.8 95.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.878 0.37 . . . . 0.66 110.537 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -62.59 -46.22 89.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 2.19 111.005 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -64.84 -40.44 95.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.66 111.363 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.43 -41.47 89.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.55 110.82 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 52' ' ' TYR . 40.3 ttmt -60.34 -49.58 77.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.474 -0.785 . . . . 2.06 110.729 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 45.4 tpp -72.1 -39.15 69.11 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.893 -0.594 . . . . 3.09 111.074 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 93.29 61.08 1.14 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.573 -0.822 . . . . 1.43 111.54 -176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -141.52 58.8 0.56 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.605 -0.807 . . . . 1.67 112.402 -176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -159.63 137.68 10.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.6 0.238 . . . . 0.55 110.537 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -71.61 -47.39 55.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.673 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 94' ' ' LEU . 46.2 tp -142.08 144.2 33.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.868 -0.606 . . . . 1.06 109.648 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 57.6 mt -122.27 129.5 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.588 -0.445 . . . . 0.31 110.421 177.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.6 mt -117.28 126.07 74.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.332 -0.395 . . . . 0.4 109.941 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG12 ' HB1' ' A' ' 82' ' ' ALA . 24.0 m -129.66 138.99 52.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.245 -0.434 . . . . 0.34 110.191 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.85 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -65.54 128.1 34.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.35 -0.611 . . . . 0.33 109.35 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 62' ' ' GLU . 15.1 ptm180 -65.5 -28.76 69.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.913 0.387 . . . . 4.14 110.362 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.92 18.73 6.27 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.152 -0.476 . . . . 2.33 111.024 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.46 166.7 22.75 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.265 -0.272 . . . . 0.47 110.378 177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 81.1 mmt-85 -56.38 132.22 76.31 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.475 -0.329 . . . . 3.98 111.024 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.61 -38.39 94.23 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.311 2.674 . . . . 0.86 112.427 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -55.93 -44.96 78.83 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.139 0.495 . . . . 2.48 110.756 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.88 -50.26 71.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.549 -0.751 . . . . 0.62 111.002 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -61.44 -40.63 95.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.877 -0.601 . . . . 1.59 111.644 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.84 -43.65 94.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.469 -0.332 . . . . 2.6 111.267 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -70.19 -52.3 24.37 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 121.064 -0.254 . . . . 1.21 111.087 178.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 HG12 ' A' ' 24' ' ' ILE . 73.2 mt -56.8 -56.78 12.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 112.518 0.562 . . . . 0.36 112.518 -174.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.39 -39.62 87.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.721 0.267 . . . . 1.67 111.721 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.552 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 25.2 t80 -67.27 -51.38 53.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.425 -0.352 . . . . 1.03 110.857 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.528 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 15.4 m-30 -63.83 -46.53 84.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.909 -0.587 . . . . 1.09 110.926 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -62.97 -40.45 97.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.999 -0.546 . . . . 0.42 111.275 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 54' ' ' ARG . 2.8 tpm_? -60.4 -42.77 96.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.871 0.367 . . . . 4.04 110.413 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 72.5 mt -66.49 -46.39 76.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.023 -0.535 . . . . 1.37 110.735 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -68.1 -21.07 64.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.899 -0.591 . . . . 1.28 111.8 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.31 37.71 6.99 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.102 -0.571 . . . . 0.48 112.222 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 HD11 ' HA2' ' A' ' 30' ' ' GLY . 50.9 mt -112.9 124.44 31.68 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.917 -0.401 . . . . 0.36 109.917 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.47 129.83 16.37 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.483 2.122 . . . . 0.46 111.763 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 64.5 t -111.92 127.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.3 -0.409 . . . . 0.5 110.262 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -105.92 131.07 53.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.379 -0.373 . . . . 0.83 110.736 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 8.7 mp0 -82.94 124.62 30.54 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.69 -0.686 . . . . 2.47 109.883 177.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.85 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 59.7 t80 -67.64 138.08 56.1 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.862 -0.608 . . . . 0.67 111.257 -175.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' HG3' HG22 ' A' ' 1' ' ' VAL . 44.8 mm-40 -75.68 48.65 0.47 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.883 -0.598 . . . . 2.46 111.738 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 172.56 -140.98 5.98 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.602 -0.808 . . . . 0.82 112.782 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 p -113.82 175.3 5.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.742 0.306 . . . . 1.53 111.082 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 m -63.64 -39.43 94.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 1.25 110.457 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 79' ' ' THR . 23.3 t -61.54 -47.35 93.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 116.0 -0.546 . . . . 0.97 110.364 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 73' ' ' LEU . 81.8 tt0 -62.31 -44.15 97.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.392 -0.822 . . . . 2.65 110.605 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 83' ' ' LEU . 24.1 tp -60.46 -47.79 84.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.593 -0.276 . . . . 0.56 111.058 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -59.84 -53.12 48.54 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.71 -0.757 . . . . 0.84 113.02 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 t -64.9 -33.68 76.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 1.46 111.039 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 8.7 tp -70.44 -43.17 70.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.316 -0.402 . . . . 1.51 110.28 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.796 HD12 ' HB3' ' A' ' 7' ' ' LEU . 19.5 tp -58.98 -50.17 75.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.575 -0.739 . . . . 1.79 110.899 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.14 -47.16 0.67 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.734 -0.746 . . . . 2.22 112.146 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.633 ' HD3' ' HD2' ' A' ' 77' ' ' PRO . 24.6 tpp180 -76.42 128.08 83.16 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.956 -0.387 . . . . 4.36 109.956 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.633 ' HD2' ' HD3' ' A' ' 76' ' ' ARG . 55.9 Cg_endo -73.37 41.33 0.58 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.759 2.306 . . . . 1.91 112.888 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.52 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 27.7 m170 -104.36 145.32 30.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.062 -0.718 . . . . 3.13 109.062 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 68' ' ' VAL . 3.5 p -78.11 64.63 3.32 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.036 0.446 . . . . 1.25 110.65 176.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.464 HG12 ' HA2' ' A' ' 71' ' ' GLY . 10.9 p -70.4 126.55 30.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.628 -0.715 . . . . 1.24 111.798 -173.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.1 m -87.31 -28.63 22.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.677 -0.692 . . . . 1.18 110.822 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' HB1' HG12 ' A' ' 37' ' ' VAL . . . -156.33 143.79 19.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.143 -0.481 . . . . 0.34 110.731 -175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 70' ' ' LEU . 2.6 pp -141.71 133.85 27.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.166 0.508 . . . . 0.88 110.563 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.82 118.66 32.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.51 -0.768 . . . . 0.35 110.618 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG22 HD12 ' A' ' 16' ' ' ILE . 54.5 t -85.84 97.74 6.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.629 -0.714 . . . . 1.05 109.971 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.6 t -79.42 -42.66 23.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.411 0.625 . . . . 0.54 109.635 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -136.47 114.15 10.38 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.226 -0.897 . . . . 2.15 109.543 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.543 ' HB3' HD13 ' A' ' 94' ' ' LEU . 49.2 Cg_endo -71.81 -26.42 19.11 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.947 2.431 . . . . 1.68 112.33 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.479 ' HA3' HG23 ' A' ' 13' ' ' THR . . . 73.24 -136.63 22.69 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.839 -0.696 . . . . 1.49 111.732 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 9' ' ' LYS . 10.9 pt-20 -83.47 -15.91 47.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.046 0.451 . . . . 3.03 110.852 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.63 145.03 53.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.32 -0.855 . . . . 1.65 112.833 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 15.2 mmp_? -87.73 36.09 0.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.543 -0.753 . . . . 4.45 110.51 173.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 11.1 tp -70.65 -29.94 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.05 0.452 . . . . 0.97 111.198 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.644 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.2 mp -69.0 -11.55 60.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 1.63 112.234 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -28.03 68.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.033 0.444 . . . . 0.86 110.915 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 82.9 mt -66.72 -29.05 68.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.73 -0.668 . . . . 1.57 111.847 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -147.17 56.93 0.5 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.926 -0.654 . . . . 1.79 111.746 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 172.09 141.45 3.41 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.154 -0.546 . . . . 2.85 111.736 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.82 139.87 15.41 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.138 -0.319 . . . . 6.7 110.138 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.757 -0.639 . . . . 7.01 109.963 -179.171 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.216 -0.354 . . . . 7.54 112.216 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 1.5 p -75.38 134.24 41.0 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.597 0.237 . . . . 6.58 110.833 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.428 HG21 ' OH ' ' A' ' 61' ' ' TYR . 15.7 m -135.2 155.0 36.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.934 0.397 . . . . 3.59 111.635 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -149.88 -44.61 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.946 -0.57 . . . . 2.66 110.657 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.645 ' HD2' HD11 ' A' ' 96' ' ' LEU . 1.6 p90 45.78 31.25 0.98 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.062 1.345 . . . . 1.16 114.1 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.05 -48.54 78.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.057 0.456 . . . . 0.64 110.403 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -61.94 -48.72 79.12 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.512 -0.767 . . . . 1.65 110.473 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' CG ' ' HG3' ' A' ' 92' ' ' ARG . 12.7 mp0 -56.29 -50.55 71.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 2.09 111.775 -178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.09 -45.55 84.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.605 0.241 . . . . 1.45 111.097 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.6 mtm180 -63.14 -43.33 98.66 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.778 -0.369 . . . . 3.56 110.777 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.31 -37.18 86.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.299 -0.41 . . . . 2.75 110.496 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.48 -40.81 98.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.123 -0.49 . . . . 0.47 110.669 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -65.94 -40.39 91.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.223 -0.444 . . . . 2.44 109.989 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -62.87 -50.1 72.24 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 1.43 111.484 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p -80.55 -51.98 8.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.052 -0.522 . . . . 1.96 111.725 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.59 -120.2 4.63 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.92 -0.582 . . . . 0.64 112.12 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -161.19 132.45 5.46 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.773 0.32 . . . . 3.52 110.495 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD12 HG22 ' A' ' 85' ' ' VAL . 45.5 mm -113.8 125.17 71.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.799 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 57.2 t -89.38 108.41 19.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 110.056 -0.35 . . . . 1.04 110.056 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 51.4 mtm -93.09 132.57 37.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.238 -0.437 . . . . 2.03 110.825 -177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 155.17 -127.36 2.05 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.508 -0.854 . . . . 1.71 112.564 178.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -165.09 -59.71 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.332 -0.247 . . . . 0.76 110.332 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.9 -36.85 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.554 -0.294 . . . . 4.68 110.858 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -66.29 -30.82 71.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.768 0.318 . . . . 1.91 110.602 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -67.09 -37.71 84.43 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.563 -0.532 . . . . 1.14 109.563 174.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 20' ' ' ALA . 57.9 mt -65.02 -41.75 92.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 121.066 0.46 . . . . 0.66 110.079 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -60.06 -48.48 81.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 2.19 110.594 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -64.86 -33.01 74.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.66 111.024 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.67 98.46 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 123.267 0.354 . . . . 0.55 110.456 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -63.71 -45.55 89.48 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.112 0.482 . . . . 2.06 110.41 175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 88.6 mtp -65.48 -39.39 91.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.591 -0.731 . . . . 3.09 111.401 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.866 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 76.71 28.64 58.86 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.322 -0.711 . . . . 1.43 111.322 -173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.59 -39.09 9.1 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.017 -0.611 . . . . 1.67 112.485 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 86' ' ' VAL . . . -72.58 135.37 45.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.805 0.336 . . . . 0.55 110.953 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 59' ' ' PRO . 26.8 mtpp -75.81 -34.11 60.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.084 -0.507 . . . . 1.85 110.881 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.681 HD22 ' HA ' ' A' ' 94' ' ' LEU . 15.2 tp -139.45 148.85 43.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.341 -0.39 . . . . 1.06 110.351 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . 71.4 mt -134.41 133.27 55.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 110.028 -0.36 . . . . 0.31 110.028 175.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 61' ' ' TYR . 67.7 mt -119.93 132.58 69.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.205 -0.295 . . . . 0.4 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.6 m -121.11 134.43 64.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.404 -0.362 . . . . 0.34 110.983 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.636 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -69.41 140.78 54.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.484 . . . . 0.33 110.353 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.5 ptt85 -62.42 -35.47 79.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.87 0.367 . . . . 4.14 111.075 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.78 40.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.195 0.521 . . . . 2.33 110.558 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HB3' ' HD2' ' A' ' 46' ' ' LYS . . . -104.28 152.23 22.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.552 -0.536 . . . . 0.47 109.552 175.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -56.36 134.21 76.16 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 123.309 0.381 . . . . 3.98 111.408 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -56.13 -35.87 95.66 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 123.113 2.542 . . . . 0.86 111.692 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.23 -45.96 75.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.6 -0.727 . . . . 2.48 110.964 177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.7 mm -72.82 -51.35 27.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.62 111.308 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HD2' ' HB3' ' A' ' 41' ' ' ALA . 10.1 mtpm? -60.59 -47.25 87.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 1.59 112.293 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -59.41 -43.56 93.0 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.571 0.212 . . . . 2.6 111.571 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.61 -50.35 72.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.591 0.234 . . . . 1.21 111.23 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 35' ' ' ILE . 71.5 mt -58.98 -51.71 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.455 -0.338 . . . . 0.36 111.534 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.646 ' HG2' HG11 ' A' ' 60' ' ' VAL . 46.6 mt-10 -62.93 -41.74 99.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.187 -0.46 . . . . 1.67 111.399 -177.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.56 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 32.0 t80 -63.53 -49.51 73.23 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.992 0.425 . . . . 1.03 111.06 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -63.52 -42.37 98.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.78 -0.645 . . . . 1.09 110.803 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.31 -39.11 93.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.647 -0.706 . . . . 0.42 111.491 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 50' ' ' GLU . 4.8 mmp_? -62.81 -41.36 99.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.701 -0.227 . . . . 4.04 110.87 178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.0 mt -61.26 -43.16 99.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.195 0.522 . . . . 1.37 110.143 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 t -83.41 -140.08 0.06 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.605 -0.725 . . . . 1.28 109.675 175.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -132.42 45.26 1.14 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.001 -0.619 . . . . 0.48 111.707 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.866 HD11 ' HA2' ' A' ' 30' ' ' GLY . 36.3 mt -108.33 120.75 45.64 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.814 0.34 . . . . 0.36 110.97 -177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.549 ' HG3' ' HG2' ' A' ' 100' ' ' GLU . 2.7 Cg_exo -74.42 122.02 7.18 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.813 2.342 . . . . 0.46 111.538 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 ' HG2' ' A' ' 50' ' ' GLU . 88.1 t -102.75 119.14 50.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.5 109.911 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.634 ' HB3' HG12 ' A' ' 36' ' ' ILE . 25.7 t80 -95.28 125.88 40.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.027 -0.533 . . . . 0.83 110.474 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -80.53 111.19 16.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.401 -0.592 . . . . 2.47 109.401 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.636 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.1 t80 -67.25 126.15 28.31 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.057 -0.519 . . . . 0.67 110.66 -176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -68.59 -28.33 66.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.684 -0.689 . . . . 2.46 109.318 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.22 167.82 49.72 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.115 -0.948 . . . . 0.82 112.194 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 69' ' ' GLU . 9.7 t -90.43 171.97 9.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.748 0.309 . . . . 1.53 110.439 178.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -62.75 -34.08 76.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.134 -0.484 . . . . 1.25 111.088 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 79' ' ' THR . 13.6 t -60.55 -50.52 80.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.997 0.427 . . . . 0.97 110.201 178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 66' ' ' THR . 45.3 mt-10 -61.34 -44.66 96.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.443 -0.799 . . . . 2.65 110.822 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.502 HD11 HD21 ' A' ' 83' ' ' LEU . 24.6 tp -59.82 -41.87 92.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.962 -0.563 . . . . 0.56 110.386 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -62.6 -45.6 95.49 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.103 -0.57 . . . . 0.84 112.257 177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -61.11 -40.31 93.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.004 0.431 . . . . 1.46 110.756 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.59 -44.38 97.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.856 -0.611 . . . . 1.51 110.675 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.663 HD12 HG11 ' A' ' 80' ' ' VAL . 96.5 mt -68.21 -47.73 67.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 1.79 110.892 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -41.08 1.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.632 -0.794 . . . . 2.22 112.229 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -68.79 130.91 91.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 4.36 111.08 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.68 45.26 1.72 Allowed 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.994 2.463 . . . . 1.91 111.98 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -137.24 143.23 42.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.513 -0.767 . . . . 3.13 109.782 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.494 HG22 HG22 ' A' ' 68' ' ' VAL . 24.8 p -67.79 89.12 0.26 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.952 -0.567 . . . . 1.25 111.521 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.663 HG11 HD12 ' A' ' 74' ' ' LEU . 7.4 p -70.9 133.56 31.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.384 -0.371 . . . . 1.24 110.397 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 m -77.84 -45.11 25.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.036 -0.529 . . . . 1.18 111.609 -174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.73 166.5 33.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.34 111.488 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD21 HD11 ' A' ' 70' ' ' LEU . 4.1 pp -147.04 138.92 24.37 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.82 -0.627 . . . . 0.88 110.295 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . . . -106.09 119.73 39.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.851 -0.613 . . . . 0.35 110.773 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.568 HG22 HD12 ' A' ' 16' ' ' ILE . 47.2 t -86.84 105.69 15.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.939 -0.573 . . . . 1.05 109.835 176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 22.0 t -80.1 -52.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.011 0.434 . . . . 0.54 110.13 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -126.85 119.91 22.67 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.797 -0.638 . . . . 2.15 109.801 178.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.13 -32.68 4.01 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.791 2.327 . . . . 1.68 112.696 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.2 -136.38 25.12 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.891 -0.671 . . . . 1.49 111.534 -175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.28 -33.3 59.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 3.03 110.546 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.2 130.78 43.49 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.479 -1.237 . . . . 1.65 112.475 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.469 ' HG3' ' CG ' ' A' ' 6' ' ' GLU . 26.9 ptt180 -77.79 45.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.435 -0.802 . . . . 4.45 110.345 175.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.427 HD13 ' O ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -73.43 -36.43 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.874 -0.603 . . . . 0.97 111.133 -174.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HA ' HD22 ' A' ' 34' ' ' LEU . 4.3 pp -83.29 -15.53 49.81 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.709 -0.396 . . . . 1.63 111.041 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.38 -51.89 63.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.083 -0.508 . . . . 0.86 111.575 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 96' ' ' LEU . 2.6 pt? -87.33 -10.17 52.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.492 -0.322 . . . . 1.57 110.792 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.2 -44.38 29.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.782 -0.723 . . . . 1.79 111.958 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 177.76 -150.02 9.68 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.344 -0.703 . . . . 2.85 111.344 177.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -173.6 117.71 0.27 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.009 0.433 . . . . 6.7 110.83 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.549 ' HG2' ' HG3' ' A' ' 59' ' ' PRO . 66.8 mm-40 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.471 -0.776 . . . . 7.01 110.005 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.779 -0.528 . . . . 7.54 111.779 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 23.1 t -65.77 131.26 45.87 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.953 -0.388 . . . . 6.58 109.953 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 22.1 m -65.52 133.41 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.987 0.423 . . . . 3.59 111.095 -177.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 10.6 t70 -123.57 -72.86 0.66 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.995 -0.548 . . . . 2.66 110.958 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.538 ' HE1' HD13 ' A' ' 36' ' ' ILE . 81.4 t80 161.93 -52.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.646 0.778 . . . . 1.16 110.092 175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.91 -50.51 71.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.274 -0.876 . . . . 0.64 112.093 -171.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -66.34 -42.85 87.55 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.102 0.477 . . . . 1.65 110.257 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 57.9 mp0 -58.33 -45.54 87.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 2.09 110.665 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.536 HD11 HD11 ' A' ' 83' ' ' LEU . 23.1 tp -67.17 -41.55 85.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.223 -0.444 . . . . 1.45 110.764 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 4' ' ' ALA . 24.4 mmm180 -59.48 -43.85 93.18 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.077 0.465 . . . . 3.56 110.707 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -69.58 -42.47 74.43 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 2.75 110.906 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.03 78.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.423 -0.353 . . . . 0.47 111.567 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.579 HE21 HD12 ' A' ' 16' ' ' ILE . 68.6 mm-40 -60.35 -37.17 79.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.117 -0.492 . . . . 2.44 111.235 177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -83.46 -48.11 10.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.159 -0.473 . . . . 1.43 111.419 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.3 p -67.41 -44.96 77.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 1.96 111.694 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -118.89 -140.66 6.35 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.431 -0.89 . . . . 0.64 112.067 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -147.54 133.68 19.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.365 -0.606 . . . . 3.52 109.365 177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.954 HG12 HG23 ' A' ' 85' ' ' VAL . 24.8 mt -122.66 125.12 72.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.142 -0.481 . . . . 0.99 110.345 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.92 97.58 4.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 1.04 111.2 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.44 135.68 33.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.909 -0.587 . . . . 2.03 109.759 177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.67 -21.63 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.515 -1.326 . . . . 1.71 113.607 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.896 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . . . 71.06 -60.61 0.51 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.226 0.61 . . . . 0.76 111.471 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -69.19 -32.27 71.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 4.68 110.264 175.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -66.29 -36.2 82.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.838 -0.619 . . . . 1.91 110.2 173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 m -63.93 -35.22 79.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.582 -0.736 . . . . 1.14 110.353 177.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.587 HG22 ' HE3' ' A' ' 28' ' ' LYS . 76.8 mt -61.97 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.082 -0.508 . . . . 0.66 110.62 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -58.72 -42.98 89.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.88 -0.6 . . . . 2.19 110.148 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.704 ' HA ' ' HA3' ' A' ' 30' ' ' GLY . 6.2 m-85 -67.89 -34.83 77.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.928 -0.578 . . . . 0.66 111.27 176.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -62.22 -36.01 80.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.649 0.261 . . . . 0.55 110.805 178.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 24' ' ' ILE . 96.5 mttt -65.28 -54.3 31.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.096 -0.502 . . . . 2.06 111.59 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.19 40.99 0.07 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.757 0.789 . . . . 3.09 110.471 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.704 ' HA3' ' HA ' ' A' ' 26' ' ' TYR . . . -81.44 -34.82 24.71 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.993 -1.003 . . . . 1.43 113.12 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.99 35.31 50.36 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 111.195 -0.762 . . . . 1.67 111.195 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' A' ' 58' ' ' ILE . . . -70.64 143.41 51.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.316 . . . . 0.55 110.299 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.637 ' HG3' HD21 ' A' ' 94' ' ' LEU . 48.3 tptt -74.95 -53.77 8.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.101 -0.499 . . . . 1.85 110.228 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 HD22 ' HA ' ' A' ' 94' ' ' LEU . 49.0 tp -142.75 125.52 16.0 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.195 -0.602 . . . . 1.06 111.167 176.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 84' ' ' ALA . 70.0 mt -100.73 121.87 52.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.957 -0.386 . . . . 0.31 109.957 174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.538 HD13 ' HE1' ' A' ' 3' ' ' PHE . 66.8 mt -105.72 130.73 56.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 109.893 -0.41 . . . . 0.4 109.893 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG12 ' CB ' ' A' ' 82' ' ' ALA . 27.0 m -127.5 134.15 66.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.705 0.288 . . . . 0.34 110.468 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.943 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -70.91 138.3 50.01 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.627 -0.26 . . . . 0.33 110.491 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 40' ' ' ASN . 10.1 ptt-85 -63.85 -35.97 82.39 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.739 -0.384 . . . . 4.14 110.181 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 57.0 m-80 -86.23 47.21 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.365 0.602 . . . . 2.33 111.103 176.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.71 161.67 18.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.407 -0.815 . . . . 0.47 109.091 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 99.2 mtt180 -53.65 132.09 55.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 O-C-N 123.377 0.423 . . . . 3.98 110.853 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 42' ' ' ARG . 34.6 Cg_exo -57.12 -38.29 95.93 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.794 2.329 . . . . 0.86 111.523 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.41 -44.43 76.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.719 . . . . 2.48 110.764 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -66.84 -44.55 88.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.62 110.304 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -60.57 -53.66 54.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.845 -0.616 . . . . 1.59 112.018 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -58.98 -44.74 91.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.867 0.365 . . . . 2.6 111.111 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.14 -49.24 65.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.086 -0.507 . . . . 1.21 111.217 -175.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.9 mt -62.49 -52.63 57.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.334 -0.393 . . . . 0.36 111.611 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.451 ' HA ' HG21 ' A' ' 60' ' ' VAL . 48.1 mt-10 -61.37 -48.89 79.18 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.732 0.271 . . . . 1.67 111.732 -176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 23.5 t80 -59.05 -49.28 78.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.605 0.241 . . . . 1.03 110.945 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -67.2 -42.64 83.82 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.93 0.345 . . . . 1.09 111.93 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.61 -39.97 95.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.79 -0.186 . . . . 0.42 111.066 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.596 ' HA ' ' NE ' ' A' ' 54' ' ' ARG . 4.7 mmp_? -62.78 -39.41 94.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.391 -0.368 . . . . 4.04 111.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 60.5 mt -62.89 -46.84 85.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.157 0.504 . . . . 1.37 110.23 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.3 m -68.87 -54.9 13.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.388 -0.824 . . . . 1.28 111.339 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.69 -18.47 2.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.929 -0.653 . . . . 0.48 111.845 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 32' ' ' ALA . 53.1 mt -62.23 129.76 92.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 122.55 0.34 . . . . 0.36 111.449 -177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.3 Cg_exo -78.25 142.13 18.82 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 123.328 2.686 . . . . 0.46 112.043 178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 50' ' ' GLU . 48.0 t -114.54 124.48 71.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.907 0.384 . . . . 0.5 110.802 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' HB3' HG12 ' A' ' 36' ' ' ILE . 65.6 t80 -98.9 132.11 44.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.436 . . . . 0.83 110.639 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.03 119.67 24.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.039 -0.528 . . . . 2.47 110.066 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.943 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 17.2 t80 -86.4 120.17 27.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.279 0.562 . . . . 0.67 110.74 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -77.94 62.43 2.74 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.101 -0.954 . . . . 2.46 111.332 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.1 -149.57 6.74 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.458 -0.877 . . . . 0.82 113.237 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.0 p -123.28 163.49 20.61 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.362 0.265 . . . . 1.53 111.24 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -42.7 89.47 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.152 -0.477 . . . . 1.25 111.543 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 79' ' ' THR . 73.9 t -64.77 -44.44 96.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.683 0.278 . . . . 0.97 110.809 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -60.33 -45.49 93.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.106 0.479 . . . . 2.65 110.389 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 83' ' ' LEU . 46.7 tp -62.64 -48.83 77.64 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.499 -0.773 . . . . 0.56 110.989 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 78' ' ' HIS . . . -60.47 -44.35 97.78 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.061 -0.59 . . . . 0.84 112.423 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -62.01 -37.72 85.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.981 0.419 . . . . 1.46 110.632 178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 4' ' ' ALA . 40.5 tp -63.77 -38.53 91.44 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.04 -0.527 . . . . 1.51 110.385 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 80' ' ' VAL . 75.1 mt -62.39 -36.56 82.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.114 -0.494 . . . . 1.79 111.2 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 147.05 -57.77 0.49 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.231 -0.985 . . . . 2.22 112.893 175.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.9 mmt-85 -76.18 155.95 84.06 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 110.088 -0.338 . . . . 4.36 110.088 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.2 10.86 1.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 121.888 1.725 . . . . 1.91 111.363 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.419 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 55.8 m170 -69.75 135.8 50.17 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.736 -0.665 . . . . 3.13 110.09 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.576 HG22 HG22 ' A' ' 68' ' ' VAL . 41.8 p -73.43 125.08 27.07 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.271 -0.422 . . . . 1.25 110.849 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.601 HG21 HD12 ' A' ' 74' ' ' LEU . 85.0 t -125.34 119.48 55.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.756 0.312 . . . . 1.24 110.29 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 34.2 m -95.48 -29.59 14.31 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.986 -0.552 . . . . 1.18 110.851 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.896 ' HB3' ' HA ' ' A' ' 20' ' ' ALA . . . -152.69 141.7 21.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.011 -0.541 . . . . 0.34 111.14 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 70' ' ' LEU . 2.5 pt? -145.71 134.97 22.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.706 -0.679 . . . . 0.88 110.11 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 35' ' ' ILE . . . -110.7 118.0 34.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.228 -0.442 . . . . 0.35 111.218 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.954 HG23 HG12 ' A' ' 16' ' ' ILE . 4.2 p -82.32 129.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.985 -0.376 . . . . 1.05 109.985 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.5 t -91.06 -41.65 13.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.008 -0.542 . . . . 0.54 109.823 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.491 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 39.0 t70 -146.57 113.96 4.39 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.648 -0.706 . . . . 2.15 110.016 176.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.481 ' HG3' HD13 ' A' ' 94' ' ' LEU . 58.3 Cg_endo -74.35 -35.52 3.79 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.729 2.286 . . . . 1.68 112.208 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.35 -138.9 22.48 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.402 -0.679 . . . . 1.49 111.402 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -69.15 -28.96 66.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.883 0.342 . . . . 3.03 110.889 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.1 m -61.62 121.39 12.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 1.65 110.927 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 76.7 mtt85 -91.05 62.71 4.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.861 -0.609 . . . . 4.45 111.644 -176.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.616 HG23 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -73.02 -33.11 41.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.97 110.389 176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD21 ' HG3' ' A' ' 33' ' ' LYS . 6.7 mp -69.57 -16.27 63.38 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.387 -0.369 . . . . 1.63 111.86 177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 92' ' ' ARG . . . -57.93 -31.78 67.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.945 0.402 . . . . 0.86 110.868 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.514 HD11 ' HA ' ' A' ' 3' ' ' PHE . 75.5 mt -66.93 -31.66 72.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.846 -0.615 . . . . 1.57 110.991 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -99.21 57.77 0.88 Allowed Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.928 -0.869 . . . . 1.79 110.928 173.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.46 -57.19 20.6 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.442 -0.409 . . . . 2.85 113.452 -171.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -175.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.699 0.285 . . . . 6.7 110.553 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.085 -0.96 . . . . 7.01 109.463 -176.816 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.169 -0.372 . . . . 7.54 112.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 p -85.58 118.93 25.4 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.716 -0.285 . . . . 6.58 110.275 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.45 ' HB ' HD23 ' A' ' 96' ' ' LEU . 9.2 m 35.01 55.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 O-C-N 124.02 0.825 . . . . 3.59 112.485 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -79.09 142.45 36.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.596 -0.729 . . . . 2.66 111.188 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.526 ' CD2' HD22 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -149.6 35.43 0.7 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.773 -0.648 . . . . 1.16 110.098 176.015 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' HD21 ' A' ' 73' ' ' LEU . . . -61.3 -50.58 72.4 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.562 -0.745 . . . . 0.64 111.39 -177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' HA ' ' HG2' ' A' ' 8' ' ' ARG . 39.6 t80 -66.95 -38.87 86.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.728 -0.669 . . . . 1.65 110.123 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 3' ' ' PHE . 18.8 mt-10 -63.16 -41.65 99.28 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.669 -0.696 . . . . 2.09 111.164 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 7' ' ' LEU . 12.8 mt -68.38 -47.9 66.15 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 111.72 0.267 . . . . 1.45 111.72 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 5' ' ' PHE . 1.5 ptm85 -63.09 -36.24 82.94 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.457 -0.497 . . . . 3.56 110.723 -177.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HD2' ' HA ' ' A' ' 9' ' ' LYS . 23.9 tptp -73.84 -35.53 64.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.433 -0.349 . . . . 2.75 110.528 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.18 94.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.393 -0.367 . . . . 0.47 110.886 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -61.41 -35.12 76.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.303 -0.408 . . . . 2.44 110.918 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.6 -49.96 16.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.98 -0.554 . . . . 1.43 111.763 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.8 m -78.88 -56.6 4.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.865 0.364 . . . . 1.96 111.81 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 87' ' ' ASP . . . -92.95 -128.41 4.76 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.826 -0.702 . . . . 0.64 111.744 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -168.99 133.22 1.45 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.901 0.381 . . . . 3.52 110.471 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 85' ' ' VAL . 4.0 mp -126.29 128.73 71.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.746 -0.661 . . . . 0.99 109.885 -178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.85 HG12 ' HB3' ' A' ' 84' ' ' ALA . 5.8 p -81.3 130.69 35.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.316 -0.624 . . . . 1.04 109.316 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.565 ' HB3' HD23 ' A' ' 74' ' ' LEU . 12.7 ptt? -116.78 129.24 55.98 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.098 0.475 . . . . 2.03 111.3 -175.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.34 -121.18 1.01 Allowed Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.71 111.336 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.508 ' O ' HG13 ' A' ' 24' ' ' ILE . . . -159.99 -59.06 0.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.703 0.287 . . . . 0.76 110.51 176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 21' ' ' ARG . 3.0 mpt_? -68.41 -33.55 74.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.091 -0.504 . . . . 4.68 110.659 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 10.0 mmpt? -60.22 -43.34 96.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 1.91 110.057 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 t -65.33 -38.42 90.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 1.14 110.684 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 20' ' ' ALA . 69.1 mt -60.56 -47.03 94.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.425 -0.352 . . . . 0.66 110.318 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -61.55 -42.25 98.55 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.227 -0.442 . . . . 2.19 111.121 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.88 -37.55 82.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.66 110.943 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HA ' HD12 ' A' ' 58' ' ' ILE . . . -67.16 -42.28 84.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.55 110.752 176.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 24' ' ' ILE . 59.3 mtpt -64.78 -48.0 76.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.653 -0.703 . . . . 2.06 111.416 -178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -78.63 -17.05 56.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.856 0.36 . . . . 3.09 111.024 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.649 ' HA2' HD11 ' A' ' 58' ' ' ILE . . . 72.06 44.65 44.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.125 -0.56 . . . . 1.43 112.223 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -120.54 51.38 0.78 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.045 -0.597 . . . . 1.67 112.376 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -156.24 139.96 16.08 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.875 -0.417 . . . . 0.55 109.875 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -75.56 -50.71 14.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 1.85 110.764 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 97' ' ' GLY . 60.3 tp -141.58 136.31 30.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.149 -0.478 . . . . 1.06 110.527 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 49' ' ' ILE . 72.9 mt -113.94 135.77 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 121.083 -0.247 . . . . 0.31 110.533 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.3 mt -124.15 129.86 73.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 110.0 -0.37 . . . . 0.4 110.0 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' CB ' ' A' ' 82' ' ' ALA . 29.9 m -121.29 133.54 67.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.556 -0.293 . . . . 0.34 110.603 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HA ' ' HB3' ' A' ' 63' ' ' PHE . . . -72.55 132.35 43.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.862 -0.154 . . . . 0.33 110.61 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.2 -28.12 69.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.685 0.279 . . . . 4.14 110.798 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 43.3 t30 -69.47 -26.81 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.878 -0.601 . . . . 2.33 111.302 177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.97 156.54 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.47 111.858 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -56.35 134.27 76.13 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 115.531 -0.759 . . . . 3.98 110.878 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.8 -35.35 97.98 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.46 2.773 . . . . 0.86 112.667 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.94 -39.19 68.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.95 -0.568 . . . . 2.48 111.061 -178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.9 mm -71.46 -50.17 42.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.881 -0.599 . . . . 0.62 110.906 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 38' ' ' ALA . 50.1 mtmt -62.72 -46.69 86.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.095 -0.502 . . . . 1.59 112.125 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.62 -46.79 84.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.481 -0.327 . . . . 2.6 111.582 -176.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -44.67 96.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.401 -0.363 . . . . 1.21 111.174 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 35' ' ' ILE . 71.4 mt -60.02 -47.72 90.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.472 -0.331 . . . . 0.36 111.432 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' HB ' ' A' ' 60' ' ' VAL . 5.0 mm-40 -58.72 -38.34 78.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 1.67 111.302 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.575 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 38.3 t80 -64.75 -52.42 57.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.988 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -68.27 -42.67 79.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.819 -0.628 . . . . 1.09 111.514 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.417 ' HB1' ' HB ' ' A' ' 58' ' ' ILE . . . -64.88 -39.51 93.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 0.42 111.625 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -63.18 -39.87 95.87 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.641 -0.424 . . . . 4.04 110.418 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 73.2 mt -65.91 -45.61 81.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.811 -0.631 . . . . 1.37 111.062 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.7 p -71.52 -45.47 62.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.106 0.479 . . . . 1.28 110.887 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.6 36.33 0.69 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.033 -0.603 . . . . 0.48 112.168 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.649 HD11 ' HA2' ' A' ' 30' ' ' GLY . 54.4 mt -113.58 124.86 30.45 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.648 0.261 . . . . 0.36 110.466 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 58' ' ' ILE . 5.9 Cg_exo -72.71 135.96 24.73 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.796 2.331 . . . . 0.46 111.635 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 ' HB ' ' A' ' 35' ' ' ILE . 57.5 t -116.56 129.24 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.29 -0.414 . . . . 0.5 110.167 177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -103.86 130.13 51.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.144 -0.48 . . . . 0.83 110.435 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -79.0 110.38 14.19 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.317 -0.623 . . . . 2.47 109.317 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.724 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 23.6 t80 -73.62 111.61 8.93 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.376 -0.601 . . . . 0.67 109.376 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -75.4 56.36 0.85 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.225 0.536 . . . . 2.46 110.485 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.89 -177.96 34.46 Favored Glycine 0 N--CA 1.441 -0.984 0 CA-C-N 115.538 -0.755 . . . . 0.82 111.979 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.561 HG23 ' H ' ' A' ' 69' ' ' GLU . 2.9 t -89.04 148.37 23.77 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.286 0.565 . . . . 1.53 111.825 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' A' ' 40' ' ' ASN . 0.3 OUTLIER -63.43 -28.23 69.84 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.101 -0.954 . . . . 1.25 111.42 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 79' ' ' THR . 15.8 t -64.35 -52.51 54.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.259 0.552 . . . . 0.97 110.156 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' H ' HG23 ' A' ' 66' ' ' THR . 35.7 tt0 -64.02 -41.77 97.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.27 -0.877 . . . . 2.65 110.689 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 45.3 tp -59.85 -43.98 94.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.048 -0.524 . . . . 0.56 110.608 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.32 -52.89 43.42 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.856 -0.611 . . . . 0.84 112.975 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.4 t -63.97 -36.36 83.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.816 0.341 . . . . 1.46 110.665 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.778 HD21 ' HA ' ' A' ' 4' ' ' ALA . 58.3 tp -64.75 -46.42 82.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.04 -0.527 . . . . 1.51 111.16 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.571 HD13 HD22 ' A' ' 83' ' ' LEU . 13.8 tp -64.36 -43.47 94.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.133 0.492 . . . . 1.79 110.409 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.88 47.04 0.14 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.903 -0.665 . . . . 2.22 111.789 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' HD2' ' A' ' 77' ' ' PRO . 25.7 tpt180 -149.41 121.2 4.21 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 109.884 -0.413 . . . . 4.36 109.884 -175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' HD2' ' HD2' ' A' ' 76' ' ' ARG . 73.7 Cg_endo -76.73 41.92 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.779 2.319 . . . . 1.91 111.632 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -153.35 146.74 24.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.357 -0.838 . . . . 3.13 108.874 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.548 HG22 HG22 ' A' ' 68' ' ' VAL . 36.4 p -64.12 105.2 0.84 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.444 -0.344 . . . . 1.25 111.422 -176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.3 118.63 27.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.463 -0.569 . . . . 1.24 109.463 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' ALA . 23.2 m -80.22 -38.29 31.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 1.18 110.145 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -153.75 142.28 20.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.551 -0.75 . . . . 0.34 110.781 -177.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.571 HD22 HD13 ' A' ' 74' ' ' LEU . 4.0 pp -129.46 140.66 51.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.155 -0.475 . . . . 0.88 110.236 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.85 ' HB3' HG12 ' A' ' 17' ' ' VAL . . . -114.42 112.85 23.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.0 0.428 . . . . 0.35 110.835 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.825 ' HA ' HG13 ' A' ' 16' ' ' ILE . 24.3 t -78.08 106.94 9.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.479 -0.782 . . . . 1.05 109.556 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.4 t -76.16 -49.85 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.045 0.45 . . . . 0.54 109.933 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.572 ' O ' ' HA3' ' A' ' 14' ' ' GLY . 36.8 m-20 -129.72 122.55 20.66 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.794 . . . . 2.15 109.92 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.44 -38.74 3.23 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.964 2.442 . . . . 1.68 112.041 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.24 -130.09 26.53 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.867 -0.682 . . . . 1.49 112.069 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.41 -35.74 68.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.854 0.359 . . . . 3.03 111.149 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.3 m -59.82 133.07 55.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.849 -0.614 . . . . 1.65 112.054 -175.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -86.6 40.25 0.88 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 4.45 110.42 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.3 tp -61.57 -28.16 43.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.069 -0.514 . . . . 0.97 111.676 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.2 mt -62.87 -21.18 65.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.197 -0.456 . . . . 1.63 111.718 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.74 -39.53 81.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.704 0.288 . . . . 0.86 111.564 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 3' ' ' PHE . 5.0 mp -84.44 -30.25 25.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.192 0.52 . . . . 1.57 110.211 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -98.81 45.82 1.56 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.911 -0.661 . . . . 1.79 112.571 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 171.53 131.86 1.41 Allowed Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.562 -0.828 . . . . 2.85 112.393 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 57.9 56.73 4.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.132 0.491 . . . . 6.7 110.85 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.104 -0.95 . . . . 7.01 109.308 -179.195 . . . . . . . . 0 0 . 1 stop_ save_